advise	 Dose adjustment of <e1> Sensipar </e1> may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor (e.g. , ketoconazole , erythromycin , <e2> itraconazole </e2> ;	Sensipar	itraconazole
other	 <e1> Anticoagulant </e1> therapy should be monitored , particularly during the first few weeks , after initiating therapy with BEXTRA in patients receiving <e2> warfarin </e2> or similar agents .	Anticoagulant	warfarin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , <e1> phenylbutazone </e1> , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	phenylbutazone	temazepam
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1> fenoprofen </e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e2> sulindac </e2> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	fenoprofen	sulindac
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1> oxolinic acid </e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	oxolinic acid	trimethoprim
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , <e1> carbamazepine </e1> , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , <e2> rifampin </e2> , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	carbamazepine	rifampin
other	 Therefore , co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain <e1> antidepressants </e1> (e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , haloperidol , risperidone , thioridazine ) , beta-blockers (e.g. , metoprolol ) , and <e2> Type 1C antiarrhythmics </e2> (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	antidepressants	Type 1C antiarrhythmics
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; <e1> methyldopa </e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e2> oxyphenbutazone </e2> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	methyldopa	oxyphenbutazone
advise	 Other 5-HT1B/1D Agonists Concomitant use of other <e1> 5-HT1B/1D agonists </e1> within 24 hours of treatment with <e2> AXERT </e2> is contraindicated .	5-HT1B/1D agonists	AXERT
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , <e1> Felbatol </e1> ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , <e2> prednisolone </e2> ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Felbatol	prednisolone
other	 therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g . ketoconazole , <e1> ampicillin </e1> esters , <e2> iron </e2> salts , digoxin ) .	ampicillin	iron
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of EQUETROTM are the following : Cisplatin , <e1> doxorubicin HCL </e1> , felbamate , rifampin , phenobarbital , Phenytoin (2) , primidone , methsuximide , and theophylline Thus , if a patient has been titrated to a stable dosage on <e2> EQUETROTM </e2> , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for EQUETROTM may be necessary .	doxorubicin HCL	EQUETROTM
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and <e1> tetracycline </e1> , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , <e2> Crixivan </e2> , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	tetracycline	Crixivan
other	 In large , well controlled trials in patients with schizophrenia or related psychoses , <e1> olanzapine </e1> 5 to 20 mg/day was significantly superior to <e2> haloperidol </e2> 5 to 20 mg/day in overall improvements in psychopathology rating scales and in the treatment of depressive and negative symptoms , and was comparable in effects on positive psychotic symptoms .	olanzapine	haloperidol
other	 Central nervous system depressant (CNS) drugs including <e1> alcohol </e1> , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and <e2> tranquilizers </e2>	alcohol	tranquilizers
other	 Ketoconazole : Co-administration of 200 mg twice-daily <e1> ketoconazole </e1> with aliskiren resulted in an approximate 80% increase in plasma levels of <e2> aliskiren </e2> .	ketoconazole	aliskiren
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1> quinine </e1> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e2> sulfamethoxazole </e2> ;unreliable prothrombin time determinations; warfarin sodium overdosage .	quinine	sulfamethoxazole
other	 However , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg <e1> cerivastatin sodium </e1> approximately 4 hours after the same evening meal resulted in a decrease in the <e2> cerivastatin </e2> AUC of less than 8% , and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone .	cerivastatin sodium	cerivastatin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , <e1> dopamine </e1> and dopamine agonists , <e2> ethionamide </e2> , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	dopamine	ethionamide
other	 No interactions have been observed with beta-receptor blockers , <e1> calcium antagonists </e1> , DRUG0 and <e2> loop diuretics </e2> and ACE inhibitors .	calcium antagonists	loop diuretics
other	 <e1> Phenytoin </e1> / <e2> Phenobarbital </e2> : The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin D , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .	Phenytoin	Phenobarbital
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e1> quinine </e1> ; ranitidine *; <e2> salicylates </e2> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	quinine	salicylates
other	 Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ) : <e1> MAOI </e1> could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - <e2> Tricyclic antidepressants </e2> : Flupenthixol increases the effect of Tricyclic antidepressants	MAOI	Tricyclic antidepressants
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , <e1> Phenergan </e1> ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , <e2> Vesprin </e2> ] , trimeprazine [e.g. , Temaril ]) or	Phenergan	Vesprin
other	 Lithium : Increased serum lithium levels and symptoms of <e1> lithium </e1> toxicity have been reported in patients receiving <e2> ACE inhibitors </e2> during therapy with lithium .	lithium	ACE inhibitors
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , <e1> protease inhibitors </e1> , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , <e2> verapamil </e2> , zileuton .	protease inhibitors	verapamil
other	 Codeine in combination with other <e1> narcotic analgesics </e1> , general anesthetics , phenothiazines , tranquilizers , <e2> sedative-hypnotics </e2> , or other CNS depressants (including alcohol ) has additive depressant effects .	narcotic analgesics	sedative-hypnotics
other	 Avoid the use of preparations such as decongestants and local <e1> anesthetics </e1> which contain any sympathomimetic amine (e.g. , <e2> epinephrine </e2> , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .	anesthetics	epinephrine
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , <e1> clobazam </e1> , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , <e2> warfarin </e2> (5) , ziprasidone , and zonisamide .	clobazam	warfarin
other	 <e1> Antacids </e1> : Concomitant administration of antacids may reduce plasma levels of <e2> diflunisal </e2> .	Antacids	diflunisal
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute <e1> alcohol </e1> intake , amiodarone , chboramphenicol , chlordiazepoxide , <e2> cimetidine </e2> , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone	alcohol	cimetidine
other	 Magnesium - and/or <e1> aluminum </e1> -containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing <e2> zinc </e2> or other metal cations , or Videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE .	aluminum	zinc
other	 - <e1> Anabolic steroids </e1> ( nandrolone [e.g. , <e2> Anabolin </e2> ] , oxandrolone [e.g. , Anavar ] , oxymetholone [e.g. , Anadrol ] , stanozolol [e.g. , Winstrol ]) or	Anabolic steroids	Anabolin
other	 Certain <e1> antibiotics </e1> , especially <e2> neomycin </e2> , streptomycin and kanamycin , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .	antibiotics	neomycin
other	 <e1> Fluoxetine </e1> and moclobemide increased blood <e2> glucose </e2> at different times after the DRUG0 overload .	Fluoxetine	glucose
other	 Medications can interfere with folate utilization , including : anticonvulsant medications (such as phenytoin , and <e1> primidone </e1> ) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic ) Methotrexate There has been concern about the interaction between vitamin B12 and <e2> folic acid </e2> .	primidone	folic acid
other	 acetaminophen / theophylline , lidocaine / quinidine , phenobarbital / acetaminophen , <e1> phenobarbital </e1> / valproic acid , quinidine / <e2> lidocaine </e2> , theophylline / acetaminophen , and valproic acid / phenobarbital .	phenobarbital	lidocaine
other	 If chlorprothixene is given concomitantly with <e1> opioids </e1> , the opioid dose should be reduced (by approx . 50%) , because <e2> chlorprothixene </e2> amplifies the therapeutic actions and side-effects of opioids massively .	opioids	chlorprothixene
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1> oxyphenbutazone </e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	oxyphenbutazone	sulfonamides
other	 Other nephrotoxic medications : agents such as aminoglycosides , <e1> cyclosporine </e1> , and <e2> pentamidine </e2> may enhance the potential for drug-induced renal toxicity , and should be used concomitantly only with great caution .	cyclosporine	pentamidine
other	 Benzthiazide may interact with alcohol , blood thinner s , decongestant drugs (allergy , cold , and sinus medicines) , diabetic drugs , lithium , norepinephrine , <e1> NSAIDs </e1> like Aleve or <e2> Ibuprofen </e2> , and high blood pressure medications .	NSAIDs	Ibuprofen
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : <e1> alcohol </e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e2> indomethacin </e2> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	alcohol	indomethacin
other	 Example inhibitors include azole antifungals , ciprofloxacin , <e1> clarithromycin </e1> , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and <e2> verapamil </e2> .	clarithromycin	verapamil
other	 In monkeys , the effects of (-)-NANM , but not <e1> (+)-NANM </e1> or PCP , were antagonized by <e2> naloxone </e2> ;	(+)-NANM	naloxone
mechanism	 <e1> Lithium </e1> generally should not be given with <e2> diuretics </e2> because they reduce its renal clearance and add a high risk of lithium toxicity .	Lithium	diuretics
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , <e1> carbamazepine </e1> , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , <e2> nitroprusside </e2> , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	carbamazepine	nitroprusside
int	 <e1> Chlorotrianisene </e1> may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , <e2> cyclosporine </e2> , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .	Chlorotrianisene	cyclosporine
other	 However , in clinical studies the consequences of concomitant <e1> irbesartan </e1> on the pharmacodynamics of <e2> warfarin </e2> were negligible .	irbesartan	warfarin
other	 Before taking glimepiride , tell your doctor if you are taking any of the following medicines : - <e1> aspirin </e1> or another salicylate such as magnesium/choline salicylate ( <e2> Trilisate </e2> ) , salsalate ( Disalcid , others) , choline salicylate ( Arthropan ) , magnesium salicylate ( Magan ) , or bismuth subsalicylate ( Pepto-Bismol );	aspirin	Trilisate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1> glucagon </e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	glucagon	trimethoprim
other	 The concentrations of <e1> SN38 </e1> , the active metabolite of irinotecan , were on average 33% higher in patients receiving bolus-IFL in combination with <e2> AVASTIN </e2> when compared with bolus-IFL alone .	SN38	AVASTIN
other	 Drug-Drug Interactions <e1> Albuterol </e1> - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other <e2> beta2 agonists </e2> ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .	Albuterol	beta2 agonists
advise	 <e1> Azlocillin </e1> should not be administered concomitantly with amikacin , <e2> ciprofloxacin </e2> , gentamicin , netilmicin , or tobramycin .	Azlocillin	ciprofloxacin
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : <e1> adrenocortical steroids </e1> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral <e2> contraceptives </e2> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	adrenocortical steroids	contraceptives
other	 Antacids and sucralfate : <e1> Sucralfate </e1> and antacids containing magnesium or <e2> aluminum </e2> , as well as formulations containing divalent and trivalent cations such as Videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .	Sucralfate	aluminum
other	 In clinical studies , coadministration of <e1> WelChol </e1> with <e2> atorvastatin </e2> , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor .	WelChol	atorvastatin
effect	 A rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of <e1> selective serotonin reuptake inhibitors </e1> ( SSRIs ) and agents for migraine therapy , such as Imitrex ( sumatriptan succinate ) and <e2> dihydroergotamine </e2> .	selective serotonin reuptake inhibitors	dihydroergotamine
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , cyclophosphamide , doxorubicin , <e1> teniposide </e1> , and prednisone with <e2> vincristine </e2> plus bleomycin ) without receiving antiretroviral therapy .	teniposide	vincristine
other	 Cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents , such as <e1> propranolol </e1> and <e2> metoprolol </e2> .	propranolol	metoprolol
other	 Bentiromide may interact with acetaminophen (e.g. , Tylenol ) , chloramphenicol (e.g. , Chloromycetin ) , local anesthetics (e.g. , benzocaine and <e1> lidocaine </e1> ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some <e2> multivitamins </e2> ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	lidocaine	multivitamins
effect	 Drugs that reportedly may increase oral <e1> anticoagulant </e1> response , ie , increased prothrombin response , in man include : alcohol *; <e2> allopurinol </e2> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anticoagulant	allopurinol
effect	 Additive CNS depression may occur when <e1> antihistamines </e1> are administered concomitantly with other CNS depressants including <e2> barbiturates </e2> , tranquilizers , and alcohol .	antihistamines	barbiturates
other	 Other No clinically important pharmacokinetic interactions occurred when <e1> Lotensin </e1> was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or <e2> cimetidine </e2> .	Lotensin	cimetidine
other	 <e1> Antacids </e1> and <e2> kaolin </e2> : Antacids and kaolin can reduce absorption of chloroquine ;	Antacids	kaolin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1> miconazole </e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e2> triclofos sodium </e2> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	miconazole	triclofos sodium
other	 <e1> ketoconazole </e1> ) , macrolide antibiotics (e.g . erythromycin ) , and HIV protease inhibitors (e.g . ritonavir , indinavir and <e2> saquinavir </e2> ) should have their dose of SUBUTEX or SUBOXONE adjusted .	ketoconazole	saquinavir
other	 Interactions may also occur with the following : anti-depressants / anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers (e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , <e1> guanadrel </e1> , metrizamide , cabergoline , lithium , narcotic pain medication (e.g. , <e2> codeine </e2> ) , drugs used to aid sleep , drowsiness-causing antihistamines (e.g. , diphenhydramine ) , any other drugs that may make you drowsy .	guanadrel	codeine
mechanism	 Agents with Increased Levels in the Presence of Carbamazepine : <e1> EQUETROTM </e1> increases the plasma levels of the following agents : <e2> Clomipramine HCl </e2> , Phenytoin (6) , and primidone Thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with EQUETROTM , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .	EQUETROTM	Clomipramine HCl
other	 Lithium : <e1> Ibuprofen </e1> produced an elevation of plasma lithium levels and a reduction in renal <e2> lithium </e2> clearance in a study of eleven normal volunteers .	Ibuprofen	lithium
other	 The plasma maximum concentration and area under the plasma concentration-time curve of diltiazem , desacetyldiltiazem , and desmethyldiltiazem were unchanged after coadministration of <e1> sirolimus </e1> , and no potentiation of the effects of <e2> diltiazem </e2> on diastolic or systolic blood pressure or on the electrocardiographic parameters was seen .	sirolimus	diltiazem
other	 The results from a study in which eight HIV-infected individuals were treated with <e1> zidovudine </e1> , 8 +/- 0.4 mg/kg/day , showed that the pharmacokinetics of zidovudine were not affected during concomitant administration of <e2> Itraconazole </e2> , 100 mg b.i.d .	zidovudine	Itraconazole
other	 Using in situ hybridization , we observed that <e1> METH </e1> caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist SCH-23390 but not by an <e2> atypical neuroleptic </e2> clozapine .	METH	atypical neuroleptic
other	 Interactions may also occur with the following : <e1> anti-depressants </e1> / anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers (e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , <e2> guanadrel </e2> , metrizamide , cabergoline , lithium , narcotic pain medication (e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines (e.g. , diphenhydramine ) , any other drugs that may make you drowsy .	anti-depressants	guanadrel
other	 Since <e1> PLETAL </e1> is extensively metabolized by cytochrome P-450 isoenzymes , caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A . such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as <e2> omeprazole </e2> .	PLETAL	omeprazole
other	 poor metabolizers of debrisoquin : Interactions of <e1> carvedilol </e1> with strong inhibitors of CYP2D6 (such as quinidine , fluoxetine , <e2> paroxetine </e2> , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	carvedilol	paroxetine
other	 Monitor <e1> salicylate </e1> levels or the therapeutic effect for which <e2> aspirin </e2> is given;	salicylate	aspirin
advise	 Vitamin A and oral retinoids : Concomitant administration of vitamin A and/or other oral <e1> retinoids </e1> with <e2> acitretin </e2> must be avoided because of the risk of hypervitaminosis A .	retinoids	acitretin
advise	 Close supervision and careful adjustment of the dosage are required when <e1> nortriptyline hydrochloride </e1> is used with other anticholinergic drugs or <e2> sympathomimetic drugs </e2> .	nortriptyline hydrochloride	sympathomimetic drugs
other	 <e1> Insulin </e1> or Oral <e2> Hypoglycemics </e2> : Agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .	Insulin	Hypoglycemics
other	 In a clinical pharmacology study , <e1> indomethacin </e1> or sulindac was administered to hypertensive patients receiving <e2> VASOTEC </e2> .	indomethacin	VASOTEC
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e1> barbiturates </e1> ; <e2> carbamazepine </e2> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	barbiturates	carbamazepine
effect	 Toxicology studies of <e1> heroin </e1> -related deaths reveal frequent involvement of other central nervous system depressants , including <e2> alcohol </e2> , benzodiazepines such as diazepam ( Valium ) , and , to a rising degree , methadone .	heroin	alcohol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : <e1> alcohol </e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e2> naproxen </e2> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	alcohol	naproxen
other	 acetaminophen / <e1> theophylline </e1> , lidocaine / quinidine , phenobarbital / acetaminophen , <e2> phenobarbital </e2> / valproic acid , quinidine / lidocaine , theophylline / acetaminophen , and valproic acid / phenobarbital .	theophylline	phenobarbital
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> EQUETROTM </e1> are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , <e2> niacinamide </e2> , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	EQUETROTM	niacinamide
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , <e1> clofibrate </e1> , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , <e2> phenytoin </e2> , salicylates , tamoxifen .	clofibrate	phenytoin
other	 DRUG0 : Immediate Release Capsules : Since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and <e1> nifedipine </e1> , it is recommended that <e2> digoxin </e2> levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .	nifedipine	digoxin
other	 Central Nervous System Depressants : The concomitant use of DURAGESIC ( fentanyl transdermal system) with other <e1> central nervous system depressants </e1> , including but not limited to other opioids , sedatives , hypnotics , tranquilizers (e.g. , benzodiazepines ) , general anesthetics , phenothiazines , <e2> skeletal muscle relaxants </e2> , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	central nervous system depressants	skeletal muscle relaxants
other	 Therefore , co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain <e1> antidepressants </e1> (e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , <e2> haloperidol </e2> , risperidone , thioridazine ) , beta-blockers (e.g. , metoprolol ) , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	antidepressants	haloperidol
other	 <e1> Phenytoin </e1> / Phenobarbital : The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of <e2> vitamin D </e2> , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .	Phenytoin	vitamin D
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and <e1> tetracycline </e1> , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , <e2> Fortovase </e2> , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	tetracycline	Fortovase
other	 <e1> Anesthetics </e1> / Sedatives / Hypnotics / <e2> Opioids </e2> : Co-administration of PRECEDEX with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .	Anesthetics	Opioids
other	 Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an <e1> aluminum </e1> and magnesium containing antacid ( <e2> Maalox </e2> ) decreased fexofenadine AUC by 41% and cmax by 43% .	aluminum	Maalox
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1> anabolic steroids </e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; <e2> methylphenidate </e2> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anabolic steroids	methylphenidate
other	 DRUG0 : Immediate Release Capsules : Since there have been isolated reports of patients with elevated <e1> digoxin </e1> levels , and there is a possible interaction between digoxin and <e2> nifedipine </e2> , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .	digoxin	nifedipine
other	 Drug-Drug Interactions Albuterol - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other <e1> beta2 agonists </e1> ) because the action of <e2> albuterol </e2> on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .	beta2 agonists	albuterol
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , <e1> haloperidol </e1> , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and <e2> zonisamide </e2> .	haloperidol	zonisamide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , <e1> itraconazole </e1> , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , <e2> risperidone </e2> , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	itraconazole	risperidone
other	 - Anabolic steroids ( <e1> nandrolone </e1> [e.g. , <e2> Anabolin </e2> ] , oxandrolone [e.g. , Anavar ] , oxymetholone [e.g. , Anadrol ] , stanozolol [e.g. , Winstrol ]) or	nandrolone	Anabolin
other	 The effect of <e1> ceftibuten </e1> on the pharmacokinetics of <e2> theophylline </e2> administered orally has not been investigated .	ceftibuten	theophylline
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; <e1> aminosalicylic acid </e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation <e2> anesthetics </e2> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	aminosalicylic acid	anesthetics
other	 <e1> Calcium Channel Blockers </e1> , Dihydropyridine : e.g. , felodipine , <e2> nifedipine </e2> , nicardipine	Calcium Channel Blockers	nifedipine
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all central nervous system depressants (eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , <e1> tricyclic antidepressants </e1> , phenothiazines , tranquilizers , skeletal muscle relaxants and <e2> antihistamines </e2> ) may result in additive central nervous system depressant effects .	tricyclic antidepressants	antihistamines
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , <e1> nortriptyline </e1> , olanzapine , oral contraceptives (3) , oxcarbazepine , <e2> Phenytoin </e2> (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	nortriptyline	Phenytoin
other	 <e1> Epinephrine </e1> also should be used cautiously with other drugs (e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of <e2> sympathomimetic drugs </e2> .	Epinephrine	sympathomimetic drugs
other	 Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ) : MAOI could theoretically affect <e1> flupenthixol </e1> pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - <e2> Tricyclic antidepressants </e2> : Flupenthixol increases the effect of Tricyclic antidepressants	flupenthixol	Tricyclic antidepressants
other	 Therefore , co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , haloperidol , risperidone , thioridazine ) , beta-blockers (e.g. , <e1> metoprolol </e1> ) , and Type 1C antiarrhythmics (e.g. , <e2> propafenone </e2> , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	metoprolol	propafenone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e1> antibiotics </e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	antibiotics	sulfonamides
other	 When concomitant administration of <e1> ketoconazole </e1> with aripiprazole occurs , <e2> aripiprazole </e2> dose should be reduced to one-half of its normal dose .	ketoconazole	aripiprazole
mechanism	 <e1> Tagamet </e1> , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , <e2> theophylline </e2> and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	Tagamet	theophylline
mechanism	 Mineral Oil -Concomitant intake of <e1> mineral oil </e1> and <e2> vitamin K </e2> may reduce the absorption of vitamin K .	cholestyramine	vitamin K
other	 The principal drugs given (number of patients in parentheses) were : cardiac glycosides (115) , sedatives and hypnotics (103) , coronary vasodilators (52) , oral <e1> hypoglycemics </e1> (45) , cough and cold preparations (45) , NSAIDs (38) , antihyperlipidemics (29) , antigout drugs (24) , oral contraceptives (18) , bronchodilators (13) , <e2> insulin </e2> (10) , and beta blockers (10) .	hypoglycemics	insulin
other	 - Drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , <e1> estrogens </e1> , furosemide , oral contraceptives , rifampin , quinidine , theophylline , <e2> vitamin D </e2> .	estrogens	vitamin D
mechanism	 Because oral <e1> anticoagulants </e1> may interfere with the hepatic metabolism of <e2> phenytoin </e2> , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .	anticoagulants	phenytoin
other	 Antifungals : In vitro and/or in vivo data indicate that <e1> fluconazole </e1> , itraconazole , and oral <e2> ketoconazole </e2> markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG .	fluconazole	ketoconazole
other	 If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or <e1> sedative </e1> / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of desipramine and <e2> benzodiazepines </e2> (e.g. , chlordiazepoxide or diazepam ) are additive .	sedative	benzodiazepines
other	 <e1> ISUPREL </e1> should be used with caution , if at all , when potent inhalational anesthetics such as halothane are employed because of potential to sensitize the myocardium to effects of <e2> sympathomimetic amines </e2> .	ISUPREL	sympathomimetic amines
other	 therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g . ketoconazole , <e1> ampicillin </e1> esters , iron salts , <e2> digoxin </e2> ) .	ampicillin	digoxin
other	 Therefore , interactions could occur following concomitant administration of <e1> psychotropic drugs </e1> (e.g. , narcotics , <e2> analgesics </e2> , antiemetics , sedatives , tranquilizers ) .	psychotropic drugs	analgesics
other	 Antacids and sucralfate : <e1> Sucralfate </e1> and antacids containing <e2> magnesium </e2> or aluminum , as well as formulations containing divalent and trivalent cations such as Videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .	Sucralfate	magnesium
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : <e1> aminoglycosides </e1> (e.g. , gentamicin , amikacin ) , <e2> amphotericin B </e2> , cyclosporine , non-steroidal anti-inflammatory drugs (e.g. , ibuprofen ) , tacrolimus , vancomycin .	aminoglycosides	amphotericin B
other	 Potassium Supplements and <e1> Potassium-Sparing Diuretics </e1> : <e2> Fosinopril sodium </e2> can attenuate potassium loss caused by thiazide diuretics .	Potassium-Sparing Diuretics	Fosinopril sodium
other	 Ganciclovir : Administration of <e1> VIDEX </e1> 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 (114)% increase in the steady-state AUC of <e2> didanosine </e2> (n = 12) .	VIDEX	didanosine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; <e1> amiodarone </e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e2> clofibrate </e2> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	amiodarone	clofibrate
other	 If <e1> phenytoin </e1> or other hepatic enzyme inducers are taken concurrently with Norpace or Norpace CR , lower plasma levels of <e2> disopyramide </e2> may occur .	phenytoin	disopyramide
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , <e1> Thorazine </e1> ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , <e2> prochlorperazine </e2> [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Thorazine	prochlorperazine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1> salicylates </e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	salicylates	tolbutamide
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , <e1> warfarin </e1> , thiazide diuretics (acidic) or propranolol (basic) , as well as tetracycline <e2> penicillin G </e2> , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .	warfarin	penicillin G
other	 Exposed histidines on toxin A are available for <e1> zinc </e1> chelation , and these have been exploited in the development of a novel purification protocol for <e2> toxin A </e2> using zinc -chelating chromatography .	zinc	toxin A
other	 Bentiromide may interact with acetaminophen (e.g. , Tylenol ) , chloramphenicol (e.g. , Chloromycetin ) , local <e1> anesthetics </e1> (e.g. , benzocaine and lidocaine ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some multivitamins ) , procainamide (e.g. , <e2> Pronestyl </e2> ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	anesthetics	Pronestyl
other	 Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , <e1> bumetanide </e1> , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and <e2> zidovudine </e2> ) .	bumetanide	zidovudine
other	 In clinical trials , <e1> FLOLAN </e1> was used with digoxin , diuretics , <e2> anticoagulants </e2> , oral vasodilators , and supplemental oxygen .In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated , apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15% , respectively , on the second day of therapy and had returned to baseline values by day 87 .	FLOLAN	anticoagulants
other	 Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g. , intravenous <e1> aminoglycosides </e1> (e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin B , <e2> foscarnet </e2> , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .	aminoglycosides	foscarnet
mechanism	 Administration of <e1> quinolones </e1> with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or <e2> zinc </e2> , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	quinolones	zinc
other	 <e1> Diuretic </e1> : Hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to <e2> hydrochlorothiazide </e2> alone .	Diuretic	hydrochlorothiazide
advise	 If concomitant treatment with <e1> sumatriptan </e1> and an SSRI (e.g. , fluoxetine , fluvoxamine , <e2> paroxetine </e2> , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .	sumatriptan	paroxetine
other	 <e1> Rifampin </e1> significantly decreased the AUC(ss) of amprenavir by 82% , but <e2> amprenavir </e2> had no effect on rifampin pharmacokinetics .	Rifampin	amprenavir
other	 Tell your doctor if you are taking any of the following drugs : blood thinner s ( Coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( Tegretol ) <e1> cimetidine </e1> ( Tagamet ) estrogens fluoxetine ( Prozac ) intraconazole ( <e2> Sporanox </e2> ) ketoconazole ( Nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	cimetidine	Sporanox
other	 Benzodiazepines : Combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( <e1> alprazolam </e1> , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , <e2> temazepam </e2> ) .	alprazolam	temazepam
other	 The administration of local <e1> anesthetic solutions </e1> containing epinephrine or <e2> norepinephrine </e2> to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .	anesthetic solutions	norepinephrine
other	 Phenobarbital or <e1> Primidone </e1> : No formal pharmacokinetic studies have been performed examining the addition of <e2> tiagabine </e2> to regimens containing phenobarbital or primidone .	Primidone	tiagabine
other	 Both efavirenz and nevirapine have been compared to triple therapy with the PI <e1> indinavir </e1> over 48 weeks as initial therapy , with similar responses being observed with <e2> nevirapine </e2> regimens and superiority observed with efavirenz .	indinavir	nevirapine
other	 <e1> Ethanol </e1> :Clinical evidence has shown that <e2> etretinate </e2> can be formed with concurrent ingestion of acitretin and ethanol .	Ethanol	etretinate
effect	 Lithium : Lithium toxicity has been reported in patients receiving <e1> lithium </e1> concomitantly with drugs which cause elimination of sodium , including <e2> ACE inhibitors </e2> .	lithium	ACE inhibitors
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , <e1> mirtazapine </e1> , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , <e2> praziquantel </e2> , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	mirtazapine	praziquantel
advise	 Close observation of the patient is recommended when a <e1> beta-blocker </e1> is administered to patients receiving catecholamine-depleting drugs such as <e2> reserpine </e2> , because of possible additive effects and the production of hypotension and/or marked bradycardia , which may produce vertigo , syncope , or postural hypotension .	beta-blocker	reserpine
other	 No drug interaction studies have been conducted for <e1> COLAZAL </e1> , however the use of orally administered <e2> antibiotics </e2> could , theoretically , interfere with the release of mesalamine in the colon .	COLAZAL	antibiotics
advise	 Therefore you may need to take a <e1> vitamin B12 </e1> supplement while taking <e2> aminosalicylic acid </e2> .	vitamin B12	aminosalicylic acid
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to <e1> alprazolam </e1> or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam ) : Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , <e2> isoniazid </e2> , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .	alprazolam	isoniazid
other	 Drug Interactions : The central anticholinergic syndrome can occur when DRUG0 agents such as AKINETON are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the <e1> quinidine </e1> salts , and <e2> antihistamines </e2> .	quinidine	antihistamines
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1> diazoxide </e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e2> phenytoin </e2> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diazoxide	phenytoin
advise	 Therefore , co-administration of <e1> bupropion </e1> with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g. , nortriptyline , <e2> imipramine </e2> , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , haloperidol , risperidone , thioridazine ) , beta-blockers (e.g. , metoprolol ) , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	bupropion	imipramine
other	 <e1> Glibenclamide </e1> : In a study of 7 healthy male volunteers , <e2> acitretin </e2> treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .	Glibenclamide	acitretin
other	 - a nonsteroidal anti-inflammatory drug ( <e1> NSAID </e1> ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( <e2> Indocin </e2> ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	NSAID	Indocin
other	 Drug-Drug Interactions Albuterol - <e1> STRATTERA </e1> should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other <e2> beta2 agonists </e2> ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .	STRATTERA	beta2 agonists
other	 It is recommended that buspirone hydrochloride not be used concomitantly with <e1> MAO inhibitors </e1> Because the effects of concomitant administration of buspirone HCl with most other <e2> psychotropic drugs </e2> have not been studied , the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution .	MAO inhibitors	psychotropic drugs
other	 Concurrent use of butorphanol with central nervous system depressants (e.g. , alcohol , <e1> barbiturates </e1> , tranquilizers , and antihistamines ) may result in increased <e2> central nervous system depressant </e2> effects .	barbiturates	central nervous system depressant
mechanism	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma <e1> phenytoin </e1> concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , <e2> trazodone </e2>	phenytoin	trazodone
mechanism	 The following are examples of drugs known to inhibit the metabolism of other related <e1> benzodiazepines </e1> , presumably through inhibition of CYP3A : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some <e2> macrolide antibiotics </e2> .	benzodiazepines	macrolide antibiotics
other	 <e1> Antithyroid agents </e1> may decrease thyroidal uptake of sodium iodide I131 , a rebound in uptake may occur up to 5 days after sudden withdrawal of <e2> Carbimazole </e2> .	Antithyroid agents	Carbimazole
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , <e1> danazol </e1> , diuretics , sympathomimetic agents (e.g. , epinephrine , <e2> salbutamol </e2> , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	danazol	salbutamol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1> diflunisal </e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e2> phenylbutazone </e2> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diflunisal	phenylbutazone
other	 The principal drugs given (number of patients in parentheses) were : cardiac glycosides (115) , sedatives and hypnotics (103) , coronary vasodilators (52) , oral hypoglycemics (45) , cough and cold preparations (45) , <e1> NSAIDs </e1> (38) , <e2> antihyperlipidemics </e2> (29) , antigout drugs (24) , oral contraceptives (18) , bronchodilators (13) , insulin (10) , and beta blockers (10) .	NSAIDs	antihyperlipidemics
other	 The availability of potent <e1> non-nucleoside reverse transcriptase inhibitor </e1> ( NNRTI )-based regimens for antiretroviral therapy and concerns regarding protease inhibitor ( <e2> PI </e2> )-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	non-nucleoside reverse transcriptase inhibitor	PI
other	 As with other antihypertensive agents , the antihypertensive effect of <e1> losartan </e1> may be blunted by the <e2> non-steroidal anti-inflammatory drug </e2> indomethacin	losartan	non-steroidal anti-inflammatory drug
other	 Serum <e1> infliximab </e1> concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids , <e2> antibiotics </e2> ( metronidazole or ciprofloxacin ) and aminosalicylates .	infliximab	antibiotics
other	 Oral contraceptives : Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral <e1> contraceptive </e1> containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the AUC of ethinyl estradiol by 43% , and decreased the AUC of <e2> norethindrone </e2> by 8%;	contraceptive	norethindrone
other	 Agents Affecting Sympathetic Activity The sympathetic nervous system may be especially important in supporting blood pressure in patients receiving <e1> captopril </e1> alone or with <e2> diuretics </e2> .	captopril	diuretics
other	 Drugs which may enhance the neuromuscular blocking action of TRACRIUM include : enflurane ; isoflurane ; <e1> halothane </e1> ;certain antibiotics , especially the aminoglycosides and <e2> polymyxins </e2> ; lithium ; magnesium salts; procainamide ;and quinidine .	halothane	polymyxins
other	 Analgesic / <e1> anti-inflammatory </e1> (e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , <e2> indomethacin </e2> ) .	anti-inflammatory	indomethacin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , <e1> ethionamide </e1> , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , <e2> resorcinol </e2> , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	ethionamide	resorcinol
other	 No interactions have been observed between nizatidine and <e1> theophylline </e1> , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and <e2> warfarin </e2> .	theophylline	warfarin
other	 Potential interactions between TAXOL , a substrate of CYP3A4 , and protease inhibitors ( ritonavir , saquinavir , <e1> indinavir </e1> , and <e2> nelfinavir </e2> ) , which are substrates and/or inhibitors of CYP3A4 , have not been evaluated in clinical trials .	indinavir	nelfinavir
int	 A potential interaction between oral <e1> miconazole </e1> and oral <e2> hypoglycemic agents </e2> leading to severe hypoglycemia has been reported .	miconazole	hypoglycemic agents
other	 <e1> Cephalosporins </e1> - Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , <e2> cefamandole </e2> , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	Cephalosporins	cefamandole
other	 In vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , <e1> tolbutamide </e1> , and metformin showed no influence on the extent of <e2> nateglinide </e2> protein binding .	tolbutamide	nateglinide
other	 [Stimulation by cerulein --an analog of the octapeptide cholecystokinin--of <e1> 3H-spiroperidol </e1> binding after the long-term administration of neuroleptics ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of <e2> haloperidol </e2> (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures , whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain .	3H-spiroperidol	haloperidol
other	 Chlorpromazine : <e1> Chlorpromazine </e1> blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat <e2> amphetamine </e2> poisoning .	Chlorpromazine	amphetamine
other	 When cholestyramine <e1> resin </e1> is given for long periods of time , concomitant supplementation with water-miscible (or parenteral) forms of <e2> fat-soluble vitamins </e2> should be considered .	resin	fat-soluble vitamins
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , <e1> fluoxetine </e1> , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , <e2> quinupristin </e2> , troleandomycin , valproate (1) , verapamil , zileuton .	fluoxetine	quinupristin
other	 Studies have shown that <e1> lansoprazole </e1> does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or <e2> terfenadine </e2> in healthy subjects .	lansoprazole	terfenadine
other	 Chlorotrianisene may interact with antidepressants , <e1> aspirin </e1> , barbiturates , bromocriptine , calcium supplements , corticosteroids , <e2> corticotropin </e2> , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .	aspirin	corticotropin
mechanism	 For example , since <e1> cholestyramine </e1> may reduce the gastrointestinal absorption of both the oral <e2> anticoagulants </e2> and vitamin K , the net effects are unpredictable .	cholestyramine	anticoagulants
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , <e1> prednisolone </e1> ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	prednisolone	temazepam
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , <e1> cyclosporine </e1> ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , <e2> Fortovase </e2> , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	cyclosporine	Fortovase
other	 Reported examples of this interaction include the following : Immunosuppressive s : Cyclosporine ( <e1> CYP3A4 </e1> substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of <e2> cyclosporine </e2> resulting in elevated creatinine , despite reduction in dose of cyclosporine .	CYP3A4	cyclosporine
other	 - <e1> Cholestyramine </e1> and colestipol resins : Cholestytamine and <e2> colestipol </e2> resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract	Cholestyramine	colestipol
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , <e1> insulin </e1> , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , <e2> 6-mercaptopurine </e2> , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	insulin	6-mercaptopurine
effect	 If <e1> desipramine hydrochloride </e1> is to be combined with other <e2> psychotropic agents </e2> such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of desipramine and benzodiazepines (e.g. , chlordiazepoxide or diazepam ) are additive .	desipramine hydrochloride	psychotropic agents
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1> chloral hydrate </e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e2> ranitidine </e2> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chloral hydrate	ranitidine
other	 Carbamazepine : Coadministration of carbamazepine (200 mg BID) , a potent CYP3A4 inducer , with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both <e1> aripiprazole </e1> and its active metabolite , <e2> dehydro-aripiprazole </e2> .	aripiprazole	dehydro-aripiprazole
other	 The concomitant intake of <e1> alcohol </e1> and Acamprosate does not affect the pharmacokinetics of either alcohol or <e2> acamprosate </e2> .	alcohol	acamprosate
mechanism	 Levothyroxine Sodium Absorption : The following agents may bind and decrease absorption of <e1> levothyroxine sodium </e1> from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour (e.g. , infant formula) , <e2> sucralfate </e2> .	levothyroxine sodium	sucralfate
other	 The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose ( <e1> NaCMC </e1> ) and carboxymethylcellulose-cysteine ( CMC-Cys ) conjugates on the intestinal permeation of sodium fluorescein ( <e2> NaFlu </e2> ) and model peptide drugs , bacitracin and insulin .	NaCMC	NaFlu
advise	 Dosage adjustment of <e1> STRATTERA </e1> may be necessary when coadministered with CYP2D6 inhibitors , e.g. , <e2> paroxetine </e2> , fluoxetine , and quinidine .	STRATTERA	paroxetine
other	 For comprehensive information concerning laboratory test alterations associated with <e1> ritonavir </e1> , physicians should refer to the complete prescribing information for <e2> NORVIR </e2> ( DRUG0 ) .	ritonavir	NORVIR
other	 Those for which effectiveness is reported includes diphenhydramine , hydroxyzine , orphenadrine , pyrilamine , phenyltoloxamine , promethazine , <e1> methdilazine </e1> , and <e2> tripelennamine </e2> .	methdilazine	tripelennamine
mechanism	 Warfarin : <e1> Quinolones </e1> , including enoxacin , decrease the clearance of <e2> R-warfarin </e2> , the less active isomer of racemic warfarin .	Quinolones	R-warfarin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1> ethacrynic acid </e1> ; <e2> fenoprofen </e2> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ethacrynic acid	fenoprofen
other	 Magnesium / <e1> Aluminum </e1> -containing <e2> Antacid Products </e2> : Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium / aluminum -containing antacid products .	Aluminum	Antacid Products
other	 In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with TAXOL should be premedicated with corticosteroids (such as <e1> dexamethasone </e1> ) , diphen-hydramine and H2 antagonists (such as <e2> cimetidine </e2> or ranitidine ) .	dexamethasone	cimetidine
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( <e1> Voltaren </e1> , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , <e2> Aleve </e2> );	Voltaren	Aleve
other	 Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone , they modify the mitogenic effect of <e1> EGF </e1> and <e2> insulin </e2> .	EGF	insulin
effect	 Because <e1> lithium </e1> may enhance the serotonergic effects of <e2> escitalopram </e2> , caution should be exercised when LEXAPRO and lithium are coadministered .	lithium	escitalopram
advise	 In simultaneous treatment with <e1> imidazole drugs </e1> and <e2> coumarin drugs </e2> , the anticoagulant effect should be carefully titrated and monitored .	imidazole drugs	coumarin drugs
int	 <e1> Etonogestrel </e1> may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , <e2> Tegretol </e2> , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Etonogestrel	Tegretol
other	 Such individuals are referred to as poor metabolizers of drugs such as <e1> debrisoquin </e1> , dextromethorphan , the tricyclic antidepressants , and <e2> clozapine </e2> .	debrisoquin	clozapine
other	 <e1> Phenytoin </e1> , nicotine , and <e2> rifampin </e2> may decrease Clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective Clozapine dose .	Phenytoin	rifampin
advise	 This time window is different than for other oral formulations of <e1> ciprofloxacin </e1> , which are usually administered 2 hours before or 6 hours after <e2> antacids </e2> .	ciprofloxacin	antacids
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving <e1> benzodiazepines </e1> metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam ) : Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as <e2> erythromycin </e2> and clarithromycin , and grapefruit juice .	benzodiazepines	erythromycin
other	 <e1> Antacids </e1> containing <e2> magnesium trisilicate </e2> , when administered concomitantly with nitrofurantoin , reduce both the rate and extent of absorption .	Antacids	magnesium trisilicate
other	 <e1> MAO inhibitors </e1> , narcotic analgesics (e.g. , meperidine ) , <e2> nitrates </e2> and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .	MAO inhibitors	nitrates
other	 Dicumarol : It has been reported that <e1> allopurinol </e1> prolongs the half-life of the <e2> anticoagulant </e2> , dicumarol .	allopurinol	anticoagulant
other	 When used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , <e1> rifabutin </e1> , sildenafil , theophylline (intravenous and oral) , triazolam , trimethoprim / sulfamethoxazole or <e2> zidovudine </e2> .	rifabutin	zidovudine
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all <e1> central nervous system depressants </e1> (eg , alcohol , sedatives , <e2> hypnotics </e2> , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .	central nervous system depressants	hypnotics
mechanism	 CONCLUSIONS : <e1> Macrolide antibiotics </e1> inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e. , atorvastatin , cerivastatin , lovastatin , <e2> simvastatin </e2> ) .	Macrolide antibiotics	simvastatin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , <e1> protease inhibitors </e1> , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , <e2> verapamil </e2> , zileuton .	protease inhibitors	verapamil
other	 Concomitant medications were grouped as ACE inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , <e1> cardiac glycosides </e1> , inducers of CYP3A4 , substrates and inhibitors of CYP3A4 , substrates and inhibitors of P-glycoprotein , nitrates , sulphonylureas , loop diuretics , <e2> potassium sparing diuretics </e2> , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and QTc-prolonging drugs .	cardiac glycosides	potassium sparing diuretics
effect	 Drugs Decreasing Heparin Effect : <e1> Digitalis </e1> , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of <e2> heparin sodium </e2> .	Digitalis	heparin sodium
other	 Because changes in glucose concentrations with <e1> valdecoxib </e1> coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dL , dose adjustment for <e2> glyburide </e2> (5 mg QD and 10 mg BID) with valdecoxib coadministration (up to 40 mg QD) is not indicated .	valdecoxib	glyburide
other	 <e1> Venlafaxine </e1> : Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either <e2> zaleplon </e2> or venlafaxine .	Venlafaxine	zaleplon
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , <e1> clindamycin </e1> , colistin , and sodium colistemethate ) , magnesium salts , lithium , local <e2> anesthetics </e2> , procainamide , and quinidine .	clindamycin	anesthetics
other	 Central nervous system depressant (CNS) drugs including alcohol , antidepressants , <e1> antihistamines </e1> , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , <e2> sedatives </e2> , sleeping pills and tranquilizers	antihistamines	sedatives
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , <e1> Topamax </e1> , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , <e2> phenylbutazone </e2> , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Topamax	phenylbutazone
other	 Bentiromide may interact with acetaminophen (e.g. , <e1> Tylenol </e1> ) , chloramphenicol (e.g. , Chloromycetin ) , local anesthetics (e.g. , benzocaine and lidocaine ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some multivitamins ) , <e2> procainamide </e2> (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	Tylenol	procainamide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1> disulfiram </e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e2> glucagon </e2> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	disulfiram	glucagon
other	 In general , these are drugs that have one or more pharmacologic activities similar to <e1> bepridil hydrochloride </e1> , including anti-arrhythmic agents such as quinidine and procainamide , <e2> cardiac glycosides </e2> and tricyclic anti-depressants .	bepridil hydrochloride	cardiac glycosides
other	 Antiacid , clarithromycin , Didanosine , Fluconazole , Fluoxetine , Indanavir , Ketoconazole , <e1> Phenytoin </e1> , Phenobarbitol , carbamazepine , Rifabutin , Rifampin , Ritanovir , <e2> Saquinavir </e2> .	Phenytoin	Saquinavir
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , <e1> Mellaril </e1> ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , <e2> Vesprin </e2> ] , trimeprazine [e.g. , Temaril ]) or	Mellaril	Vesprin
other	 Digoxin , Nimodipine and Losartan : Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and <e1> losartan </e1> has no significant effect on plasma levels of <e2> bosentan </e2> .	losartan	bosentan
int	 <e1> Chlorotrianisene </e1> may interact with antidepressants , aspirin , <e2> barbiturates </e2> , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .	Chlorotrianisene	barbiturates
other	 Therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and Type 1C antiarrhythmics (e.g. , propafenone , <e1> flecainide </e1> and encainide ) , or that inhibit this enzyme (e.g. , <e2> quinidine </e2> ) , should be approached with caution .	flecainide	quinidine
other	 Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , <e1> indinavir </e1> , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to <e2> dasatinib </e2> and should be avoided .	indinavir	dasatinib
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , <e1> glucocorticoids </e1> , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , <e2> praziquantel </e2> , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	glucocorticoids	praziquantel
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1> miconazole </e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	miconazole	sulfinpyrazone
effect	 <e1> Dexbrompheniramine </e1> can interact with alcohol or other <e2> CNS depressants </e2> (may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	Dexbrompheniramine	CNS depressants
other	 Antacids : In a clinical pharmacology study , coadministration of an <e1> antacid </e1> ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that <e2> antacids </e2> may impair absorption of fosinopril .	antacid	antacids
other	 Triazolam - Combined administration of racemic <e1> citalopram </e1> (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate <e2> triazolam </e2> (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam .	citalopram	triazolam
other	 Drugs That Should Not Be Coadministered With VIRACEPT <e1> Antiarrhythmics </e1> : amiodarone , quinidine Antihistamines : astemizole , terfenadine Antimigraine : ergot derivatives Antimycobacterial agents : rifampin Benzodiazepines midazolam , <e2> triazolam </e2> GI motility agents : cisapride	Antiarrhythmics	triazolam
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; <e1> aminosalicylic acid </e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	aminosalicylic acid	quinine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1> dextran </e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e2> phenylbutazone </e2> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextran	phenylbutazone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , <e1> itraconazole </e1> , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and <e2> zonisamide </e2> .	itraconazole	zonisamide
other	 These in vitro studies suggest that concomitant administration of zalcitabine and <e1> lamivudine </e1> in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased <e2> antiretroviral </e2> effect of zalcitabine .	lamivudine	antiretroviral
other	 In addition , under the influence of sympatholytic medicinal products such as beta-blockers , <e1> clonidine </e1> , guanethidine , and <e2> reserpine </e2> , the signs of hypoglycemia may be reduced or absent .	clonidine	reserpine
other	 METHODS : <e1> Hydrocortisone </e1> (100 mg) and <e2> d-amphetamine </e2> (20 mg) were administered orally to 16 healthy male and female volunteers in a four-session , placebo-controlled , within-subject , crossover design .	Hydrocortisone	d-amphetamine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , <e1> clarithromycin </e1> (1) , dalfopristin , danazol , delavirdine , diltiazem , <e2> erythromycin </e2> (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	clarithromycin	erythromycin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e1> thyroid drugs </e1> ; tolbutamide ; <e2> triclofos sodium </e2> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	thyroid drugs	triclofos sodium
advise	 However , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a <e1> quinolone antimicrobial </e1> is administered with <e2> warfarin </e2> or its derivatives .	quinolone antimicrobial	warfarin
other	 Cardiac effects of dopamine are antagonized by <e1> beta-adrenergic blocking agents </e1> , such as <e2> propranolol </e2> and metoprolol .	beta-adrenergic blocking agents	propranolol
effect	 Butalbital , acetaminophen and <e1> caffeine </e1> may enhance the effects of : other narcotic analgesic s , alcohol , general anesthetics , tranquilizers such as <e2> chlordiazepoxide </e2> , sedative-hypnotics , or other CNS depressants , causing increased CNS depression .	caffeine	chlordiazepoxide
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( <e1> thiocyanate </e1> , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , <e2> nitroprusside </e2> , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	thiocyanate	nitroprusside
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , <e1> amiodarone </e1> , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , <e2> iodine-containing compounds </e2> , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	amiodarone	iodine-containing compounds
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1> dextran </e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e2> prolonged narcotics </e2> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextran	prolonged narcotics
other	 The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including <e1> nonsteroidal anti-inflammatory agents </e1> and other drugs that are highly protein bound , salicylates , <e2> sulfonamides </e2> , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	nonsteroidal anti-inflammatory agents	sulfonamides
effect	 Concomitant use of <e1> antihistamines </e1> with alcohol , <e2> tricyclic antidepressants </e2> , barbiturates , or other central nervous system depressants may have an additive effect .	antihistamines	tricyclic antidepressants
mechanism	 The absorption of <e1> lymecycline </e1> may be affected by the simultaneous administration of indigestion remedies , <e2> iron </e2> or zinc supplements .	lymecycline	iron
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , anticoagulants ( blood thinner s) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines) , central nervous system (CNS) depressants (using these medicines with <e1> barbiturates </e1> may result in increased CNS depressant effects) , divalproex sodium , <e2> valproic acid </e2> (using these medicines with barbiturates may change the amount of either medicine that you need to take) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control) .	barbiturates	valproic acid
other	 <e1> Theophylline </e1> serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and <e2> PEGASYS </e2> .	Theophylline	PEGASYS
other	 The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ACE inhibitors , disopyramide , fibrates , fluoxetine , MAO inhibitors , propoxyphene , salicylates , <e1> somatostatin analog </e1> (e.g. , <e2> octreotide </e2> ) , sulfonamide antibiotics .	somatostatin analog	octreotide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , <e1> Phenytoin </e1> (4) , praziquantel , protease inhibitors , <e2> quetiapine </e2> , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	Phenytoin	quetiapine
other	 In three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with <e1> fluoxetine </e1> 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with <e2> cimetidine </e2> 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers .	fluoxetine	cimetidine
other	 Agents with Increased Levels in the Presence of Carbamazepine : EQUETROTM increases the plasma levels of the following agents : Clomipramine HCl , Phenytoin (6) , and <e1> primidone </e1> Thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with <e2> EQUETROTM </e2> , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .	primidone	EQUETROTM
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , <e1> doxorubicin </e1> , vincristine , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , cyclophosphamide , doxorubicin , teniposide , and <e2> prednisone </e2> with vincristine plus bleomycin ) without receiving antiretroviral therapy .	doxorubicin	prednisone
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> finasteride </e1> doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , <e2> HMG-CoA reductase inhibitors </e2> , prostaglandin synthetase inhibitors (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	finasteride	HMG-CoA reductase inhibitors
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1> miconazole </e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e2> warfarin sodium </e2> overdosage .	miconazole	warfarin sodium
other	 Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and <e1> monoamine oxidase (MAO) inhibitors </e1> (concurrent use with <e2> antihistamines </e2> may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	monoamine oxidase (MAO) inhibitors	antihistamines
other	 Barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , <e1> anticoagulants </e1> , and <e2> beta blockers </e2> .	anticoagulants	beta blockers
other	 Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic <e1> iron supplement </e1> containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental <e2> iron </e2> reduced extent of absorption by 80% and 31% , respectively .	iron supplement	iron
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : <e1> alcohol </e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e2> fenoprofen </e2> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	alcohol	fenoprofen
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , <e1> doxycycline </e1> , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , <e2> risperidone </e2> , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	doxycycline	risperidone
effect	 Cholinesterase Inhibitors : <e1> Dipyridamole </e1> may counteract the anticholinesterase effect of <e2> cholinesterase inhibitors </e2> , thereby potentially aggravating myasthenia gravis .	Dipyridamole	cholinesterase inhibitors
other	 The following drugs have been coadministered with Kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , <e1> chlorthalidone </e1> , and <e2> hydrochlorothiazide </e2> .	chlorthalidone	hydrochlorothiazide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1> monoamine oxidase inhibitors </e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	monoamine oxidase inhibitors	quinine
effect	 Cyclosporine : Because <e1> cyclosporine </e1> can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine , and because renal excretion is the primary elimination route of <e2> fibrate drugs </e2> including TRICOR , there is a risk that an interaction will lead to deterioration .	cyclosporine	fibrate drugs
other	 Radioligand binding experiments using the uptake inhibitor hydrogen-3 <e1> mazindol </e1> revealed a significant decrease by approximately 30% in <e2> norepinephrine </e2> uptake-1 carrier density in functional classes II to III and IV myocardium versus nonfailing myocardium (p < 0.05) .	mazindol	norepinephrine
other	 <e1> Amitriptyline </e1> in combination with clonidine enhances the manifestation of corneal lesions in rats Epidural Injection <e2> Clonidine </e2> may potentiate the CNS-depressive effect of alcohol , barbiturates or other sedating drugs .	Amitriptyline	Clonidine
other	 Coadministration of <e1> SULAR </e1> with phenytoin or any known CYP3A4 inducer should be avoided and alternative <e2> antihypertensive </e2> therapy should be considered .	SULAR	antihypertensive
other	 When such drugs are withdrawn from patients receiving <e1> Acarbose </e1> in combination with sulfonylureas or <e2> insulin </e2> , patients should be observed closely for any evidence of hypoglycemia .	Acarbose	insulin
mechanism	 Increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased <e1> indinavir </e1> metabolism due to <e2> SUSTIVA </e2> .	indinavir	SUSTIVA
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1> chymotrypsin </e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e2> indomethacin </e2> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chymotrypsin	indomethacin
other	 Other Drugs : In healthy volunteers , amlodipine , phenytoin , <e1> glyburide </e1> , ranitidine , omeprazole , hormone replacement therapy (a combination of conjugated <e2> estrogens </e2> and medroxyprogesterone ) , antacid DRUG0 and magnesium hydroxide s) and theophylline did not affect the pharmacokinetics of TIKOSYN .	glyburide	estrogens
other	 Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( <e1> MAOI </e1> ) : MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - <e2> Ethanol </e2> : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	MAOI	Ethanol
effect	 Drugs that have been reported to diminish oral <e1> anticoagulant </e1> response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; <e2> antihistamines </e2> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	anticoagulant	antihistamines
mechanism	 Ascorbic acid : Doses of ascorbic acid ( <e1> vitamin C </e1> ) 1 g/day have been reported to increase plasma concentration of <e2> synthetic estrogens </e2> by ~47% , possibly by inhibiting conjugation;	vitamin C	synthetic estrogens
other	 Magnesium / <e1> Aluminum </e1> -containing <e2> Antacid Products </e2> : Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium / aluminum -containing antacid products .	Aluminum	Antacid Products
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1> cinchophen </e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e2> thyroid drugs </e2> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	cinchophen	thyroid drugs
other	 Nabilone should be administered with caution to patients who are taking other psychoactive drugs or <e1> CNS depressants </e1> , including alcohol , <e2> barbiturates </e2> and narcotic analgesics , or to those with a history of psychiatric disorder (including manic-depressive illness and schizophrenia) .	CNS depressants	barbiturates
other	 Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine ( <e1> etodolac </e1> capsules and tablets) results in reduced protein binding of <e2> warfarin </e2> , but there was no change in the clearance of free warfarin .	etodolac	warfarin
other	 Sildenafil is contraindicated in patients using <e1> long-acting nitrates </e1> or who may need to use <e2> short-acting nitrates </e2> , because the combination may cause a sharp fall of the blood pressure .	long-acting nitrates	short-acting nitrates
other	 Ritonavir : Coadministration of <e1> ritonavir </e1> with VIRACEPT resulted in a 152% increase in <e2> nelfinavir </e2> plasma AUC and very little change in ritonavir plasma A.C .	ritonavir	nelfinavir
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( <e1> Gris-PEG </e1> , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( <e2> rifampin </e2> ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Gris-PEG	rifampin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , <e1> fluvoxamine </e1> , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , <e2> protease inhibitors </e2> , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	fluvoxamine	protease inhibitors
other	 The aim of this paper was to study the interaction between <e1> neurotensin </e1> and both enkephalins or its synthetic analogue <e2> D-Ala2-metenkephalinamide </e2> , or tuftsin , on the antinonciceptive effect of these peptides in mice after intracisternal injection .	neurotensin	D-Ala2-metenkephalinamide
other	 The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , <e1> monoamine oxidase inhibitors </e1> , and <e2> beta adrenergic blocking agents </e2> .	monoamine oxidase inhibitors	beta adrenergic blocking agents
effect	 Pharmacodynamic Interactions : The CNS-depressant action of the <e1> benzodiazepine class </e1> of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , <e2> antianxiety agents </e2> , the DRUG0 , DRUG0 and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .	benzodiazepine class	antianxiety agents
int	 <e1> Chlorotrianisene </e1> may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , <e2> tamoxifen </e2> , and warfarin .	Chlorotrianisene	tamoxifen
other	 <e1> Veratrum alkaloids </e1> : <e2> Amphetamines </e2> inhibit the hypotensive effect of veratrum alkaloids .	Veratrum alkaloids	Amphetamines
other	 The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered <e1> AVONEX </e1> ) indicates that this alteration in clearance does not necessitate reduction of the <e2> TYSABRI </e2> dose to maintain safety , General) .	AVONEX	TYSABRI
effect	 Sumatriptan - There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a <e1> selective serotonin reuptake inhibitor </e1> ( SSRI ) and <e2> sumatriptan </e2> .	selective serotonin reuptake inhibitor	sumatriptan
other	 <e1> Lithium </e1> : Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including <e2> ACE inhibitors </e2> .	Lithium	ACE inhibitors
mechanism	 The mechanism for this interaction probably is adsorption of <e1> nitrofurantoin </e1> onto the surface of <e2> magnesium trisilicate </e2> .	nitrofurantoin	magnesium trisilicate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , <e1> p-aminosalicylic acid </e1> , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , <e2> lithium </e2> , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	p-aminosalicylic acid	lithium
effect	 poor metabolizers of debrisoquin : Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine , fluoxetine , paroxetine , and <e1> propafenone </e1> ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of <e2> carvedilol </e2> .	propafenone	carvedilol
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of EQUETROTM are the following : Cisplatin , doxorubicin HCL , felbamate , rifampin , phenobarbital , Phenytoin (2) , primidone , <e1> methsuximide </e1> , and <e2> theophylline </e2> Thus , if a patient has been titrated to a stable dosage on EQUETROTM , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for EQUETROTM may be necessary .	methsuximide	theophylline
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , <e1> niacin </e1> , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , <e2> progestogens </e2> (e.g. , in oral contraceptives ) .	niacin	progestogens
other	 <e1> Lotensin </e1> has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking agents , <e2> diuretics </e2> , digoxin , and hydralazine , without evidence of clinically important adverse interactions .	Lotensin	diuretics
other	 The concomitant use of transdermal fentanyl with <e1> ritonavir </e1> or other potent 3A4 inhibitors such as ketoconazole , itraconazole , <e2> troleandomycin </e2> , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .	ritonavir	troleandomycin
other	 Valproate : Available data suggest that there is no significant effect of valproate on the clearance of <e1> Felbatol </e1> at steady state , Therefore , the addition of <e2> valproate </e2> is not expected to cause a clinically important effect on Felbatol ( felbamate ) plasma concentrations .	Felbatol	valproate
mechanism	 This decrease in bioavailability was about 5% when <e1> gabapentin </e1> was administered 2 hours after <e2> Maalox </e2> .	gabapentin	Maalox
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1> nalidixic acid </e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e2> phenytoin </e2> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	nalidixic acid	phenytoin
other	 Additionally , <e1> aripiprazole </e1> and <e2> dehydroaripiprazole </e2> did not show potential for altering CYP1A2-mediated metabolism in vitro .	aripiprazole	dehydroaripiprazole
other	 Tell your doctor if you are taking any of the following drugs : <e1> blood thinner </e1> s ( Coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( Tegretol ) cimetidine ( Tagamet ) <e2> estrogens </e2> fluoxetine ( Prozac ) intraconazole ( Sporanox ) ketoconazole ( Nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	blood thinner	estrogens
other	 These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , <e1> phenytoin </e1> , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and <e2> isoniazid </e2> .	phenytoin	isoniazid
effect	 Additive CNS depression may occur when <e1> antihistamines </e1> are administered concomitantly with other <e2> CNS depressants </e2> including barbiturates , tranquilizers , and alcohol .	antihistamines	CNS depressants
other	 Caution should be used when administering or taking TARCEVA with ketoconazole and other strong CYP3A4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , <e1> itraconazole </e1> , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( TAO ) , and <e2> voriconazole </e2> .	itraconazole	voriconazole
other	 The gonadotropin levels may be transiently elevated by <e1> spironolactone </e1> , minimally elevated by levodopa , and suppressed by oral contraceptives and <e2> digoxin </e2> .	spironolactone	digoxin
other	 Serial plasma and urine samples for measurement of amprenavir , <e1> rifabutin </e1> , and <e2> rifampin </e2> and their 25-O-desacetyl metabolites , were measured by high-performance liquid chromatography .	rifabutin	rifampin
mechanism	 Methotrexate : Ibuprofen , as well as other <e1> nonsteroidal anti-inflammatory drugs </e1> , probably reduces the tubular secretion of <e2> methotrexate </e2> based on in vitro studies in rabbit kidney slices .	nonsteroidal anti-inflammatory drugs	methotrexate
mechanism	 <e1> Barbiturates </e1> , carbamazepine , and phenytoin decrease the half-life of <e2> doxycycline </e2> .	Barbiturates	doxycycline
other	 <e1> acetaminophen </e1> / theophylline , <e2> lidocaine </e2> / quinidine , phenobarbital / acetaminophen , phenobarbital / valproic acid , quinidine / lidocaine , theophylline / acetaminophen , and valproic acid / phenobarbital .	acetaminophen	lidocaine
advise	 The use of antacids should be considered in place of H2 blockers or <e1> proton pump inhibitors </e1> in patients receiving <e2> SPRYCEL </e2> therapy .	proton pump inhibitors	SPRYCEL
other	 <e1> Monoamine oxidase (MAO) inhibitors </e1> such as isocarboxazid (e.g. , Marplan ) , phenelzine (e.g. , <e2> Nardil </e2> ) , procarbazine (e.g. , Matulane ) , selegiline (e.g. , Eldepryl ) , and tranylcypromine (e.g. , Parnate ) : Using these medicines with L-tryptophan may increase the chance of side effects .	Monoamine oxidase (MAO) inhibitors	Nardil
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , <e1> diazepam </e1> , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , <e2> lovastatin </e2> , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	diazepam	lovastatin
other	 Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , <e1> prostaglandin synthetase inhibitors </e1> (also referred to as NSAIDs ) , and <e2> quinolone anti-infectives </e2> without evidence of clinically significant adverse interactions .	prostaglandin synthetase inhibitors	quinolone anti-infectives
other	 The effectiveness of progestin -only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , <e1> carbamazepine </e1> , and <e2> barbiturates </e2> , and the antituberculosis drug rifampin .	carbamazepine	barbiturates
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1> ranitidine </e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ranitidine	trimethoprim
advise	 Because there is a theoretical basis that these effects may be additive , use of <e1> ergotamine </e1> -containing or ergot-type medications (like dihydroergotamine or methysergide ) and <e2> naratriptan </e2> within 24 hours is contraindicated .	ergotamine	naratriptan
other	 In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with TAXOL should be premedicated with <e1> corticosteroids </e1> (such as dexamethasone ) , diphen-hydramine and H2 antagonists (such as cimetidine or <e2> ranitidine </e2> ) .	corticosteroids	ranitidine
other	 Selective serotonin reuptake inhibitors ( <e1> SSRIs </e1> ) (e.g. , fluoxetine , fluvoxamine , paroxetine , <e2> sertraline </e2> ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-HT1 agonists .	SSRIs	sertraline
effect	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1> NIMBEX </e1> include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and <e2> sodium colistemethate </e2> ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .	NIMBEX	sodium colistemethate
other	 ACE Inhibitors and <e1> Angiotensin II Receptor Antagonists </e1> (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving INSPRA 25 to 50 mg also received <e2> ACE inhibitors </e2> or angiotensin II receptor antagonists ( ACEI / ARB ) .	Angiotensin II Receptor Antagonists	ACE inhibitors
other	 The pharmacokinetics and protein binding of <e1> fosphenytoin </e1> , phenytoin , and <e2> diazepam </e2> were not altered when diazepam and Cerebyx were concurrently administered in single submaximal doses .	fosphenytoin	diazepam
other	 The effects of concomitant administration of <e1> cimetidine </e1> on the pharmacokinetics of <e2> bupropion </e2> and its active metabolites were studied in 24 healthy young male volunteers .	cimetidine	bupropion
advise	 Patients who are applying <e1> Panretin </e1> gel should not concurrently use products that contain <e2> DEET </e2> (N , N-diethyl-m-toluamide ) , a common component of insect repellent products .	Panretin	DEET
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , <e1> phenothiazine derivatives </e1> , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral <e2> contraceptives </e2> ) .	phenothiazine derivatives	contraceptives
other	 May interact with wthionamide ( <e1> Trecator-SC </e1> ) and <e2> isoniazid </e2> ( Nydrazid ) .	Trecator-SC	isoniazid
other	 In clinical studies , coadministration of <e1> WelChol </e1> with atorvastatin , <e2> lovastatin </e2> , or simvastatin did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor .	WelChol	lovastatin
other	 Garlic Capsules Garlic capsules should not be used while taking saquinavir ( <e1> FORTOVASE </e1> ) as the sole <e2> protease inhibitor </e2> due to the risk of decreased saquinavir plasma concentrations .	FORTOVASE	protease inhibitor
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , <e1> doxycycline </e1> , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , <e2> valproate </e2> , warfarin (5) , ziprasidone , and zonisamide .	doxycycline	valproate
other	 Digoxin , Nimodipine and Losartan : <e1> Bosentan </e1> has no significant pharmacokinetic interactions with <e2> digoxin </e2> and nimodipine , and losartan has no significant effect on plasma levels of bosentan .	Bosentan	digoxin
other	 Etonogestrel may interact with the following medications : acetaminophen ( <e1> Tylenol </e1> ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , <e2> clofibrate </e2> ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Tylenol	clofibrate
other	 The following agents may increase certain actions or side effects of DRUG0 . amantadine antiarrhythmic agents of class (e.g . quinidine ) , antihistamines <e1> antipsychotic agents </e1> (e.g . phenothiazines ) , <e2> benzodiazepines </e2> .	antipsychotic agents	benzodiazepines
other	 <e1> INDOCIN </e1> and <e2> potassium-sparing diuretics </e2> each may be associated with increased serum potassium levels .	INDOCIN	potassium-sparing diuretics
other	 <e1> Amphotericin </e1> , Foscarnet , and Aminoglycosides : Drugs such as amphotericin , <e2> foscarnet </e2> , and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID -associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure) .	Amphotericin	foscarnet
effect	 These results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and <e1> retinoids </e1> , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of <e2> insulin </e2> and EGF .	retinoids	insulin
other	 In addition , <e1> Fondaparinux </e1> neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and <e2> digoxin </e2> , nor the pharmacokinetics of digoxin at steady state .	Fondaparinux	digoxin
other	 Studies have shown that <e1> lansoprazole </e1> does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system , such as warfarin , antipyrine , indomethacin , <e2> ibuprofen </e2> , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .	lansoprazole	ibuprofen
other	 Drug-Drug Interactions Albuterol - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other <e1> beta2 agonists </e1> ) because the action of <e2> albuterol </e2> on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .	beta2 agonists	albuterol
mechanism	 Hydrochlorothiazide : In normal volunteers , concomitant administration of <e1> diflunisal </e1> and <e2> hydrochlorothiazide </e2> resulted in significantly increased plasma levels of hydrochlorothiazide .	diflunisal	hydrochlorothiazide
mechanism	 The absorption of oral <e1> gemifloxacin </e1> is significantly reduced by the concomitant administration of an antacid containing <e2> aluminum </e2> and magnesium .	gemifloxacin	aluminum
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1> cinchophen </e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; <e2> methylphenidate </e2> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	cinchophen	methylphenidate
other	 The behavioral effects of the stereoisomers of N-allylnormetazocine ( <e1> NANM </e1> ) were compared with those of phencyclidine ( <e2> PCP </e2> ) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation .	NANM	PCP
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e1> phenylbutazone </e1> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	phenylbutazone	tolbutamide
other	 <e1> Ethosuximide </e1> : <e2> Amphetamines </e2> may delay intestinal absorption of ethosuximide .	Ethosuximide	Amphetamines
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1> anabolic steroids </e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e2> oxyphenbutazone </e2> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anabolic steroids	oxyphenbutazone
other	 The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ACE inhibitors , disopyramide , <e1> fibrates </e1> , fluoxetine , MAO inhibitors , propoxyphene , salicylates , somatostatin analog (e.g. , octreotide ) , <e2> sulfonamide antibiotics </e2> .	fibrates	sulfonamide antibiotics
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , <e1> prednisolone </e1> ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	prednisolone	temazepam
other	 When used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , <e1> fluconazole </e1> , indinavir , midazolam , rifabutin , sildenafil , theophylline (intravenous and oral) , triazolam , trimethoprim / <e2> sulfamethoxazole </e2> or zidovudine .	fluconazole	sulfamethoxazole
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , <e1> Nuprin </e1> , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( <e2> Anaprox </e2> , Naprosyn , Aleve );	Nuprin	Anaprox
other	 These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , <e1> phenytoin </e1> , nicotinic acid , sympathomimet-ics , <e2> calcium channel blocking drugs </e2> , and isoniazid .	phenytoin	calcium channel blocking drugs
other	 Central nervous system depressant (CNS) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , <e1> methyldopa </e1> , beta-blockers ) , motion sickness medications , <e2> muscle relaxants </e2> , narcotics , sedatives , sleeping pills and tranquilizers	methyldopa	muscle relaxants
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1> influenza virus vaccine </e1> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e2> sulindac </e2> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	influenza virus vaccine	sulindac
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , <e1> buspirone </e1> , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , <e2> Phenytoin </e2> (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	buspirone	Phenytoin
other	 Hormonal contraceptives Co-administration of Trileptal with an oral <e1> contraceptive </e1> has been shown to influence the plasma concentrations of the two hormonal components , <e2> ethinylestradiol </e2> (EE) and levonorgestrel (LNG) .	contraceptive	ethinylestradiol
other	 Oral <e1> Hypoglycemic Agents </e1> : In one study , flurbiprofen was given to adult diabetics who were already receiving glyburide (n=4) , metformin (n=2) chlorpropamide with phenformin (n= 3) or <e2> glyburide </e2> with phenformin (n=6) .	Hypoglycemic Agents	glyburide
other	 Endothelium-intact aortic rings from high- <e1> estradiol </e1> rats were supersensitive to noradrenaline when compared to vehicle- , <e2> progesterone </e2> - and progesterone + high- estradiol -treated rats (pD2 values = 7.77+/-0.12 , 7.21+/-0.13 , 6.93+/-0.04 and 7.22+/-0.18 , respectively) .	estradiol	progesterone
other	 In patients taking furosemide , nifedipine , <e1> diltiazem </e1> , ACE inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of <e2> hydrodolasetron </e2> .	diltiazem	hydrodolasetron
other	 Certain antibiotic , cisplatin , cyclosporine , <e1> diuretic </e1> , foscarnet , and <e2> vaccines </e2> .	diuretic	vaccines
advise	 Caution is advised when <e1> TRISENOX </e1> is coadministered with other medications that can prolong the QT interval (e.g . certain antiarrhythmics or <e2> thioridazine </e2> ) or lead to electrolyte abnormalities (such as diuretics or amphotericin B ) .	TRISENOX	thioridazine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1> metronidazole </e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e2> thyroid drugs </e2> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	metronidazole	thyroid drugs
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , <e1> felodipine </e1> , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , <e2> oxcarbazepine </e2> , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	felodipine	oxcarbazepine
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , <e1> Prolixin </e1> ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , <e2> Sparine </e2> ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Prolixin	Sparine
other	 May interact with thyroid medication (e.g. , levothyroxine ) , <e1> iodine </e1> -containing products , antacids , H2-antagonists (e.g. , famotidine , <e2> ranitidine </e2> ) , and proton pump inhibitors (e.g. , lansoprazole , omeprazole ) .	iodine	ranitidine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1> monoamine oxidase inhibitors </e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	monoamine oxidase inhibitors	quinine
other	 <e1> Phenobarbital </e1> : Estimates of steady-state pharmacokinetic parameters for DRUG0 or <e2> gabapentin </e2> (300 mg TID;	Phenobarbital	gabapentin
other	 Among the <e1> polyene antibiotics </e1> , many , like <e2> filipin </e2> , cannot be used clinically because they are toxic;	polyene antibiotics	filipin
other	 - Cholestyramine and <e1> colestipol </e1> resins : Cholestytamine and colestipol <e2> resins </e2> have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract	colestipol	resins
other	 Some <e1> drugs </e1> /substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of <e2> CYP3A4 </e2> (enzyme induction) .	drugs	CYP3A4
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1> pyrazolones </e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	pyrazolones	trimethoprim
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , <e1> cyclosporin </e1> , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , <e2> oxcarbazepine </e2> , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	cyclosporin	oxcarbazepine
mechanism	 Co-administration of <e1> bosentan </e1> decreased the plasma concentrations of <e2> glyburide </e2> by approximately 40% .	bosentan	glyburide
other	 Before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( <e1> Trilisate </e1> ) , salsalate ( Disalcid , others) , <e2> choline salicylate </e2> ( Arthropan ) , magnesium salicylate ( Magan ) , or bismuth subsalicylate ( Pepto-Bismol );	Trilisate	choline salicylate
other	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including , for example , <e1> ondansetron </e1> , granisetron , dolasetron , palonosetron , and <e2> alosetron </e2> ) is contraindicated .	ondansetron	alosetron
other	 The homodimeric disintegrin contortrostatin was compared directly to the monomeric disintegrins <e1> echistatin </e1> and <e2> flavoridin </e2> for the ability to affect protein tyrosine phosphorylation in tumor cells .	echistatin	flavoridin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1> salicylates </e1> ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	salicylates	sulfinpyrazone
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , <e1> Prolixin </e1> ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , <e2> Trilafon </e2> ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Prolixin	Trilafon
other	 ANTACID ( <e1> Magnesium-Aluminum Hydroxide </e1> ) : Cerivastatin plasma concentrations were not affected by co-administration of <e2> antacid </e2> .	Magnesium-Aluminum Hydroxide	antacid
effect	 The concomitant use of vasopressor s , vasoconstricting agents (such as <e1> ergonovine </e1> ) and some <e2> oxytocic drugs </e2> may result in severe hypertension .	ergonovine	oxytocic drugs
effect	 Interactions attributed to the combined use of <e1> baclofen </e1> injection and epidural <e2> morphine </e2> include hypotension and dyspnea .	baclofen	morphine
other	 The principal drugs given (number of patients in parentheses) were : <e1> cardiac glycosides </e1> (115) , sedatives and hypnotics (103) , coronary vasodilators (52) , oral hypoglycemics (45) , cough and cold preparations (45) , NSAIDs (38) , antihyperlipidemics (29) , antigout drugs (24) , oral contraceptives (18) , bronchodilators (13) , <e2> insulin </e2> (10) , and beta blockers (10) .	cardiac glycosides	insulin
other	 The bioavailability of the capsule formulation of <e1> cefprozil </e1> was not affected when administered 5 minutes following an <e2> antacid </e2> .	cefprozil	antacid
other	 <e1> Allopurinol </e1> : The AUC of didanosine was increased about 4-fold when allopurinol at 300 mg/day was coadministered with a single 200-mg dose of <e2> VIDEX </e2> to two patients with renal impairment (CLcr=15 and 18 mL/min) .	Allopurinol	VIDEX
other	 Monoamine oxidase (MAO) inhibitors such as <e1> isocarboxazid </e1> (e.g. , Marplan ) , phenelzine (e.g. , <e2> Nardil </e2> ) , procarbazine (e.g. , Matulane ) , selegiline (e.g. , Eldepryl ) , and tranylcypromine (e.g. , Parnate ) : Using these medicines with L-tryptophan may increase the chance of side effects .	isocarboxazid	Nardil
other	 Epinephrine also should be used cautiously with other drugs (e.g. , digitalis , <e1> glycosides </e1> ) that sensitize the myocardium to the actions of <e2> sympathomimetic drugs </e2> .	glycosides	sympathomimetic drugs
other	 acetaminophen / theophylline , lidocaine / quinidine , phenobarbital / <e1> acetaminophen </e1> , phenobarbital / valproic acid , quinidine / <e2> lidocaine </e2> , theophylline / acetaminophen , and valproic acid / phenobarbital .	acetaminophen	lidocaine
other	 <e1> INOmax </e1> has been administered with tolazoline , <e2> dopamine </e2> , dobutamine , steroids , surfactant , and high-frequency ventilation .	INOmax	dopamine
other	 - Drugs whose efficacy is impaired by phenytoin include : <e1> anticoagulants </e1> , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , <e2> rifampin </e2> , quinidine , theophylline , vitamin D .	anticoagulants	rifampin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1> diazoxide </e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e2> oxyphenbutazone </e2> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diazoxide	oxyphenbutazone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , <e1> methadone </e1> , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , <e2> protease inhibitors </e2> , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	methadone	protease inhibitors
other	 Cephalosporins - Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , <e1> latamoxef </e1> ) or methylthiadiazole ( <e2> cefazolin </e2> ) can cause vitamin K deficiency and hypoprothrombinemia .	latamoxef	cefazolin
other	 Sympathomimetic amines may reduce the antihypertensive effects of <e1> reserpine </e1> , veratrum alkaloids , methyldopa and <e2> mecamylamine </e2> .	reserpine	mecamylamine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , <e1> cimetidine </e1> , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , <e2> nefazodone </e2> , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	cimetidine	nefazodone
other	 The effect of <e1> TORADOL </e1> on <e2> methotrexate </e2> clearance has not been studied .	TORADOL	methotrexate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; <e1> allopurinol </e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e2> salicylates </e2> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	allopurinol	salicylates
other	 Iron Supplements and Foods Fortified With Iron Concomitant administration of <e1> cefdinir </e1> with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or <e2> vitamins </e2> supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31% , respectively .	cefdinir	vitamins
other	 It may increase excretion of barbiturates , <e1> lithium </e1> , and <e2> ASA </e2> and may also increase the toxicity of salicylates .	lithium	ASA
other	 Since there have been isolated reports of patients with elevated <e1> digoxin </e1> levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing <e2> nifedipine </e2> to avoid possible over- or under-digitalization .	digoxin	nifedipine
other	 Phenytoin : If <e1> acitretin </e1> is given concurrently with phenytoin , the protein binding of <e2> phenytoin </e2> may be reduced .	acitretin	phenytoin
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all central nervous system depressants (eg , alcohol , sedatives , hypnotics , other <e1> opioids </e1> , general anesthetics , <e2> barbiturates </e2> , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .	opioids	barbiturates
other	 Dopamine Antagonists : Since apomorphine is a <e1> dopamine agonist </e1> , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , <e2> thioxanthenes </e2> ) or metoclopramide , may diminish the effectiveness of APOKYN .	dopamine agonist	thioxanthenes
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1> ibuprofen </e1> ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e2> prolonged narcotics </e2> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ibuprofen	prolonged narcotics
mechanism	 Antacids increase the rate of absorption of <e1> pseudoephedrine </e1> , while <e2> kaolin </e2> decreases it .	pseudoephedrine	kaolin
other	 <e1> Phenobarbital </e1> : It appears that phenobarbital may reduce plasma <e2> felbamate </e2> concentrations .	Phenobarbital	felbamate
other	 Tacrolimus <e1> Felodipine </e1> may increase the blood concentration of <e2> tacrolimus </e2> .	Felodipine	tacrolimus
other	 Although there is no documentation of such , a similar interaction between <e1> ethotoin </e1> and the <e2> coumarin anticoagulants </e2> may occur .	ethotoin	coumarin anticoagulants
other	 Compounds tested in man include warfarin , theophylline , <e1> phenytoin </e1> , diazepam , aminopyrine and <e2> antipyrine </e2> .	phenytoin	antipyrine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( <e1> Neoral </e1> , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , <e2> Kadian </e2> , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Neoral	Kadian
mechanism	 Benzodiazepines : Combination <e1> hormonal contraceptives </e1> may decrease the clearance of some <e2> benzodiazepines </e2> ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .	hormonal contraceptives	benzodiazepines
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; <e1> methylphenidate </e1> ; metronidazole ; <e2> miconazole </e2> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	methylphenidate	miconazole
other	 <e1> Beta Blockers </e1> : Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45 ( <e2> dihydroergotamine mesylate </e2> ) Injection , USP to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .	Beta Blockers	dihydroergotamine mesylate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1> chlorpropamide </e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; <e2> methylphenidate </e2> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chlorpropamide	methylphenidate
other	 In vivo interaction studies in humans have demonstrated that digoxin and <e1> warfarin </e1> do not affect the PK properties of <e2> anagrelide </e2> , nor does anagrelide affect the PK properties of digoxin or warfarin .	warfarin	anagrelide
other	 The concurrent use of two or more drugs with anticholinergic activity--such as an antipsychotic drug (eg , chlorpromazine ) , an antiparkinsonian drug (eg , trihexyphenidyl ) , and/or a <e1> tricyclic antidepressant </e1> (eg , <e2> amitriptyline </e2> )--commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .	tricyclic antidepressant	amitriptyline
other	 The gastrointestinal absorption of <e1> cimetidine </e1> and <e2> ranitidine </e2> is accelerated when they are coadministered with cisapride .	cimetidine	ranitidine
mechanism	 In addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , <e1> nevirapine </e1> , phenytoin , dexamethasone , or carbamazepine ) with <e2> CANCIDAS </e2> may result in clinically meaningful reductions in caspofungin concentrations .	nevirapine	CANCIDAS
mechanism	 Hydrochlorothiazide : In normal volunteers , concomitant administration of <e1> diflunisal </e1> and <e2> hydrochlorothiazide </e2> resulted in significantly increased plasma levels of hydrochlorothiazide .	diflunisal	hydrochlorothiazide
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , <e1> diltiazem </e1> , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , <e2> valproate </e2> (1) , verapamil , zileuton .	diltiazem	valproate
other	 Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , <e1> protease inhibitors </e1> , quinidine , and <e2> verapamil </e2> .	protease inhibitors	verapamil
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , <e1> Serentil </e1> ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , <e2> Mellaril </e2> ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Serentil	Mellaril
mechanism	 These alterations in <e1> digoxin </e1> pharmacokinetics produced by <e2> amiodarone </e2> explain the increase in serum digoxin level that has been observed when this drug combination has been used clinically .	digoxin	amiodarone
advise	 Avoid the concomitant use of <e1> chlorprothixene </e1> and <e2> tramadol </e2> ( Ultram ) .	chlorprothixene	tramadol
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; <e1> alcohol </e1> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; <e2> rifampin </e2> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	alcohol	rifampin
other	 INDOCIN can reduce the antihypertensive effects of <e1> captopril </e1> and <e2> losartan </e2> .	captopril	losartan
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain <e1> antibiotics </e1> (e . g. , <e2> aminoglycosides </e2> , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .	antibiotics	aminoglycosides
effect	 <e1> Fenfluramine </e1> may increase slightly the effect of antihypertensive drugs , e.g. , <e2> guanethidine </e2> , methyldopa , reserpine .	Fenfluramine	guanethidine
effect	 Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( <e1> NSAIDs </e1> ) , and aspirin may increase the risk of bleeding when administered concomitantly with <e2> ardeparin </e2> .	NSAIDs	ardeparin
mechanism	 Benzodiazepines : Combination <e1> hormonal contraceptives </e1> may decrease the clearance of some benzodiazepines ( <e2> alprazolam </e2> , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .	hormonal contraceptives	alprazolam
mechanism	 If <e1> phenytoin </e1> or other hepatic enzyme inducers are taken concurrently with Norpace or <e2> Norpace CR </e2> , lower plasma levels of disopyramide may occur .	phenytoin	Norpace CR
other	 Administration of quinolones with antacids containing aluminum , magnesium , or <e1> calcium </e1> , with <e2> sucralfate </e2> , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	calcium	sucralfate
other	 In a study with concomitant administration of aspirin and <e1> fosinopril sodium </e1> , the bioavailability of unbound <e2> fosinoprilat </e2> was not altered .	fosinopril sodium	fosinoprilat
other	 <e1> Tolazamide </e1> : A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 gm/day) 11 days after the addition of <e2> doxepin </e2> (75 mg/day) .	Tolazamide	doxepin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; <e1> cimetidine </e1> ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e2> quinidine </e2> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	cimetidine	quinidine
other	 cimetidine ) and many that are substrates for P450 2D6 (many other antidepressants , <e1> phenothiazines </e1> , and the <e2> Type 1C antiarrhythmics </e2> propafenone and flecainide ) .	phenothiazines	Type 1C antiarrhythmics
other	 Probenecid : Concomitant administration of <e1> TORADOL </e1> ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in <e2> ketorolac </e2> plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .	TORADOL	ketorolac
other	 The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose ( NaCMC ) and carboxymethylcellulose-cysteine ( <e1> CMC-Cys </e1> ) conjugates on the intestinal permeation of <e2> sodium fluorescein </e2> ( NaFlu ) and model peptide drugs , bacitracin and insulin .	CMC-Cys	sodium fluorescein
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1> diflunisal </e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e2> glucagon </e2> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diflunisal	glucagon
other	 A clinical study in healthy male volunteers (n=24) demonstrated that mixing <e1> NovoLog </e1> with <e2> NPH human insulin </e2> immediately before injection produced some attenuation in the peak concentration of NovoLog , but that the time to peak and the total bioavailability of NovoLog were not significantly affected .	NovoLog	NPH human insulin
other	 The risk of using <e1> bromocriptine mesylate </e1> in combination with other drugs has not been systematically evaluated , but <e2> alcohol </e2> may potentiate the side effects of bromocriptine mesylate .	bromocriptine mesylate	alcohol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1> disulfiram </e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e2> quinidine </e2> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	disulfiram	quinidine
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e1> chlordiazepoxide </e1> ; cholestyramine ;diet high in vitamin K ; diuretics *; <e2> ethchlorvynol </e2> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	chlordiazepoxide	ethchlorvynol
other	 <e1> Benzodiazepines </e1> : Combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , <e2> chlordiazepoxide </e2> , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .	Benzodiazepines	chlordiazepoxide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : <e1> alcohol </e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e2> indomethacin </e2> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	alcohol	indomethacin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , <e1> clonazepam </e1> , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , <e2> tramadol </e2> , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	clonazepam	tramadol
other	 <e1> Cyclosporine </e1> : Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the <e2> quinolone class </e2> .	Cyclosporine	quinolone class
other	 In vitro studies have shown no binding displacement between <e1> entacapone </e1> and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and <e2> diazepam </e2> .	entacapone	diazepam
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , <e1> danazol </e1> , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , <e2> niacinamide </e2> , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	danazol	niacinamide
other	 Coadministration of phenytoin with 40 mg <e1> SULAR </e1> tablets in epileptic patients lowered the <e2> nisoldipine </e2> plasma concentrations to undetectable levels .	SULAR	nisoldipine
mechanism	 If <e1> phenytoin </e1> or other hepatic enzyme inducers are taken concurrently with <e2> Norpace </e2> or Norpace CR , lower plasma levels of disopyramide may occur .	phenytoin	Norpace
effect	 Platelet inhibitors : Drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , <e1> dipyridamole </e1> , hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving <e2> heparin sodium </e2> .	dipyridamole	heparin sodium
effect	 <e1> Phospholine Iodide </e1> potentiates other <e2> cholinesterase inhibitors </e2> such as succinylcholine or DRUG0 and carbamate insecticide s .	Phospholine Iodide	cholinesterase inhibitors
other	 - a sulfa-based drug such as <e1> sulfamethoxazole </e1> - trimethoprim ( Bactrim , <e2> Septra </e2> ) , sulfisoxazole ( Gantrisin ) , or sulfasalazine ( Azulfidine );	sulfamethoxazole	Septra
other	 Therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , <e1> carbamazepine </e1> , and <e2> Type 1C antiarrhythmics </e2> (e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme (e.g. , quinidine ) , should be approached with caution .	carbamazepine	Type 1C antiarrhythmics
other	 Cephalosporins - <e1> Cephalosporins </e1> containing side chains of N-methylthiotetrazole ( cefmenoxime , <e2> cefoperazone </e2> , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	Cephalosporins	cefoperazone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1> pentoxifylline </e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e2> salicylates </e2> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	pentoxifylline	salicylates
effect	 Propoxyphene : In cases of <e1> propoxyphene </e1> overdosage , <e2> amphetamine </e2> CNS stimulation is potentiated and fatal convulsions can occur .	propoxyphene	amphetamine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , <e1> quinupristin </e1> , troleandomycin , valproate (1) , verapamil , <e2> zileuton </e2> .	quinupristin	zileuton
other	 <e1> Benzodiazepines </e1> : Combination <e2> hormonal contraceptives </e2> may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .	Benzodiazepines	hormonal contraceptives
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , <e1> b-adrenergic blocking agents </e1> , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , <e2> heparin </e2> , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	b-adrenergic blocking agents	heparin
other	 <e1> Antiarrhythmic agents, class I </e1> (such as flecainide , lidocaine , or quinidine ) : concurrent use with <e2> arbutamine </e2> may have a proarrhythmic effect .	Antiarrhythmic agents, class I	arbutamine
other	 Caffeine <e1> Theobromine </e1> Grepafloxacin , like other quinolones , may inhibit the metabolism of <e2> caffeine </e2> and theobromine .	Theobromine	caffeine
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , <e1> perphenazine </e1> [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , <e2> promazine </e2> [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	perphenazine	promazine
advise	 Dose adjustment of <e1> Sensipar </e1> may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor (e.g. , ketoconazole , <e2> erythromycin </e2> , itraconazole ;	Sensipar	erythromycin
effect	 Sumatriptan - There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a <e1> selective serotonin reuptake inhibitor </e1> ( SSRI ) and <e2> sumatriptan </e2> .	selective serotonin reuptake inhibitor	sumatriptan
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : <e1> androgens </e1> and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , <e2> perphenazine </e2> , phenylbutazone , phenytoin , salicylates , tamoxifen .	androgens	perphenazine
mechanism	 The concomitant administration of <e1> uricosuric agents </e1> and <e2> allopurinol </e2> has been associated with a decrease in the excretion of oxypurines (hypoxanthine and xanthine) and an increase in urinary uric acid excretion compared with that observed with allopurinol alone .	uricosuric agents	allopurinol
other	 <e1> Digoxin </e1> : Studies of concomitant administration of <e2> flurbiprofen </e2> and digoxin to healthy men (n= 14) did not show a change in the steady state serum levels of either drug .	Digoxin	flurbiprofen
other	 Because there is a theoretical basis that these effects may be additive , use of <e1> ergotamine </e1> -containing or <e2> ergot-type medications </e2> (like dihydroergotamine or methysergide ) and AXERT within 24 hours of each other should be avoided .	ergotamine	ergot-type medications
other	 <e1> Amantadine </e1> , tricyclic antidepressants , and <e2> MAOIs </e2> may increase anticholinergic effect of clidinium .	Amantadine	MAOIs
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain <e1> antibiotics </e1> (e . g. , aminoglycosides , <e2> tetracyclines </e2> , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .	antibiotics	tetracyclines
other	 Co-administration of lovastatin , atenolol , <e1> warfarin </e1> , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and <e2> amlodipine </e2> did not result in clinically significant increases in aliskiren exposure .	warfarin	amlodipine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , <e1> perchlorate </e1> , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , <e2> heparin </e2> , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	perchlorate	heparin
other	 Other Cardiovascular Agents : <e1> Enalapril </e1> and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , hydralazine , <e2> prazosin </e2> and digoxin without evidence of clinically significant adverse interactions .	Enalapril	prazosin
other	 The co-administration of Natrecor with IV vasodilators such as nitroglycerin , <e1> nitroprusside </e1> , milrinone , or IV <e2> ACE inhibitors </e2> has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials) .	nitroprusside	ACE inhibitors
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( <e1> Motrin </e1> , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( <e2> Indocin </e2> ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	Motrin	Indocin
other	 <e1> Amitriptyline </e1> in combination with clonidine enhances the manifestation of corneal lesions in rats Epidural Injection Clonidine may potentiate the CNS-depressive effect of alcohol , <e2> barbiturates </e2> or other sedating drugs .	Amitriptyline	barbiturates
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1> influenza virus vaccine </e1> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	influenza virus vaccine	sulfinpyrazone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1> influenza virus vaccine </e1> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e2> miconazole </e2> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	influenza virus vaccine	miconazole
other	 <e1> Ranitidine </e1> 150 mg twice daily did not interact significantly with <e2> nisoldipine </e2> (AUC was decreased by 15-20 %) .	Ranitidine	nisoldipine
effect	 Although this effect was noted even when <e1> cholestyramine </e1> was given 4 hours prior to <e2> fluvastatin </e2> , this regimen did not result in diminished efficacy .	cholestyramine	fluvastatin
other	 <e1> Protease inhibitors </e1> : Amprenavir , lopinavir , <e2> nelfinavir </e2> , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;	Protease inhibitors	nelfinavir
other	 Based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination (e.g. , <e1> cimetidine </e1> and <e2> ketoconazole </e2> ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination (e.g. , phenobarbital and phenytoin ) .	cimetidine	ketoconazole
other	 In addition , studies in healthy volunteers have shown that <e1> TIKOSYN </e1> does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol (40 mg twice daily) , phenytoin , <e2> theophylline </e2> , or oral contraceptives .	TIKOSYN	theophylline
other	 <e1> apomorphine </e1> - prior ingestion of diphenidol may decrease the <e2> emetic </e2> response to apomorphine in the treatment of poisoning .	apomorphine	emetic
other	 Since Zarontin ( ethosuximide ) may interact with concurrently administered <e1> antiepileptic drugs </e1> , periodic serum level determinations of these drugs may be necessary (eg , ethosuximide may elevate <e2> phenytoin </e2> serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels) .	antiepileptic drugs	phenytoin
other	 In addition , studies in healthy volunteers have shown that <e1> TIKOSYN </e1> does not affect the pharmacokinetics or pharmacodynamics of <e2> warfarin </e2> , or the pharmacokinetics of propranolol (40 mg twice daily) , phenytoin , theophylline , or oral contraceptives .	TIKOSYN	warfarin
other	 Therefore , interactions could occur following concomitant administration of <e1> psychotropic drugs </e1> (e.g. , narcotics , <e2> analgesics </e2> , antiemetics , sedatives , tranquilizers ) .	psychotropic drugs	analgesics
effect	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1> NIMBEX </e1> include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , <e2> lincomycin </e2> , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .	NIMBEX	lincomycin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e1> antibiotics </e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e2> ethacrynic acid </e2> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	antibiotics	ethacrynic acid
int	 <e1> Chlorotrianisene </e1> may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , <e2> nicotine </e2> , somatropin , tamoxifen , and warfarin .	Chlorotrianisene	nicotine
other	 The growth of Pseudomonas aeruginosa , particularly serotype O11 , in <e1> pentazocine </e1> and <e2> tripelennamine </e2>	pentazocine	tripelennamine
other	 When the <e1> STADOL NS </e1> was administered 30 minutes after the sumatriptan nasal spray , the AUC of <e2> butorphanol </e2> increased 11% and Cmax decreased 18% .	STADOL NS	butorphanol
int	 <e1> Benzthiazide </e1> may interact with alcohol , blood thinner s , decongestant drugs (allergy , cold , and sinus medicines) , diabetic drugs , <e2> lithium </e2> , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	Benzthiazide	lithium
other	 <e1> Nimodipine </e1> had no effect on <e2> ginsenosides </e2> response .	Nimodipine	ginsenosides
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , <e1> amiodarone </e1> , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , <e2> succinimides </e2> , sulfonamides , tolbutamide , trazodone	amiodarone	succinimides
other	 Effects of Erythromycin on Felbatol The coadministration of <e1> erythromycin </e1> (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax , Cmin , AUC , CI/kg or tmax at <e2> felbamate </e2> daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy .	erythromycin	felbamate
other	 The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including <e1> nonsteroidal anti-inflammatory agents </e1> and other drugs that are highly protein bound , salicylates , sulfonamides , <e2> chloramphenicol </e2> , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	nonsteroidal anti-inflammatory agents	chloramphenicol
other	 The following agents may increase certain actions or side effects of DRUG0 . amantadine antiarrhythmic agents of class (e.g . quinidine ) , antihistamines <e1> antipsychotic agents </e1> (e.g . phenothiazines ) , <e2> benzodiazepines </e2> .	antipsychotic agents	benzodiazepines
effect	 Drugs that reportedly may increase oral <e1> anticoagulant </e1> response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; <e2> methyldopa </e2> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anticoagulant	methyldopa
advise	 Nucleoside Analogues Didanosine Co-administration of <e1> COPEGUS </e1> and <e2> didanosine </e2> is not recommended .	COPEGUS	didanosine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1> oxyphenbutazone </e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	oxyphenbutazone	sulfonamides
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , <e1> delavirdine </e1> , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , <e2> risperidone </e2> , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	delavirdine	risperidone
other	 Agents with Increased Levels in the Presence of <e1> Carbamazepine </e1> : EQUETROTM increases the plasma levels of the following agents : Clomipramine HCl , <e2> Phenytoin </e2> (6) , and primidone Thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with EQUETROTM , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .	Carbamazepine	Phenytoin
other	 In another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome P450 3A4 , increased the exposure (AUC) of <e1> des-ciclesonide </e1> by approximately 3.6-fold at steady state , while levels of <e2> ciclesonide </e2> remained unchanged .	des-ciclesonide	ciclesonide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1> nalidixic acid </e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e2> sulindac </e2> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	nalidixic acid	sulindac
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1> sulfinpyrazone </e1> ; sulfonamides , long acting; sulindac ; <e2> thyroid drugs </e2> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	sulfinpyrazone	thyroid drugs
mechanism	 <e1> SUSTIVA </e1> has the potential to decrease plasma concentrations of <e2> itraconazole </e2> and ketoconazole .	SUSTIVA	itraconazole
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1> cholestyramine </e1> ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral <e2> contraceptives </e2> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	cholestyramine	contraceptives
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , aminoglycosides , indomethacin ) , myelotoxic (e.g. , cytotoxic chemotherapy) , cardiotoxic (e.g. , <e1> doxorubicin </e1> ) or hepatotoxic (e.g. , <e2> methotrexate </e2> , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	doxorubicin	methotrexate
advise	 Exert particular caution in combining <e1> chlorprothixene </e1> with other anticholinergic drugs ( tricyclic antidepressants and <e2> antiparkinsonian agents </e2> ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .	chlorprothixene	antiparkinsonian agents
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , <e1> niacin </e1> , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , <e2> thyroid hormones </e2> , estrogens , progestogens (e.g. , in oral contraceptives ) .	niacin	thyroid hormones
other	 Compounds tested in man include warfarin , theophylline , phenytoin , diazepam , <e1> aminopyrine </e1> and <e2> antipyrine </e2> .	aminopyrine	antipyrine
other	 Antacids , <e1> kaolin </e1> -pectin , sulfasalazine , neomycin , <e2> cholestyramine </e2> , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .	kaolin	cholestyramine
other	 Increases in plasma levels of <e1> tricyclic antidepressants </e1> , and in the frequency and severity of side effects , particularly <e2> anticholinergic </e2> , have been reported when cimetidine was added to the drug regimen .	tricyclic antidepressants	anticholinergic
effect	 A direct causal relationship has not been established , but physicians should consider the possibility that <e1> diclofenac </e1> may alter a diabetic patient s response to insulin or oral <e2> hypoglycemic agents </e2> .	diclofenac	hypoglycemic agents
other	 Since the pharmacokinetics of BUSULFEX were studied in patients treated with phenytoin , the clearance of <e1> BUSULFEX </e1> at the recommended dose may be lower and exposure (AUC) higher in patients not treated with <e2> phenytoin </e2> .	BUSULFEX	phenytoin
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , <e1> sympathomimetic agents </e1> (e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral <e2> contraceptives </e2> ) .	sympathomimetic agents	contraceptives
advise	 Itraconazole plasma concentrations should be monitored when <e1> Itraconazole </e1> and <e2> isoniazid </e2> are coadministered .	Itraconazole	isoniazid
other	 - a <e1> monoamine oxidase inhibitor </e1> ( MAOI ) such as isocarboxazid ( Marplan ) , tranylcypromine ( Parnate ) , or phenelzine ( <e2> Nardil </e2> );	monoamine oxidase inhibitor	Nardil
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , <e1> androgens </e1> and related anabolic hormones , complex anions ( thiocyanate , <e2> perchlorate </e2> , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	androgens	perchlorate
other	 Bentiromide may interact with acetaminophen (e.g. , Tylenol ) , chloramphenicol (e.g. , <e1> Chloromycetin </e1> ) , local anesthetics (e.g. , benzocaine and lidocaine ) , <e2> para-aminobenzoic acid </e2> ( PABA )-containing preparations (e.g. , sunscreens and some multivitamins ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	Chloromycetin	para-aminobenzoic acid
other	 <e1> cimetidine </e1> ) and many that are substrates for P450 2D6 (many other antidepressants , <e2> phenothiazines </e2> , and the Type 1C antiarrhythmics propafenone and flecainide ) .	cimetidine	phenothiazines
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1> cholestyramine </e1> ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; <e2> primidone </e2> ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	cholestyramine	primidone
other	 Co-administration of <e1> aliskiren </e1> did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , <e2> celecoxib </e2> , atenolol , atorvastatin , ramipril or hydrochlorothiazide .	aliskiren	celecoxib
other	 Imidazoles (e . g. , ketoconazole , miconazole , clotrimazole , <e1> fluconazole </e1> , etc.) : in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to <e2> amphotericin B </e2> .	fluconazole	amphotericin B
effect	 <e1> Corticosteroids </e1> and Corticotropin ( ACTH ) : may potentiate <e2> amphotericin B </e2> - induced hypokalemia which may predispose the patient to cardiac dysfunction .	Corticosteroids	amphotericin B
other	 <e1> Triazolam </e1> - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either <e2> citalopram </e2> or triazolam .	Triazolam	citalopram
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e1> chlordiazepoxide </e1> ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; <e2> rifampin </e2> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	chlordiazepoxide	rifampin
other	 While all the selective serotonin reuptake inhibitors ( SSRIs ) , e . g. , fluoxetine , <e1> sertraline </e1> , and <e2> paroxetine </e2> , inhibit P450 2D6 , they may vary in the extent of inhibition .	sertraline	paroxetine
other	 Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and <e1> antineoplastic agents </e1> , specifically , dacarbazine , cis-platinum , <e2> tamoxifen </e2> and interferon-alfa .	antineoplastic agents	tamoxifen
other	 Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar , <e1> ketamine </e1> , or droperidol but not after administration of <e2> fentayl </e2> alone or after pentobarbital .	ketamine	fentayl
other	 Potential drug interactions between Keppra and other AEDs ( <e1> carbamazepine </e1> , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of <e2> levetiracetam </e2> and these AEDs during placebo-controlled clinical studies .	carbamazepine	levetiracetam
other	 DRUG0 : Immediate Release Capsules : There have been rare reports of an interaction between quinidine and <e1> nifedipine </e1> (with a decreased plasma level of <e2> quinidine </e2> ) .	nifedipine	quinidine
other	 <e1> Magnesium </e1> - and/or aluminum -containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or Videx ( <e2> didanosine </e2> ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE .	Magnesium	didanosine
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , <e1> mesoridazine </e1> [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , <e2> Phenergan </e2> ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	mesoridazine	Phenergan
other	 The in vitro anti-cryptosporidial activity of buforin II alone and in combination with <e1> azithromycin </e1> and <e2> minocycline </e2> was investigated .	azithromycin	minocycline
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1> monoamine oxidase inhibitors </e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	monoamine oxidase inhibitors	trimethoprim
other	 The plasma maximum concentration and area under the plasma concentration-time curve of diltiazem , <e1> desacetyldiltiazem </e1> , and <e2> desmethyldiltiazem </e2> were unchanged after coadministration of sirolimus , and no potentiation of the effects of diltiazem on diastolic or systolic blood pressure or on the electrocardiographic parameters was seen .	desacetyldiltiazem	desmethyldiltiazem
other	 Because <e1> dexfenfluramine </e1> is a serotonin releaser and reuptake inhibitor , dexfenfluramine should not be used concomitantly with a <e2> MAO inhibitor </e2> .	dexfenfluramine	MAO inhibitor
mechanism	 Uricosuric Agents : Since the excretion of oxipurinol is similar to that of urate , <e1> uricosuric agents </e1> , which increase the excretion of urate , are also likely to increase the excretion of <e2> oxipurinol </e2> and thus lower the degree of inhibition of xanthine oxidase .	uricosuric agents	oxipurinol
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , <e1> MS Contin </e1> ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( <e2> Theo-Dur </e2> ) , and vitamin C .	MS Contin	Theo-Dur
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e1> antibiotics </e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e2> metronidazole </e2> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	antibiotics	metronidazole
other	 Non-selective MAO inhibitors including <e1> tranylcypromine sulfate </e1> , phenelzine sulfate , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective <e2> MAO inhibitors </e2> may cause hypertension .	tranylcypromine sulfate	MAO inhibitors
other	 The co-administration of <e1> Natrecor </e1> with IV vasodilators such as <e2> nitroglycerin </e2> , nitroprusside , milrinone , or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials) .	Natrecor	nitroglycerin
advise	 <e1> Nabilone </e1> should be administered with caution to patients who are taking other psychoactive drugs or CNS depressants , including alcohol , <e2> barbiturates </e2> and narcotic analgesics , or to those with a history of psychiatric disorder (including manic-depressive illness and schizophrenia) .	Nabilone	barbiturates
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e1> barbiturates </e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e2> cholestyramine </e2> ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	barbiturates	cholestyramine
other	 Effects of other Antiepilepsy Drugs ( <e1> AEDs </e1> ) on <e2> GABITRIL </e2> : Carbamazepine : Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs .	AEDs	GABITRIL
other	 Before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another <e1> salicylate </e1> such as magnesium/choline salicylate ( Trilisate ) , salsalate ( Disalcid , others) , choline salicylate ( Arthropan ) , magnesium salicylate ( Magan ) , or bismuth subsalicylate ( <e2> Pepto-Bismol </e2> );	salicylate	Pepto-Bismol
other	 Nonsteroidal anti-inflammatory agents ( <e1> NSAIDS </e1> ) : Concomitant use of <e2> aspirin </e2> (or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .	NSAIDS	aspirin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , <e1> antifungals </e1> ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , <e2> Kadian </e2> , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	antifungals	Kadian
other	 Antiarrhythmics : bepridil , <e1> lidocaine </e1> (systemic) and <e2> quinidine </e2>	lidocaine	quinidine
other	 <e1> Beta Blockers </e1> : Although the results of a clinical study did not indicate a safe problem associated with the administration of <e2> D.H.E. 45 </e2> ( dihydroergotamine mesylate ) Injection , USP to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .	Beta Blockers	D.H.E. 45
other	 Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics : <e1> amiodarone </e1> , quinidine Antihistamines : astemizole , terfenadine Antimigraine : ergot derivatives Antimycobacterial agents : <e2> rifampin </e2> Benzodiazepines midazolam , triazolam GI motility agents : cisapride	amiodarone	rifampin
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , anticoagulants ( blood thinner s) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines) , central nervous system (CNS) depressants (using these medicines with <e1> barbiturates </e1> may result in increased CNS depressant effects) , divalproex sodium , valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take) , and oral contraceptives containing <e2> estrogens </e2> ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control) .	barbiturates	estrogens
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; <e1> haloperidol </e1> ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e2> warfarin sodium </e2> under-dosage .	haloperidol	warfarin sodium
advise	 Consequently , it is recommended not to exceed a single 2.5 mg <e1> Vardenafil </e1> dose in a 72-hour period when used in combination with <e2> ritonavir </e2> .	Vardenafil	ritonavir
advise	 Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g. , <e1> epinephrine </e1> , norepinephrine ) , since it has been reported that <e2> tricyclic antidepressants </e2> can potentiate the effects of catecholamines .	epinephrine	tricyclic antidepressants
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , <e1> warfarin </e1> (5) , ziprasidone , and <e2> zonisamide </e2> .	warfarin	zonisamide
other	 Administration of quinolones with antacids containing <e1> aluminum </e1> , magnesium , or calcium , with sucralfate , with metal cations such as <e2> iron </e2> , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	aluminum	iron
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	trimethoprim
advise	 Other <e1> CNS depressant drugs </e1> should be used with caution in patients taking <e2> fenfluramine </e2> , since the effects may be additive .	CNS depressant drugs	fenfluramine
other	 Other Concomitant Therapy In healthy subjects there were no clinically significant interactions when <e1> felodipine </e1> was given concomitantly with <e2> indomethacin </e2> or spironolactone .	felodipine	indomethacin
other	 Carbamazepine : <e1> Isoniazid </e1> is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the <e2> anticonvulsant </e2> should be made .	Isoniazid	anticonvulsant
other	 No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including cyclosporine , <e1> corticosteroids </e1> , and either azathioprine or <e2> mycophenolate mofetil </e2> .	corticosteroids	mycophenolate mofetil
mechanism	 Anticonvulsants : In a pharmacokinetic study , maximum plasma concentrations of <e1> felodipine </e1> were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg , phenytoin , carbamazepine , or <e2> phenobarbital </e2> ) than in healthy volunteers .	felodipine	phenobarbital
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , <e1> buspirone </e1> , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , <e2> topiramate </e2> , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	buspirone	topiramate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , <e1> citalopram </e1> , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , <e2> Phenytoin </e2> (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	citalopram	Phenytoin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , <e1> azole antifungals </e1> , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , <e2> troleandomycin </e2> , valproate (1) , verapamil , zileuton .	azole antifungals	troleandomycin
other	 Anticoagulants : Potentiation of warfarin -type ( <e1> CYP2C9 </e1> and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving <e2> amiodarone </e2> and can result in serious or fatal bleeding .	CYP2C9	amiodarone
mechanism	 Saquinavir : Coadministration of <e1> saquinavir </e1> (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with <e2> VIRACEPT </e2> resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in saquinavir plasma A.C .	saquinavir	VIRACEPT
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	sulfonamides
other	 The absorption of tetracycline , <e1> furosemide </e1> , penicillin G , hydrochlorothiazide , and <e2> gemfibrozil </e2> was significantly decreased when given simultaneously with colestipol hydrochloride ;	furosemide	gemfibrozil
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other <e1> benzodiazepines </e1> (caution is recommended during coadministration with alprazolam ) : Available data from clinical studies of benzodiazepines other than <e2> alprazolam </e2> suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .	benzodiazepines	alprazolam
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; <e1> methyldopa </e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e2> naproxen </e2> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	methyldopa	naproxen
other	 <e1> Isoflurane </e1> , enflurane , and <e2> halothane </e2> decrease the ED50 of NUROMAX by 30% to 45% .	Isoflurane	halothane
effect	 <e1> Antihistamines </e1> may enhance the effects of tricyclic antidepressants , barbiturates , <e2> alcohol </e2> , and other CNS depressants .	Antihistamines	alcohol
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( <e1> Daypro </e1> ) , and naproxen ( Anaprox , <e2> Naprosyn </e2> , Aleve );	Daypro	Naprosyn
effect	 Spontaneous reports of serotonin syndrome associated with co-administration of <e1> ZYVOX </e1> and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( <e2> SSRIs </e2> ) , have been reported .	ZYVOX	SSRIs
other	 Therefore , co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain <e1> antidepressants </e1> (e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , haloperidol , <e2> risperidone </e2> , thioridazine ) , beta-blockers (e.g. , metoprolol ) , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	antidepressants	risperidone
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , <e1> Topamax </e1> , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	Topamax	temazepam
other	 This drug may interact with alcohol or other <e1> CNS depressants </e1> (may potentiate the CNS depressant effects of either these medications or antihistamines ) , <e2> anticholinergics </e2> or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	CNS depressants	anticholinergics
effect	 Concomitant use of <e1> digoxin </e1> and <e2> sympathomimetics </e2> increases the risk of cardiac arrhythmias .	digoxin	sympathomimetics
other	 However , the antagonism of the theophylline -induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone , and DPCPX -induced anxiogenic effects were neither reversed by <e1> CGS 21680 </e1> nor by <e2> CPA </e2> .	CGS 21680	CPA
other	 Interactions for vitamin D analogues ( Vitamin D2 , Vitamin D3 , <e1> Calcitriol </e1> , and Calcidiol ) : Cholestyramine : <e2> Cholestyramine </e2> has been reported to reduce intestinal absorption of fat soluble vitamins ;	Calcitriol	Cholestyramine
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a <e1> quinolone </e1> , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or <e2> zinc </e2> may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	quinolone	zinc
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e1> disulfiram </e1> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e2> influenza virus vaccine </e2> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	disulfiram	influenza virus vaccine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1> dextrothyroxine </e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e2> sulindac </e2> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextrothyroxine	sulindac
other	 Patients receiving other narcotic analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other <e1> CNS depressants </e1> (including <e2> alcohol </e2> ) concomitantly with DILAUDID may exhibit an additive CNS depression .	CNS depressants	alcohol
other	 Coadministration of valdecoxib and Ortho-Novum 1/35 increased the exposure of <e1> norethindrone </e1> and <e2> ethinyl estradiol </e2> by 20% and 34% , respectively .	norethindrone	ethinyl estradiol
advise	 If concomitant treatment with <e1> AXERT </e1> and an <e2> SSRI </e2> is clinically warranted , appropriate observation of the patient is advised .	AXERT	SSRI
other	 <e1> Ketoconazole </e1> (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with <e2> Vardenafil </e2> (5 mg) in healthy volunteers .	Ketoconazole	Vardenafil
other	 No significant difference was found between the mean values of the volume of distribution of <e1> cloxacillin </e1> with and without <e2> probenecid </e2> (13.0 and 12.6 liters , respectively) .	cloxacillin	probenecid
other	 Terfenadine : No clinically significant changes occurred in heart rate or corrected QT intervals , or in terfenadine metabolite or lomefloxacin pharmacokinetics , during concurrent administration of <e1> lomefloxacin </e1> and <e2> terfenadine </e2> at steady-state in 28 healthy males .	lomefloxacin	terfenadine
mechanism	 Phenytoin : <e1> Isoniazid </e1> may increase serum levels of <e2> phenytoin </e2> .	Isoniazid	phenytoin
effect	 <e1> Verapamil </e1> also significantly decreased the incidence of lymphatic invasion of adenocarcinomas , which was enhanced by <e2> bombesin </e2> .	Verapamil	bombesin
other	 - Phenothiazines ( acetophenazine [e.g. , <e1> Tindal </e1> ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , <e2> Serentil </e2> ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Tindal	Serentil
int	 <e1> Chlorotrianisene </e1> may interact with <e2> antidepressants </e2> , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .	Chlorotrianisene	antidepressants
other	 Other Drugs : In small groups of patients (7-10/interaction study) , the concomitant administration of azathioprine , gold , chloroquine , D-penicillamine , <e1> prednisolone </e1> , doxycycline , or digitoxin did not significantly affect the peak levels and AUC values of <e2> diclofenac </e2> .	prednisolone	diclofenac
other	 Cisapride should not be used concomitantly with other drugs known to prolong the QT interval : certain antiarrhythmics , including those of Class IA (such as <e1> quinidine </e1> and procainamide ) and Class III (such as <e2> sotalol </e2> );	quinidine	sotalol
other	 In monkeys , the effects of <e1> (-)-NANM </e1> , but not <e2> (+)-NANM </e2> or PCP , were antagonized by naloxone ;	(-)-NANM	(+)-NANM
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; <e1> paraldehyde </e1> ; primidone ; ranitidine *; <e2> rifampin </e2> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	paraldehyde	rifampin
other	 In clinical trials , FLOLAN was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with <e1> FLOLAN </e1> was initiated , apparent oral clearance values for furosemide (n = 23) and <e2> digoxin </e2> (n = 30) were decreased by 13% and 15% , respectively , on the second day of therapy and had returned to baseline values by day 87 .	FLOLAN	digoxin
other	 <e1> Selective serotonin reuptake inhibitors </e1> ( SSRIs ) (e.g. , <e2> fluoxetine </e2> , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-HTv agonists .	Selective serotonin reuptake inhibitors	fluoxetine
other	 Concomitant <e1> cyclophosphamide </e1> , doxorubicin , vincristine , and <e2> prednisone </e2> chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	cyclophosphamide	prednisone
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> finasteride </e1> doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , <e2> prostaglandin synthetase inhibitors </e2> (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	finasteride	prostaglandin synthetase inhibitors
other	 In a drug interaction study , co-administration of orally inhaled <e1> ciclesonide </e1> and oral erythromycin , an inhibitor of cytochrome P450 3A4 , had no effect on the pharmacokinetics of either des-ciclesonide or <e2> erythromycin </e2> .	ciclesonide	erythromycin
other	 <e1> Central nervous system depressant </e1> (CNS) drugs including alcohol , <e2> antidepressants </e2> , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers	Central nervous system depressant	antidepressants
effect	 Spontaneous reports of serotonin syndrome associated with co-administration of <e1> ZYVOX </e1> and serotonergic agents , including <e2> antidepressants </e2> such as selective serotonin reuptake inhibitors ( SSRIs ) , have been reported .	ZYVOX	antidepressants
other	 While additional research is needed , the initial clinical data in kidney recipients suggest that sirolimus , in combination with cyclosporine or <e1> tacrolimus </e1> , might have the potential to reduce the frequency of rejection episodes , permit reductions in <e2> cyclosporine </e2> or tacrolimus dosage , and permit steroid withdrawal (Kelly , 1999) .	tacrolimus	cyclosporine
other	 Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , <e1> phenytoin </e1> , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , <e2> theophylline </e2> and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	phenytoin	theophylline
other	 <e1> Phenytoin </e1> : Altered serum levels of phenytoin (increased and decreased) have been reported in patients receiving concomitant <e2> ciprofloxacin </e2> .	Phenytoin	ciprofloxacin
other	 Serum <e1> infliximab </e1> concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids , antibiotics ( metronidazole or <e2> ciprofloxacin </e2> ) and aminosalicylates .	infliximab	ciprofloxacin
advise	 However , because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients , the prothrombin time or other suitable coagulation test should be closely monitored if a <e1> quinolone antimicrobial </e1> is administered concomitantly with <e2> warfarin </e2> or its derivatives .	quinolone antimicrobial	warfarin
other	 Benzthiazide may interact with alcohol , blood thinner s , <e1> decongestant drugs </e1> (allergy , cold , and sinus medicines) , diabetic drugs , <e2> lithium </e2> , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	decongestant drugs	lithium
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , <e1> aminoglycosides </e1> , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , <e2> lithium </e2> , local anesthetics , procainamide , and quinidine .	aminoglycosides	lithium
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e1> barbiturates </e1> ; <e2> carbamazepine </e2> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	barbiturates	carbamazepine
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , <e1> Compazine </e1> ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , <e2> thioridazine </e2> [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Compazine	thioridazine
other	 The concomitant administration of <e1> Exjade </e1> and aluminum -containing <e2> antacid preparations </e2> has not been formally studied .	Exjade	antacid preparations
other	 Ketoconazole did not affect the conversion of <e1> losartan </e1> to the active metabolite after intravenous administration of losartan , and <e2> erythromycin </e2> had no clinically significant effect after oral administration .	losartan	erythromycin
other	 Coadministration of <e1> LEXAPRO </e1> and <e2> metoprolol </e2> had no clinically significant effects on blood pressure or heart rate .	LEXAPRO	metoprolol
other	 <e1> Warfarin </e1> : Quinolones may enhance the effects of the oral <e2> anticoagulant </e2> , warfarin , or its derivatives .	Warfarin	anticoagulant
other	 Rarely <e1> salicylate </e1> toxicity may occur in patients who discontinue steroids after concurrent high-dose <e2> aspirin </e2> therapy .	salicylate	aspirin
other	 Chlorotrianisene may interact with <e1> antidepressants </e1> , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , <e2> corticotropin </e2> , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .	antidepressants	corticotropin
effect	 The antihypertensive effects of <e1> methyldopa </e1> , mecamylamine , reserpine , and veratrum alkaloids may be reduced by <e2> sympathomimetics </e2> .	methyldopa	sympathomimetics
effect	 Patients who begin taking diclofenac or who increase their diclofenac dose or any other <e1> NSAID </e1> while taking digoxin , <e2> methotrexate </e2> , or cyclosporine may develop toxicity characteristics for these drugs .	NSAID	methotrexate
mechanism	 <e1> Antacids </e1> may interfere with the absorption of <e2> LEVSIN </e2> .	Antacids	LEVSIN
other	 Therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , <e1> carbamazepine </e1> , and <e2> Type 1C antiarrhythmics </e2> (eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme (eg , quinidine ) , should be approached with caution .	carbamazepine	Type 1C antiarrhythmics
other	 Benzodiazepines : Combination hormonal contraceptives may decrease the clearance of some <e1> benzodiazepines </e1> ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , <e2> oxazepam </e2> , temazepam ) .	benzodiazepines	oxazepam
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , <e1> Kaletra </e1> , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	Kaletra	temazepam
other	 Therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , <e1> carbamazepine </e1> , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide and <e2> encainide </e2> ) , or that inhibit this enzyme (e.g. , quinidine ) , should be approached with caution .	carbamazepine	encainide
other	 The absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an antacid containing <e1> aluminum </e1> and <e2> magnesium </e2> .	aluminum	magnesium
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , aminoglycosides , indomethacin ) , myelotoxic (e.g. , <e1> cytotoxic </e1> chemotherapy) , cardiotoxic (e.g. , doxorubicin ) or hepatotoxic (e.g. , methotrexate , <e2> asparaginase </e2> ) effects with PROLEUKIN may increase toxicity in these organ systems .	cytotoxic	asparaginase
other	 Magnesium / Aluminum -containing Antacid Products : Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium / <e1> aluminum </e1> -containing <e2> antacid products </e2> .	aluminum	antacid products
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1> cinchophen </e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e2> thyroid drugs </e2> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	cinchophen	thyroid drugs
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( <e1> Indocin </e1> ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , <e2> Aleve </e2> );	Indocin	Aleve
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all central nervous system depressants (eg , alcohol , <e1> sedatives </e1> , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and <e2> antihistamines </e2> ) may result in additive central nervous system depressant effects .	sedatives	antihistamines
other	 The <e1> threohydrobupropion </e1> metabolite of <e2> bupropion </e2> does not appear to be produced by the cytochrome P450 isoenzymes .	threohydrobupropion	bupropion
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1> salicylates </e1> ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	salicylates	sulfinpyrazone
advise	 Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering <e1> Gleevec </e1> with inhibitors of the CYP3A4 family (e.g. , ketoconazole , itraconazole , <e2> erythromycin </e2> , clarithromycin ) .	Gleevec	erythromycin
other	 When <e1> cholestyramine </e1> resin is given for long periods of time , concomitant supplementation with water-miscible (or parenteral) forms of <e2> fat-soluble vitamins </e2> should be considered .	cholestyramine	fat-soluble vitamins
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1> chymotrypsin </e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e2> ranitidine </e2> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chymotrypsin	ranitidine
other	 <e1> Magnesium </e1> - and/or aluminum -containing antacids , products containing ferrous sulfate ( iron ) , <e2> multivitamin preparations </e2> containing zinc or other metal cations , or Videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE .	Magnesium	multivitamin preparations
mechanism	 <e1> Tagamet </e1> , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , <e2> lidocaine </e2> , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	Tagamet	lidocaine
mechanism	 Phenytoin : <e1> Amphetamines </e1> may delay intestinal absorption of <e2> phenytoin </e2> ;	Amphetamines	phenytoin
mechanism	 <e1> DIAMOX </e1> modifies phenytoin metabolism with increased serum levels of <e2> phenytoin </e2> .	DIAMOX	phenytoin
other	 Antacids : Administration of flurbiprofen to volunteers under fasting conditions , or with <e1> antacid </e1> suspension yielded similar serum <e2> flurbiprofen </e2> time profiles in young subjects (n=12) .	antacid	flurbiprofen
other	 A similar association , though less marked , has been suggested with <e1> barbiturates </e1> , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and <e2> tetracyclines </e2> 72 .	barbiturates	tetracyclines
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e1> carbamazepine </e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; <e2> diuretics </e2> *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	carbamazepine	diuretics
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , <e1> fluoxetine </e1> , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , <e2> valproate </e2> (1) , verapamil , zileuton .	fluoxetine	valproate
other	 Administration of eplerenone with other CYP3A4 inhibitors (e.g. , <e1> erythromycin </e1> 500 mg BID , verapamil 240 mg QD , saquinavir 1200 mg TID , fluconazole 200 mg QD) resulted in increases in Cmax of <e2> eplerenone </e2> ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold .	erythromycin	eplerenone
other	 In the present study , evoked potentials were recorded at 5 , 20 , and 40 min following IP injections of saline , <e1> ethanol </e1> (2.0 g/kg) , physostigmine (0.6 mg/kg) or <e2> atropine </e2> (15.0 mg/kg) on separate days .	ethanol	atropine
effect	 Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when <e1> ALFENTA </e1> is administered in combination with other <e2> CNS depressants </e2> such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .	ALFENTA	CNS depressants
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , <e1> colistin </e1> , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , <e2> procainamide </e2> , and quinidine .	colistin	procainamide
other	 acetaminophen / theophylline , lidocaine / <e1> quinidine </e1> , phenobarbital / acetaminophen , phenobarbital / valproic acid , quinidine / lidocaine , theophylline / acetaminophen , and valproic acid / <e2> phenobarbital </e2> .	quinidine	phenobarbital
other	 On the basis of the metabolism of <e1> bexarotene </e1> by cytochrome P450 3A4 , ketoconazole , itraconazole , erythromycin , <e2> gemfibrozil </e2> , grapefruit juice , and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations .	bexarotene	gemfibrozil
advise	 Based on adult data , lower doses of <e1> caffeine </e1> may be needed following coadministration of drugs which are reported to decrease caffeine elimination (e.g. , <e2> cimetidine </e2> and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination (e.g. , phenobarbital and phenytoin ) .	caffeine	cimetidine
other	 After 14 days of co-administration , mean trough concentrations of <e1> clozapine </e1> and its metabolites , N-desmethylclozapine and clozapine N-oxide , were elevated with <e2> fluvoxamine </e2> by about three-fold compared to baseline concentrations .	clozapine	fluvoxamine
other	 Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without <e1> thiosulfate </e1> indicated that there were no changes in the elimination rate constant , volume of distribution , or total body clearance of <e2> cisplatin </e2> .	thiosulfate	cisplatin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , <e1> methadone </e1> , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e2> contraceptives </e2> (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	methadone	contraceptives
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1> monoamine oxidase inhibitors </e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e2> ranitidine </e2> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	monoamine oxidase inhibitors	ranitidine
other	 Therefore , when <e1> hydroflumethiazide </e1> and nonsteroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the <e2> diuretic </e2> is obtained.)	hydroflumethiazide	diuretic
other	 When Itraconazole was coadministered with <e1> phenytoin </e1> , rifampin , or H2antagonists , reduced plasma concentrations of <e2> itraconazole </e2> were reported .	phenytoin	itraconazole
other	 Etonogestrel may interact with the following medications : <e1> acetaminophen </e1> ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , <e2> Kadian </e2> , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	acetaminophen	Kadian
other	 [Dose-time effects of competitive displacement of radiopertechnetate by sodium perchlorate following oral and intravenous administration] The effect of various doses of <e1> sodium perchlorate </e1> in several dose fractions on the extent and the time scale of displacement of <e2> radiopertechnetate </e2> , in dependence on application mode , was studied .	sodium perchlorate	radiopertechnetate
other	 <e1> propranolol </e1> to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , AUC and Cmax , differences were 20% between <e2> isradipine </e2> given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .	propranolol	isradipine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; <e1> allopurinol </e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e2> chloral hydrate </e2> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	allopurinol	chloral hydrate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , <e1> clonazepam </e1> , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , <e2> Phenytoin </e2> (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	clonazepam	Phenytoin
effect	 Drug Interactions : The central anticholinergic syndrome can occur when DRUG0 agents such as <e1> AKINETON </e1> are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the <e2> quinidine </e2> salts , and antihistamines .	AKINETON	quinidine
other	 THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS , <e1> NON-NARCOTIC ANALGESICS </e1> AND <e2> BARBITURATES </e2> .	NON-NARCOTIC ANALGESICS	BARBITURATES
other	 Concomitant medications were grouped as <e1> ACE inhibitors </e1> , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of CYP3A4 , substrates and inhibitors of CYP3A4 , substrates and inhibitors of P-glycoprotein , nitrates , <e2> sulphonylureas </e2> , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and QTc-prolonging drugs .	ACE inhibitors	sulphonylureas
other	 <e1> Calcium Antagonist </e1> s : After repeated co-administration of <e2> Trileptal </e2> , the AUC of felodipine was lowered by 28% [90% CI : 20-33] .	Calcium Antagonist	Trileptal
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e1> sulfonamides </e1> , long acting; <e2> sulindac </e2> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	sulfonamides	sulindac
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , <e1> chlorpromazine </e1> [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , <e2> promazine </e2> [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	chlorpromazine	promazine
mechanism	 Antibiotics : In vitro and/or in vivo data show that <e1> clarithromycin </e1> , erythromycin , and troleandomycin markedly inhibit the metabolism of <e2> cisapride </e2> , which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG .	clarithromycin	cisapride
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , <e1> clobazam </e1> , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , <e2> protease inhibitors </e2> , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	clobazam	protease inhibitors
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1> chymotrypsin </e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e2> pyrazolones </e2> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chymotrypsin	pyrazolones
other	 <e1> astemizole </e1> , bepridil , sparfloxacin , and <e2> terodiline </e2> .	astemizole	terodiline
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , <e1> dopamine </e1> and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , <e2> lovastatin </e2> , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	dopamine	lovastatin
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain <e1> antibiotics </e1> (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and <e2> quinidine </e2> .	antibiotics	quinidine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation <e1> anesthetics </e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e2> naproxen </e2> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anesthetics	naproxen
other	 <e1> Bacteriostatic Antibiotics </e1> : Chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of <e2> penicillins </e2> .	Bacteriostatic Antibiotics	penicillins
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e1> griseofulvin </e1> ; <e2> haloperidol </e2> ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	griseofulvin	haloperidol
mechanism	 In vitro studies have shown that the metabolism of <e1> docetaxel </e1> may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome P450 3A4 , such as <e2> cyclosporine </e2> , terfenadine , ketoconazole , erythromycin , and troleandomycin .	docetaxel	cyclosporine
other	 propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , AUC and Cmax , differences were 20% between isradipine given singly and in combination with propranolol , and between <e1> propranolol </e1> given singly and in combination with <e2> isradipine </e2> .	propranolol	isradipine
other	 Phenytoin : In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on <e1> phenytoin </e1> monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on <e2> gabapentin </e2> pharmacokinetics .	phenytoin	gabapentin
other	 May interact <e1> anticoagulants </e1> (altered hypo-prothrombinemic effect) , barbiturates , <e2> rifampin </e2> and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol ) , corticosteroids (increased effect of corticosteroids ) .	anticoagulants	rifampin
other	 <e1> indinavir </e1> concentration <e2> rifabutin </e2> concentration	indinavir	rifabutin
effect	 <e1> TCAs </e1> decrease the hypotensive effect of <e2> guanfacine </e2> .	TCAs	guanfacine
other	 Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with <e1> acetaminophen </e1> , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , <e2> diuretics </e2> , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	acetaminophen	diuretics
other	 <e1> Eprosartan </e1> doses of up to 300 mg b.i.d . have been safely used concomitantly with sustained-release calcium channel blockers (sustained-release <e2> nifedipine </e2> ) with no clinically significant adverse interactions .	Eprosartan	nifedipine
mechanism	 <e1> Ketoconazole </e1> tablets may alter the metabolism of <e2> cyclosporine </e2> , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .	Ketoconazole	cyclosporine
other	 - Anabolic steroids ( nandrolone [e.g. , Anabolin ] , oxandrolone [e.g. , Anavar ] , <e1> oxymetholone </e1> [e.g. , Anadrol ] , stanozolol [e.g. , <e2> Winstrol </e2> ]) or	oxymetholone	Winstrol
effect	 Nephrotoxicity has been reported following concomitant administration of <e1> aminoglycoside antibiotics </e1> and <e2> cephalosporin antibiotics </e2> .	aminoglycoside antibiotics	cephalosporin antibiotics
other	 Tell your doctor if you are taking any of the following drugs : blood thinner s ( Coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( Tegretol ) cimetidine ( <e1> Tagamet </e1> ) estrogens fluoxetine ( Prozac ) intraconazole ( Sporanox ) ketoconazole ( <e2> Nizoral </e2> ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	Tagamet	Nizoral
other	 Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled <e1> corticosteroids </e1> , and <e2> analgesics </e2> .	corticosteroids	analgesics
other	 These drugs include the <e1> thiazides </e1> and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , <e2> nicotinic acid </e2> , sympathomimetics , calcium channel blocking drugs , and isoniazid .	thiazides	nicotinic acid
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1> anabolic steroids </e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e2> diflunisal </e2> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anabolic steroids	diflunisal
other	 A similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , <e1> topiramate </e1> , and possibly with ampicillin and <e2> tetracyclines </e2> 72 .	topiramate	tetracyclines
other	 <e1> Amphotericin </e1> , Foscarnet , and Aminoglycosides : Drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID -associated adverse events by interfering with the renal clearance of <e2> zalcitabine </e2> (thereby raising systemic exposure) .	Amphotericin	zalcitabine
other	 Such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , the <e1> tricyclic antidepressants </e1> , and <e2> clozapine </e2> .	tricyclic antidepressants	clozapine
other	 <e1> Rifampin </e1> : Co-administration of VIOXX with rifampin 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50% decrease in <e2> rofecoxib </e2> plasma concentrations .	Rifampin	rofecoxib
effect	 In patients receiving nonselective monoamine oxidase inhibitors ( MAOIs ) (e.g. , <e1> selegiline hydrochloride </e1> ) in combination with serotoninergic agents (e.g. , fluoxetine , fluvoxamine , <e2> paroxetine </e2> , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .	selegiline hydrochloride	paroxetine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; <e1> mefenamic acid </e1> ; <e2> methyldopa </e2> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	mefenamic acid	methyldopa
effect	 Fentanyl Anesthesia : Severe hypotension has been reported during <e1> fentanyl </e1> anesthesia with concomitant use of a beta blocker and a <e2> calcium channel blocker </e2> .	fentanyl	calcium channel blocker
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , <e1> levothyroxine </e1> , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , <e2> risperidone </e2> , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	levothyroxine	risperidone
other	 <e1> Theophylline </e1> -related adverse effects have occurred in patients when theophylline and <e2> enoxacin </e2> were coadministered .	Theophylline	enoxacin
other	 Therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and Type 1C antiarrhythmics (e.g. , <e1> propafenone </e1> , flecainide and encainide ) , or that inhibit this enzyme (e.g. , <e2> quinidine </e2> ) , should be approached with caution .	propafenone	quinidine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , <e1> anticonvulsants </e1> ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and <e2> vitamin C </e2> .	anticonvulsants	vitamin C
other	 Administration of quinolones with <e1> antacids </e1> containing <e2> aluminum </e2> , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	antacids	aluminum
other	 Interactions with <e1> Mixed Agonist/Antagonist Opioid Analgesics </e1> : Agonist/antagonist analgesics (eg , pentazocine , <e2> nalbuphine </e2> , butorphanol , dezocine and buprenorphine ) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran .	Mixed Agonist/Antagonist Opioid Analgesics	nalbuphine
other	 Although these results do not indicate a significant interaction between TORADOL and warfarin or <e1> heparin </e1> , the administration of TORADOL to patients taking <e2> anticoagulants </e2> should be done extremely cautiously , and patients should be closely monitored .	heparin	anticoagulants
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , cyclophosphamide , <e1> doxorubicin </e1> , teniposide , and prednisone with vincristine plus bleomycin ) without receiving <e2> antiretroviral </e2> therapy .	doxorubicin	antiretroviral
mechanism	 Digoxin : <e1> Enoxacin </e1> may raise serum <e2> digoxin </e2> levels in some individuals .	Enoxacin	digoxin
other	 <e1> Acarbose </e1> may affect digoxin bioavailabillty and may require dose adjustment of <e2> digoxin </e2> by 16% (90% confidence interval : 8-23%) , decrease mean C max digoxin by 26% (90% confidence interval : 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit : 19% decrease to 2% increase) .	Acarbose	digoxin
other	 <e1> Ritonavir </e1> and <e2> indinavir </e2> : Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir , the Cmax and AUC of ritonavir were reduced by approximately 20% .	Ritonavir	indinavir
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1> ibuprofen </e1> ; <e2> indomethacin </e2> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ibuprofen	indomethacin
other	 <e1> Antiarrhythmics </e1> : Other <e2> antiarrhythmic </e2> drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .	Antiarrhythmics	antiarrhythmic
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; <e1> methylphenidate </e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	methylphenidate	sulfinpyrazone
effect	 Central Nervous System Depressants : The concomitant use of <e1> DURAGESIC </e1> ( fentanyl transdermal system) with other central nervous system depressants , including but not limited to other opioids , <e2> sedatives </e2> , hypnotics , tranquilizers (e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DURAGESIC	sedatives
other	 <e1> Ketoconazole </e1> : Coadministration of ketoconazole (200 mg/day for 14 days) with a 15-mg single dose of aripiprazole increased the AUC of <e2> aripiprazole </e2> and its active metabolite by 63% and 77% , respectively .	Ketoconazole	aripiprazole
other	 There have been reports of QTc prolongation , with or without TdP , in patients taking <e1> amiodarone </e1> when <e2> fluoroquinolones </e2> , macrolide antibiotics , or azoles were administered concomitantly .	amiodarone	fluoroquinolones
other	 Single dose bioavailability studies in normal volunteers have failed to wshow an effect of <e1> aspirin </e1> on <e2> ibuprofen </e2> blood levels .	aspirin	ibuprofen
other	 Bentiromide may interact with <e1> acetaminophen </e1> (e.g. , Tylenol ) , chloramphenicol (e.g. , Chloromycetin ) , local anesthetics (e.g. , benzocaine and <e2> lidocaine </e2> ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some multivitamins ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	acetaminophen	lidocaine
other	 [The effect of <e1> cimetidine </e1> on the renal excretion of verografin and <e2> iodamide </e2> in dogs] The intravenous injection of cimetidine in a dose of 20 mg/kg enhanced verografine and iodamide excretion in chronic canine experiments .	cimetidine	iodamide
other	 Oral Contraceptive : Based on AUC and half-life , multiple-dose pharmacokinetic profiles of norethindrone and <e1> ethinyl estradiol </e1> following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of <e2> gabapentin </e2> (400 mg TID;	ethinyl estradiol	gabapentin
other	 Caution should also be taken in concurrent or serial use of other aminoglycosides and <e1> polymyxins </e1> because they may enhance neomycin s nephrotoxicity and/or ototoxicity and potentiate <e2> neomycin sulfate </e2> neuromuscular blocking effects .	polymyxins	neomycin sulfate
other	 - <e1> Sulfoxone </e1> (e.g. , <e2> Diasone </e2> ) or	Procainamide	Pronestyl
other	 Therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including <e1> antidepressants </e1> , phenothiazines , carbamazepine , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide and <e2> encainide </e2> ) , or that inhibit this enzyme (e.g. , quinidine ) , should be approached with caution .	antidepressants	encainide
other	 there was no significant change in prothrombin test results during the trials of <e1> chloral hydrate </e1> and <e2> methaqualone </e2> .	chloral hydrate	methaqualone
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; <e1> antihistamines </e1> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; <e2> glutethimide </e2> ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	antihistamines	glutethimide
other	 - a nonsteroidal anti-inflammatory drug ( <e1> NSAID </e1> ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , <e2> Cataflam </e2> ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	NSAID	Cataflam
other	 A study in eight healthy volunteers has shown a 50% increase in mean peak <e1> nimodipine </e1> plasma concentrations and a 90% increase in mean area under the curve , after a one week course of <e2> cimetidine </e2> at 1,000 mg/day and nimodipine at 90 mg/day .	nimodipine	cimetidine
other	 Central nervous system depressant (CNS) drugs including <e1> alcohol </e1> , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , <e2> sedatives </e2> , sleeping pills and tranquilizers	alcohol	sedatives
other	 <e1> Anticholinergics </e1> : Concurrent administration of certain anticholinergic compounds , such as belladonna alkaloids and <e2> dicyclomine </e2> , would be expected to compromise the beneficial effects of cisapride .	Anticholinergics	dicyclomine
other	 <e1> cimetidine </e1> ) and many that are substrates for P450 2D6 (many other antidepressants , phenothiazines , and the Type 1C antiarrhythmics propafenone and <e2> flecainide </e2> ) .	cimetidine	flecainide
effect	 Drug Interactions : The central <e1> anticholinergic </e1> syndrome can occur when DRUG0 agents such as AKINETON are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the <e2> quinidine </e2> salts , and antihistamines .	anticholinergic	quinidine
other	 However , co-administration of Duloxetine with aluminum - and magnesium -containing <e1> antacids </e1> (51 mEq) or Duloxetine with <e2> famotidine </e2> , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .	antacids	famotidine
other	 Antihistamines may have additive effects with alcohol and other <e1> CNS depressants </e1> , e.g. , hypnotics , sedatives , tranquilizers , <e2> antianxiety agents </e2> .	CNS depressants	antianxiety agents
other	 Reported examples of this interaction include the following : <e1> Immunosuppressive </e1> s : Cyclosporine ( CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of <e2> cyclosporine </e2> resulting in elevated creatinine , despite reduction in dose of cyclosporine .	Immunosuppressive	cyclosporine
other	 <e1> Carbamazepine </e1> : Coadministration of carbamazepine (200 mg BID) , a potent CYP3A4 inducer , with <e2> aripiprazole </e2> (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite , dehydro-aripiprazole .	Carbamazepine	aripiprazole
mechanism	 Antacid : When <e1> atorvastatin </e1> and <e2> Maalox TC </e2> suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35% .	atorvastatin	Maalox TC
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : <e1> Acetaminophen </e1> , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , <e2> valproate </e2> , warfarin (5) , ziprasidone , and zonisamide .	Acetaminophen	valproate
int	 The extent to which <e1> SSRI </e1> - <e2> TCA </e2> interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved .	SSRI	TCA
other	 On the basis of the estimated number of regular users of intravenous <e1> amphetamine </e1> in Ontario , the mortality rate in such users is at least four times as high as in the general population of the same age , and is comparable to that in alcoholics and <e2> heroin </e2> addicts .	amphetamine	heroin
other	 acetaminophen / theophylline , lidocaine / quinidine , phenobarbital / acetaminophen , phenobarbital / valproic acid , quinidine / <e1> lidocaine </e1> , theophylline / acetaminophen , and valproic acid / <e2> phenobarbital </e2> .	lidocaine	phenobarbital
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , <e1> danazol </e1> , diuretics , sympathomimetic agents (e.g. , epinephrine , <e2> albuterol </e2> , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	danazol	albuterol
other	 Rat kidney homogenates supplemented with coenzyme A , ATP , oxaloacetate , and Mg2+ converted <e1> 1,3-difluoroacetone </e1> to <e2> (-)-erythro-fluorocitrate </e2> in vitro .	1,3-difluoroacetone	(-)-erythro-fluorocitrate
mechanism	 In addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( <e1> efavirenz </e1> , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with <e2> CANCIDAS </e2> may result in clinically meaningful reductions in caspofungin concentrations .	efavirenz	CANCIDAS
other	 A study of interaction between BREVIBLOC and <e1> warfarin </e1> showed that concomitant administration of <e2> BREVIBLOC </e2> and warfarin does not alter warfarin plasma levels .	warfarin	BREVIBLOC
advise	 Therefore , co-administration of <e1> tricyclic antidepressants </e1> with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and Type 1C antiarrhythmics (eg , propafenone , <e2> flecainide </e2> , and encainide ) , or that inhibit this enzyme (eg , quinidine ) , should be approached with caution .	tricyclic antidepressants	flecainide
other	 <e1> MAO Inhibitors </e1> : <e2> DURAGESIC </e2> is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	MAO Inhibitors	DURAGESIC
effect	 Selective serotonin reuptake inhibitors ( SSRIs ) (e.g. , <e1> fluoxetine </e1> , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> 5-HT1 agonists </e2> .	fluoxetine	5-HT1 agonists
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1> quinidine </e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	quinidine	tolbutamide
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , <e1> azole antifungals </e1> , cimetidine , clarithromycin (1) , dalfopristin , danazol , <e2> delavirdine </e2> , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	azole antifungals	delavirdine
other	 Phenytoin / <e1> Phenobarbital </e1> : The coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin D , but may reduce endogenous plasma levels of <e2> calcitriol </e2> /ergocalcitriol by accelerating metabolism .	Phenobarbital	calcitriol
other	 The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including <e1> nonsteroidal anti-inflammatory agents </e1> and other drugs that are highly protein bound , salicylates , sulfonamides , <e2> chloramphenicol </e2> , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	nonsteroidal anti-inflammatory agents	chloramphenicol
advise	 Nephrotoxic agents : Concomitant administration of <e1> VISTIDE </e1> and agents with nephrotoxic potential [e.g. , intravenous aminoglycosides (e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin B , <e2> foscarnet </e2> , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .	VISTIDE	foscarnet
effect	 <e1> Barbiturates </e1> may decrease the effectiveness of oral contraceptives , certain <e2> antibiotics </e2> , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .	Barbiturates	antibiotics
mechanism	 Antacids containing <e1> aluminum hydroxide </e1> and magnesium hydroxide reduce the oral absorption of <e2> enoxacin </e2> by 75% .	aluminum hydroxide	enoxacin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e1> clofibrate </e1> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e2> pentoxifylline </e2> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	clofibrate	pentoxifylline
other	 Therefore , when EDECRIN and <e1> non- steroidal anti- inflammatory agents </e1> are used concomitantly , the patient should be observed closely to determine if the desired effect of the <e2> diuretic </e2> is obtained .	non- steroidal anti- inflammatory agents	diuretic
mechanism	 Metoprolol - Administration of 20 mg/day <e1> LEXAPRO </e1> for 21 days in healthy volunteers resulted in a 50% increase in Cmax and 82% increase in AUC of the beta-adrenergic blocker <e2> metoprolol </e2> (given in a single dose of 100 mg) .	LEXAPRO	metoprolol
other	 <e1> Coumarin-Type Anticoagulants </e1> : Several short-term controlled studies failed to wshow that <e2> ibuprofen </e2> significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on coumarin-type anticoagulants .	Coumarin-Type Anticoagulants	ibuprofen
other	 Therefore , co-administration of Duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ TCAs ] , such as nortriptyline , <e1> amitriptyline </e1> , and imipramine ) , phenothiazines and Type 1C antiarrhythmics (e.g. , <e2> propafenone </e2> , flecainide ) , should be approached with caution .	amitriptyline	propafenone
other	 In controlled clinical trials , however , <e1> beta blockers </e1> including <e2> metoprolol </e2> were concurrently administered with felodipine and were well tolerated .	beta blockers	metoprolol
effect	 Anti-arrhythmics and <e1> tricyclic anti-depressants </e1> could exaggerate the prolongation of the QT interval observed with <e2> bepridil hydrochloride </e2> .	tricyclic anti-depressants	bepridil hydrochloride
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , <e1> nortriptyline </e1> , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and <e2> zonisamide </e2> .	nortriptyline	zonisamide
other	 Animals dosed with <e1> 1,3-difluoroacetone </e1> did not display the 2-3 hour lag phase in either <e2> (-)-erythro-fluorocitrate </e2> synthesis or in citrate and fluoride accumulation characteristic of animals dosed with 1,3-difluoro-2-propanol .	1,3-difluoroacetone	(-)-erythro-fluorocitrate
other	 In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin , cefazolin , ampicillin , <e1> ampicillin </e1> /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these <e2> antibiotics </e2> with EXTRANEAL .	ampicillin	antibiotics
int	 Medications can interfere with folate utilization , including : anticonvulsant medications (such as phenytoin , and primidone ) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic ) Methotrexate There has been concern about the interaction between <e1> vitamin B12 </e1> and <e2> folic acid </e2> .	vitamin B12	folic acid
other	 <e1> Tricyclic Antidepressants </e1> : Use of <e2> thyroid products </e2> with imipramine and other tricyclic antidepressants may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .	Tricyclic Antidepressants	thyroid products
mechanism	 Products containing calcium and other multivalent cations (such as <e1> aluminum </e1> , magnesium , iron ) are likely to interfere with absorption of <e2> Ibandronate </e2> .	aluminum	Ibandronate
other	 - Anabolic steroids ( nandrolone [e.g. , Anabolin ] , oxandrolone [e.g. , Anavar ] , oxymetholone [e.g. , Anadrol ] , <e1> stanozolol </e1> [e.g. , <e2> Winstrol </e2> ]) or	stanozolol	Winstrol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1> chymotrypsin </e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e2> diazoxide </e2> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chymotrypsin	diazoxide
other	 Interactions between treatments with coumaphos , <e1> bishydroxycoumarin </e1> (an <e2> anticoagulant </e2> ) , trichlorfon (an organophosphorous compound ) , and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep .	bishydroxycoumarin	anticoagulant
other	 The principal drugs given (number of patients in parentheses) were : <e1> cardiac glycosides </e1> (115) , <e2> sedatives </e2> and hypnotics (103) , coronary vasodilators (52) , oral hypoglycemics (45) , cough and cold preparations (45) , NSAIDs (38) , antihyperlipidemics (29) , antigout drugs (24) , oral contraceptives (18) , bronchodilators (13) , insulin (10) , and beta blockers (10) .	cardiac glycosides	sedatives
other	 The pharmacokinetics of <e1> naltrexone </e1> and its major metabolite <e2> 6-beta-naltrexol </e2> were unaffected following co-administration with Acamprosate .	naltrexone	6-beta-naltrexol
advise	 The daily dose of <e1> ENABLEX </e1> should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g. , ketoconazole , itraconazole , <e2> ritonavir </e2> , nelfinavir , clarithromycin and nefazadone) .	ENABLEX	ritonavir
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , <e1> delavirdine </e1> , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , <e2> nicotinamide </e2> , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	delavirdine	nicotinamide
effect	 Oral Anticoagulants : In some normal volunteers , the concomitant administration of <e1> diflunisal </e1> and <e2> warfarin </e2> , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .	diflunisal	warfarin
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e1> barbiturates </e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; <e2> ranitidine </e2> *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	barbiturates	ranitidine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( <e1> thiocyanate </e1> , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , <e2> insulin </e2> , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	thiocyanate	insulin
other	 There was no evidence of drug interactions in clinical studies in which <e1> dobutamine </e1> was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , <e2> potassium chloride </e2> , folic acid , and acetaminophen .	dobutamine	potassium chloride
effect	 <e1> Tricyclic antidepressants </e1> may antagonize the hypotensive effects of <e2> clonidine </e2> .	Tricyclic antidepressants	clonidine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation <e1> anesthetics </e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e2> pentoxifylline </e2> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anesthetics	pentoxifylline
other	 In addition , <e1> Fondaparinux </e1> neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , <e2> piroxicam </e2> , and digoxin , nor the pharmacokinetics of digoxin at steady state .	Fondaparinux	piroxicam
advise	 Additionally , <e1> BREVIBLOC </e1> should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine , <e2> epinephrine </e2> , and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high .	BREVIBLOC	epinephrine
mechanism	 - Drugs that may decrease plasma <e1> phenytoin </e1> concentrations include : carbamazepine , chronic <e2> alcohol </e2> abuse , reserpine	phenytoin	alcohol
other	 Barbiturates may decrease the effectiveness of oral <e1> contraceptives </e1> , certain antibiotics , quinidine , theophylline , corticosteroids , <e2> anticoagulants </e2> , and beta blockers .	contraceptives	anticoagulants
other	 When used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline (intravenous and oral) , triazolam , <e1> trimethoprim </e1> / sulfamethoxazole or <e2> zidovudine </e2> .	trimethoprim	zidovudine
mechanism	 Concomitant administration of <e1> FACTIVE </e1> and calcium carbonate , cimetidine , <e2> omeprazole </e2> , or an estrogen / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .	FACTIVE	omeprazole
other	 - Phenothiazines ( acetophenazine [e.g. , <e1> Tindal </e1> ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , <e2> Compazine </e2> ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Tindal	Compazine
other	 Hormonal Contraceptives : It has not been established if there is a pharmacokinetic interaction between <e1> acitretin </e1> and <e2> combined oral contraceptives </e2> .	acitretin	combined oral contraceptives
mechanism	 Coadministration of <e1> Itraconazole </e1> with oral <e2> midazolam </e2> or triazolam has resulted in elevated plasma concentrations of the latter two drugs .	Itraconazole	midazolam
mechanism	 <e1> Aminosalicylic acid </e1> may decrease the amount of digoxin ( <e2> Lanoxin </e2> , Lanoxicaps ) that gets absorbed into your body .	Aminosalicylic acid	Lanoxin
other	 <e1> Antipyrine </e1> : Because <e2> atorvastatin </e2> does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .	Antipyrine	atorvastatin
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e1> chlordiazepoxide </e1> ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e2> griseofulvin </e2> ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	chlordiazepoxide	griseofulvin
effect	 Butalbital , acetaminophen and <e1> caffeine </e1> may enhance the effects of : other narcotic analgesic s , alcohol , general anesthetics , tranquilizers such as <e2> chlordiazepoxide </e2> , sedative-hypnotics , or other CNS depressants , causing increased CNS depression .	caffeine	chlordiazepoxide
other	 Since blood level of <e1> calcitriol </e1> /ergocalcitriol will be reduced , higher doses of <e2> Rocaltrol </e2> may be necessary if these drugs are administered simultaneously .	calcitriol	Rocaltrol
other	 <e1> Amiodarone </e1> taken concomitantly with quinidine increases <e2> quinidine </e2> serum concentration by 33% after two days .	Amiodarone	quinidine
other	 Medications can interfere with folate utilization , including : anticonvulsant medications (such as phenytoin , and primidone ) <e1> metformin </e1> (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic ) Methotrexate There has been concern about the interaction between <e2> vitamin B12 </e2> and folic acid .	metformin	vitamin B12
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , <e1> levothyroxine </e1> , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e2> contraceptives </e2> (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	levothyroxine	contraceptives
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , <e1> danazol </e1> , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , <e2> quinine </e2> , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	danazol	quinine
other	 Etonogestrel may interact with the following medications : acetaminophen ( <e1> Tylenol </e1> ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , <e2> morphine </e2> ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Tylenol	morphine
other	 The effects of <e1> ERGOMAR </e1> may be potentiated by triacetyloleandomycin which inhibits the metabolism of <e2> ergotamine </e2> .	ERGOMAR	ergotamine
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , <e1> clindamycin </e1> , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , <e2> procainamide </e2> , and quinidine .	clindamycin	procainamide
other	 Pharmacodynamic Interactions : The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by <e1> alcohol </e1> , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the DRUG0 , DRUG0 and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the <e2> tricyclic antidepressants </e2> , and by other anticonvulsant drugs .	alcohol	tricyclic antidepressants
effect	 Digitalis : <e1> Thyroid preparations </e1> may potentiate the toxic effects of <e2> digitalis </e2> .	Thyroid preparations	digitalis
other	 Among <e1> aspirin </e1> or NSAID users , the incidence of upper gastrointestinal adverse events in patients treated with <e2> ibandronate </e2> 2.5 mg daily (28.9%) was similar to that in placebo-treated patients (30.7%) .	aspirin	ibandronate
other	 Diltiazem : In patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with <e1> diltiazem </e1> 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of <e2> aprepitant </e2> AUC and a simultaneous 1.7-fold increase of diltiazem AUC .	diltiazem	aprepitant
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; <e1> paraldehyde </e1> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e2> warfarin sodium </e2> under-dosage .	paraldehyde	warfarin sodium
other	 Interactions between treatments with coumaphos , <e1> bishydroxycoumarin </e1> (an anticoagulant ) , trichlorfon (an organophosphorous compound ) , and <e2> phenobarbital sodium </e2> (an inducer of microsomal enzymes) were investigated in sheep .	bishydroxycoumarin	phenobarbital sodium
other	 METHOD : This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive <e1> everolimus </e1> tablets at doses of 0.5 mg , 1 mg , or 2 mg twice daily with cyclosporine and <e2> prednisone </e2> .	everolimus	prednisone
other	 Etonogestrel may interact with the following medications : <e1> acetaminophen </e1> ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( <e2> Gris-PEG </e2> , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	acetaminophen	Gris-PEG
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or <e1> propranolol </e1> (basic) , as well as <e2> tetracycline </e2> penicillin G , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .	propranolol	tetracycline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , <e1> theophylline </e1> , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and <e2> zonisamide </e2> .	theophylline	zonisamide
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , <e1> cimetidine </e1> , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , <e2> nefazodone </e2> , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	cimetidine	nefazodone
effect	 Drugs Decreasing Heparin Effect : Digitalis , tetracyclines , <e1> nicotine </e1> , or antihistamines may partially counteract the anticoagulant action of <e2> heparin sodium </e2> .	nicotine	heparin sodium
mechanism	 Oral <e1> anticoagulants </e1> may potentiate the hypoglycemic action of hypoglycemic agents , eg , tolbutamide and <e2> chlorpropamide </e2> , by inhibiting their metabolism in the liver .	anticoagulants	chlorpropamide
other	 <e1> Furosemide </e1> : Clinical studies , as well as post-marketing observations , have shown that NSAIDs can reduce the natriuretic effect of furosemide and <e2> thiazides </e2> in some patients .	Furosemide	thiazides
other	 <e1> Terfenadine </e1> : Administration of terfenadine with <e2> VIRACEPT </e2> resulted in the appearance of unchanged terfenadine in plasma;	Terfenadine	VIRACEPT
effect	 Both the sedative and anticholinergic effects of the <e1> major tranquilizers </e1> are also additive to those of <e2> desipramine </e2> .	major tranquilizers	desipramine
other	 Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , <e1> magnesium hydroxide </e1> , and simethicone ) with fosinopril reduced serum levels and urinary excretion of <e2> fosinoprilat </e2> as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	magnesium hydroxide	fosinoprilat
other	 Based on known metabolic profiles , clinically significant drug interactions are not expected between VIRACEPT and dapsone , <e1> trimethoprim </e1> / sulfamethoxazole , <e2> clarithromycin </e2> , erythromycin , itraconazole or fluconazole .	trimethoprim	clarithromycin
other	 Interactions may also occur with the following : anti-depressants / <e1> anti-anxiety drugs </e1> , drugs used to treat an overactive thyroid , <e2> beta-blockers </e2> (e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication (e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines (e.g. , diphenhydramine ) , any other drugs that may make you drowsy .	anti-anxiety drugs	beta-blockers
effect	 <e1> TCAs </e1> decrease the hypotensive effect of <e2> guanfacine </e2> .	TCAs	guanfacine
other	 - <e1> Cholestyramine </e1> and colestipol resins : Cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing <e2> diuretic </e2> absorption from the gastrointestinal tract	Cholestyramine	diuretic
other	 Iodine or iodine excess may decrease the effect of <e1> Carbimazole </e1> , and an <e2> iodine </e2> deficiency can increase the effect of Carbimazole .	Carbimazole	iodine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , <e1> cimetidine </e1> , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , <e2> valproate </e2> (1) , verapamil , zileuton .	cimetidine	valproate
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e1> carbamazepine </e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e2> warfarin sodium </e2> under-dosage .	carbamazepine	warfarin sodium
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , <e1> magnesium </e1> salts , lithium , local anesthetics , <e2> procainamide </e2> , and quinidine .	magnesium	procainamide
mechanism	 The effect may be mediated by <e1> cimetidine </e1> s known inhibition of hepatic cytochrome P-450 , the enzyme system responsible for the first-pass metabolism of <e2> diltiazem </e2> .	cimetidine	diltiazem
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , <e1> amiodarone </e1> , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , <e2> estrogens </e2> , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone	amiodarone	estrogens
mechanism	 Valproate : The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but <e1> valproate </e1> significantly decreased <e2> tiagabine </e2> binding in vitro from 96.3 to 94.8% , which resulted in an increase of approximately 40% in the free DRUG0 concentration .	valproate	tiagabine
other	 Other Drugs : In healthy volunteers , amlodipine , phenytoin , glyburide , <e1> ranitidine </e1> , omeprazole , hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone ) , antacid DRUG0 and magnesium hydroxide s) and theophylline did not affect the pharmacokinetics of <e2> TIKOSYN </e2> .	ranitidine	TIKOSYN
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , <e1> clofibrate </e1> ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , <e2> Invirase </e2> , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	clofibrate	Invirase
effect	 The antihypertensive effects of methyldopa , mecamylamine , reserpine , and <e1> veratrum alkaloids </e1> may be reduced by <e2> sympathomimetics </e2> .	veratrum alkaloids	sympathomimetics
advise	 Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g. , itraconazole , <e1> ritonavir </e1> , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when <e2> almotriptan </e2> is used concomitantly with these medications .	ritonavir	almotriptan
other	 If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or <e1> sedative </e1> / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of <e2> desipramine </e2> and benzodiazepines (e.g. , chlordiazepoxide or diazepam ) are additive .	sedative	desipramine
other	 In this study we investigated the effect of <e1> ginsenosides </e1> on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers nimodipine (L-type) , <e2> omega-conotoxin GVIA </e2> (N-type) , or omega-agatoxin IVA (P-type) in bovine chromaffin cells .	ginsenosides	omega-conotoxin GVIA
other	 <e1> Anticoagulant </e1> therapy should be monitored , particularly during the first few weeks , after initiating therapy with <e2> BEXTRA </e2> in patients receiving warfarin or similar agents .	Anticoagulant	BEXTRA
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1> dextrothyroxine </e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e2> oxyphenbutazone </e2> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextrothyroxine	oxyphenbutazone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e1> contraceptives </e1> (3) , oxcarbazepine , Phenytoin (4) , <e2> praziquantel </e2> , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	contraceptives	praziquantel
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , <e1> antifungals </e1> ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and <e2> vitamin C </e2> .	antifungals	vitamin C
other	 The intensity , uniformity and time course of anticoagulant interference by phenobarbital , <e1> secobarbital </e1> , glutethimide , chloral hydrate and <e2> methaqualone </e2> were systematically investigated in 16 patients receiving coumarin therapy .	secobarbital	methaqualone
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; <e1> antihistamines </e1> ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e2> warfarin sodium </e2> under-dosage .	antihistamines	warfarin sodium
other	 Although deferasirox has a lower affinity for aluminum than for <e1> iron </e1> , Exjade should not be taken with <e2> aluminum </e2> -containing antacid preparations .	iron	aluminum
effect	 Organic nitrates - <e1> L-arginine </e1> supplements theoretically may potentiate the effects of organic <e2> nitrates </e2> if taken concomitantly .	L-arginine	nitrates
other	 H2 Receptor Antagonists : <e1> Cimetidine </e1> coadministration leads to an increased peak plasma concentration and AUC of cisapride , there is no effect on cisapride absorption when it is coadministered with <e2> ranitidine </e2> .	Cimetidine	ranitidine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , <e1> clofibrate </e1> ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , <e2> Kaletra </e2> , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	clofibrate	Kaletra
other	 Drug Interactions : Flupenthixol may interact with some drugs , like <e1> Monoamine oxidase inhibitors </e1> ( MAOI ) : MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of <e2> Tricyclic antidepressants </e2>	Monoamine oxidase inhibitors	Tricyclic antidepressants
other	 Ritonavir : Coadministration of ritonavir with <e1> VIRACEPT </e1> resulted in a 152% increase in nelfinavir plasma AUC and very little change in <e2> ritonavir </e2> plasma A.C .	VIRACEPT	ritonavir
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or propranolol (basic) , as well as tetracycline penicillin G , phenobarbital , thyroid and <e1> thyroxine </e1> preparations , estrogens and progestins , and <e2> digitalis </e2> .	thyroxine	digitalis
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , <e1> cyclosporin </e1> , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , <e2> valproate </e2> , warfarin (5) , ziprasidone , and zonisamide .	cyclosporin	valproate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( <e1> thiocyanate </e1> , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , <e2> somatostatin analogs </e2> , sulfonamides , sulfonylureas , thiazide diuretics .	thiocyanate	somatostatin analogs
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , <e1> cyclosporin </e1> , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , <e2> praziquantel </e2> , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	cyclosporin	praziquantel
effect	 Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using <e1> beta-blockers </e1> or digitalis concomitantly with <e2> Tiazac </e2> .	beta-blockers	Tiazac
other	 <e1> H2 Receptor Antagonists </e1> : Cimetidine coadministration leads to an increased peak plasma concentration and AUC of cisapride , there is no effect on cisapride absorption when it is coadministered with <e2> ranitidine </e2> .	H2 Receptor Antagonists	ranitidine
effect	 The actions of the <e1> benzodiazepines </e1> may be potentiated by <e2> barbiturates </e2> , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .	benzodiazepines	barbiturates
other	 Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or <e1> PCP </e1> in pigeons , but did not antagonize the decreases in FI or FR responding produced by high doses of DRUG0 or either stereoisomer of <e2> NANM </e2> .	PCP	NANM
other	 Unmodified NaCMC (1% m/v) significantly improved the transport ratio (R= P(app) polymer/ P(app) control) of <e1> NaFlu </e1> to 1.3 and 1% (m/v) NaCMC conjugated with <e2> cysteine </e2> further enhanced the permeation .	NaFlu	cysteine
other	 Both <e1> itraconazole </e1> and its major metabolite , <e2> hydroxyitraconazole </e2> , are inhibitors of the cytochrome P450 3A4 enzyme system .	itraconazole	hydroxyitraconazole
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , <e1> Advil </e1> , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( <e2> Relafen </e2> ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	Advil	Relafen
other	 poor metabolizers of <e1> debrisoquin </e1> : Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine , fluoxetine , paroxetine , and <e2> propafenone </e2> ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	debrisoquin	propafenone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , <e1> clozapine </e1> , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e2> contraceptives </e2> (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	clozapine	contraceptives
other	 Concomitant medications were grouped as ACE inhibitors , oral <e1> anticoagulants </e1> , calcium channel blockers , beta blockers , cardiac glycosides , inducers of CYP3A4 , substrates and inhibitors of CYP3A4 , substrates and inhibitors of P-glycoprotein , <e2> nitrates </e2> , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and QTc-prolonging drugs .	anticoagulants	nitrates
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( <e1> Dilantin </e1> , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , <e2> Kaletra </e2> , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Dilantin	Kaletra
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , <e1> estrogens </e1> , progestogens (e.g. , in oral <e2> contraceptives </e2> ) .	estrogens	contraceptives
other	 Concurrent administration of <e1> etanercept </e1> (another TNF -blocking agent) and anakinra (an <e2> interleukin-1 antagonist </e2> ) has been associated with an increased risk of serious infections , and increased risk of neutropenia and no additional benefit compared to these medicinal products alone .	etanercept	interleukin-1 antagonist
effect	 Co-administration of <e1> nelfinavir </e1> at steady-state with a single dose of <e2> azithromycin </e2> (2 x 600 mg tablets) results in increased azithromycin serum concentrations .	nelfinavir	azithromycin
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : <e1> corticosteroids </e1> , niacin , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , <e2> thyroid hormones </e2> , estrogens , progestogens (e.g. , in oral contraceptives ) .	corticosteroids	thyroid hormones
mechanism	 The effect may be mediated by <e1> cimetidine </e1> s known inhibition of hepatic cytochrome P-450 , the enzyme system responsible for the first-pass metabolism of <e2> diltiazem </e2> .	cimetidine	diltiazem
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , <e1> desipramine </e1> , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , <e2> Phenytoin </e2> (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	desipramine	Phenytoin
other	 In vitro , buspirone does not displace tightly bound drugs like <e1> phenytoin </e1> , propranolol , and <e2> warfarin </e2> from serum proteins .	phenytoin	warfarin
effect	 Preliminary data which suggest that <e1> dapsone </e1> may inhibit the anti-inflammatory activity of <e2> Lamprene </e2> have not been confirmed .	dapsone	Lamprene
other	 In vitro studies indicate that , at therapeutic concentrations of <e1> salicylate </e1> (300 m g/mL) , the binding of ketorolac was reduced from approximately 99.2% to 97.5% , representing a potential twofold increase in unbound <e2> ketorolac </e2> plasma levels .	salicylate	ketorolac
other	 In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of <e1> PRINIVIL </e1> alone were compared to PRINIVIL given concomitantly with indomethacin , the use of <e2> indomethacin </e2> was associated with a reduced antihypertensive effect , although the difference between the two regimens was not significant .	PRINIVIL	indomethacin
other	 It may increase excretion of barbiturates , <e1> lithium </e1> , and <e2> ASA </e2> and may also increase the toxicity of salicylates .	lithium	ASA
other	 <e1> Amitriptyline </e1> in combination with clonidine enhances the manifestation of corneal lesions in rats Epidural Injection <e2> Clonidine </e2> may potentiate the CNS-depressive effect of alcohol , barbiturates or other sedating drugs .	Amitriptyline	Clonidine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1> chloral hydrate </e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e2> miconazole </e2> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chloral hydrate	miconazole
mechanism	 <e1> Cholestyramine </e1> resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or <e2> propranolol </e2> (basic) , as well as tetracycline penicillin G , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .	Cholestyramine	propranolol
other	 A dose increase of <e1> lopinavir </e1> / <e2> ritonavir </e2> to 533/133 mg twice daily with food isrecommended in combination with nevirapine .	lopinavir	ritonavir
other	 Based on adult data , lower doses of <e1> caffeine </e1> may be needed following coadministration of drugs which are reported to decrease caffeine elimination (e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination (e.g. , <e2> phenobarbital </e2> and phenytoin ) .	caffeine	phenobarbital
advise	 A dose adjustment is not needed when <e1> zidovudine </e1> is administered with <e2> VIRACEPT </e2> .	zidovudine	VIRACEPT
other	 THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH <e1> CENTRAL NERVOUS SYSTEM DEPRESSANTS </e1> SUCH AS NARCOTICS , <e2> NON-NARCOTIC ANALGESICS </e2> AND BARBITURATES .	CENTRAL NERVOUS SYSTEM DEPRESSANTS	NON-NARCOTIC ANALGESICS
other	 Drugs that reduce the number of blood platelets by causing bone marrow depression (such as <e1> antineoplastic agents </e1> ) or drugs which inhibit platelet function (eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , <e2> hydrochloroquine </e2> , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .	antineoplastic agents	hydrochloroquine
other	 In addition , olanzapine is not associated with a risk of agranulocytosis as seen with <e1> clozapine </e1> or clinically significant hyperprolactinaemia as seen with <e2> risperidone </e2> or prolongation of the QT interval .	clozapine	risperidone
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : <e1> adrenocortical steroids </e1> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e2> meprobamate </e2> ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	adrenocortical steroids	meprobamate
other	 Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics : amiodarone , <e1> quinidine </e1> Antihistamines : astemizole , terfenadine Antimigraine : ergot derivatives Antimycobacterial agents : rifampin <e2> Benzodiazepines </e2> midazolam , triazolam GI motility agents : cisapride	quinidine	Benzodiazepines
other	 <e1> Somatrem </e1> / Somatropin : Excessive concurrent use of <e2> thyroid hormone </e2> may accelerate epiphyseal closure .	Somatrem	thyroid hormone
other	 <e1> Amphotericin B </e1> or potassium-depleting diuretics ( benzothiadiazines and related drugs , <e2> ethacrynic acid </e2> and furosemide ) enhanced hypokalemia .	Amphotericin B	ethacrynic acid
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : <e1> aminoglycosides </e1> (e.g. , gentamicin , amikacin ) , amphotericin B , cyclosporine , non-steroidal anti-inflammatory drugs (e.g. , <e2> ibuprofen </e2> ) , tacrolimus , vancomycin .	aminoglycosides	ibuprofen
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , <e1> Trileptal </e1> , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	Trileptal	temazepam
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of EQUETROTM are the following : Cisplatin , doxorubicin HCL , felbamate , rifampin , <e1> phenobarbital </e1> , Phenytoin (2) , primidone , methsuximide , and theophylline Thus , if a patient has been titrated to a stable dosage on <e2> EQUETROTM </e2> , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for EQUETROTM may be necessary .	phenobarbital	EQUETROTM
other	 <e1> Hormonal Contraceptives </e1> , Including Oral , Injectable , Transdermal , and Implantable Contraceptives : An interaction study demonstrated that co-administration of <e2> bosentan </e2> and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31% , respectively .	Hormonal Contraceptives	bosentan
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1> diflunisal </e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e2> influenza virus vaccine </e2> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diflunisal	influenza virus vaccine
other	 Chlorotrianisene may interact with antidepressants , aspirin , <e1> barbiturates </e1> , bromocriptine , calcium supplements , corticosteroids , corticotropin , <e2> cyclosporine </e2> , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .	barbiturates	cyclosporine
other	 In the DIAMOND trials , 1252 patients were treated with <e1> TIKOSYN </e1> and diuretics concomitantly of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and <e2> diuretics </e2> .	TIKOSYN	diuretics
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , <e1> amiodarone </e1> , androgens and related anabolic hormones , complex anions ( thiocyanate , <e2> perchlorate </e2> , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	amiodarone	perchlorate
other	 - a steroid medicine such as prednisone ( Deltasone , Orasone , others) , <e1> methylprednisolone </e1> ( Medrol , others) , <e2> prednisolone </e2> ( Prelone , Pediapred , others) , and others;	methylprednisolone	prednisolone
effect	 Serious cardiac dysrhythmias , some resulting in death , have occurred in patients receiving <e1> terfenadine </e1> concomitantly with other <e2> macrolide antibiotics </e2> .	terfenadine	macrolide antibiotics
other	 Interactions with Mixed Agonist/Antagonist Opioid Analgesics : <e1> Agonist/antagonist analgesics </e1> (eg , pentazocine , nalbuphine , butorphanol , dezocine and <e2> buprenorphine </e2> ) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran .	Agonist/antagonist analgesics	buprenorphine
other	 <e1> Efavirenz </e1> has demonstrated superiority over <e2> nelfinavir </e2> in nucleoside-experienced patients , although combining these 2 agents may represent the best approach in these circumstances .	Efavirenz	nelfinavir
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : <e1> alcohol </e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e2> naproxen </e2> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	alcohol	naproxen
other	 In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , <e1> propantheline </e1> , digoxin , and warfarin , the bioavailability of <e2> fosinoprilat </e2> was not altered by coadministration of fosinopril with any one of these drugs .	propantheline	fosinoprilat
mechanism	 Previous studies have demonstrated a significant reduction in the oral bioavailability of <e1> trovafloxacin </e1> and ciprofloxacin when administered concomitantly with an intravenous opiate such as <e2> morphine </e2> .	trovafloxacin	morphine
other	 Coadministration of <e1> VIRACEPT </e1> and drugs that induce CYP3A may decrease <e2> nelfinavir </e2> plasma concentrations and reduce its therapeutic effect .	VIRACEPT	nelfinavir
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of EQUETROTM are the following : Cisplatin , doxorubicin HCL , felbamate , rifampin , phenobarbital , <e1> Phenytoin </e1> (2) , primidone , methsuximide , and theophylline Thus , if a patient has been titrated to a stable dosage on <e2> EQUETROTM </e2> , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for EQUETROTM may be necessary .	Phenytoin	EQUETROTM
other	 Tell your doctor if you are taking any of the following drugs : <e1> blood thinner </e1> s ( Coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( Tegretol ) cimetidine ( Tagamet ) estrogens <e2> fluoxetine </e2> ( Prozac ) intraconazole ( Sporanox ) ketoconazole ( Nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	blood thinner	fluoxetine
other	 Effects of Other Antiepileptic Drugs on Felbatol <e1> Phenytoin </e1> : Phenytoin causes an approximate doubling of the clearance of Felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45% decrease in the steady-state trough concentrations of <e2> Felbatol </e2> as compared to the same dose of Felbatol given as monotherapy .	Phenytoin	Felbatol
other	 Rifabutin : Coadministration of rifabutin and <e1> VIRACEPT </e1> resulted in a 32% decrease in <e2> nelfinavir </e2> plasma AUC and a 207% increase in rifabutin plasma A.C .	VIRACEPT	nelfinavir
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e1> phenyramidol </e1> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	phenyramidol	trimethoprim
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; <e1> allopurinol </e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e2> oxolinic acid </e2> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	allopurinol	oxolinic acid
other	 Repeated oral administration of coumaphos in sheep : interactions of coumaphos with <e1> bishydroxycoumarin </e1> , trichlorfon , and <e2> phenobarbital sodium </e2> .	bishydroxycoumarin	phenobarbital sodium
other	 Coadministration of <e1> valdecoxib </e1> (10 mg BID for 7 days) with glyburide (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of <e2> glyburide </e2> .	valdecoxib	glyburide
other	 The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose ( NaCMC ) and carboxymethylcellulose-cysteine ( CMC-Cys ) conjugates on the intestinal permeation of <e1> sodium fluorescein </e1> ( NaFlu ) and model peptide drugs , bacitracin and <e2> insulin </e2> .	sodium fluorescein	insulin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , <e1> Topamax </e1> , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , <e2> theophylline </e2> ( Theo-Dur ) , and vitamin C .	Topamax	theophylline
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; <e1> methyldopa </e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e2> prolonged narcotics </e2> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	methyldopa	prolonged narcotics
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , <e1> morphine </e1> ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( <e2> Theo-Dur </e2> ) , and vitamin C .	morphine	Theo-Dur
advise	 Nephrotoxic agents : Concomitant administration of <e1> VISTIDE </e1> and agents with nephrotoxic potential [e.g. , intravenous aminoglycosides (e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin B , foscarnet , intravenous pentamidine , vancomycin , and <e2> non-steroidal anti-inflammatory agents </e2> ] is contraindicated .	VISTIDE	non-steroidal anti-inflammatory agents
other	 Dexbrompheniramine can interact with <e1> alcohol </e1> or other <e2> CNS depressants </e2> (may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	alcohol	CNS depressants
other	 <e1> Psychoactive Drugs </e1> : Hallucinations have been reported when <e2> TORADOL </e2> was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .	Psychoactive Drugs	TORADOL
other	 <e1> Carbamazepine </e1> : Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with <e2> isoniazid </e2> , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .	Carbamazepine	isoniazid
other	 Caution should also be applied for other sympathomimetics , and for aminophylline and <e1> theophylline </e1> and <e2> tricyclic antidepressants </e2> , which may also precipitate arrhythmias .	theophylline	tricyclic antidepressants
effect	 Drugs that reportedly may increase oral <e1> anticoagulant </e1> response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; <e2> disulfiram </e2> ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anticoagulant	disulfiram
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e2> phenylbutazone </e2> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	phenylbutazone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1> influenza virus vaccine </e1> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	influenza virus vaccine	tolbutamide
other	 Naproxen , <e1> naproxen sodium </e1> and other <e2> NSAIDs </e2> have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .	naproxen sodium	NSAIDs
other	 Other Drugs : Based on the results of drug interaction studies , no dosage adjustment is recommended when SUSTIVA ( efavirenz ) is given with the following : aluminum/magnesium hydroxide antacids , azithromycin , cetirizine , famotidine , fluconazole , lamivudine , lorazepam , <e1> nelfinavir </e1> , paroxetine , and <e2> zidovudine </e2> .	nelfinavir	zidovudine
other	 <e1> Ketoconazole </e1> : When a single 125-mg dose of <e2> Aprepitant </e2> was administered on Day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong CYP3A4 inhibitor , the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .	Ketoconazole	Aprepitant
other	 <e1> Resins </e1> : Since bile acid sequestrants may bind other drugs given concurrently , patients should take TRICOR at least 1 hour before or 4-6 hours after a <e2> bile acid binding resin </e2> to avoid impeding its absorption .	Resins	bile acid binding resin
other	 Potential interactions between TAXOL , a substrate of CYP3A4 , and protease inhibitors ( ritonavir , saquinavir , <e1> indinavir </e1> , and <e2> nelfinavir </e2> ) , which are substrates and/or inhibitors of CYP3A4 , have not been evaluated in clinical trials .	indinavir	nelfinavir
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , <e1> amiodarone </e1> , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , <e2> halothane </e2> , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone	amiodarone	halothane
other	 substrates , in vitro data suggest similar effects of <e1> grepafloxacin </e1> in CYP3A4 mediated metabolism and <e2> theophylline </e2> metabolism .	grepafloxacin	theophylline
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute <e1> alcohol </e1> intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , <e2> H2-antagonists </e2> , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone	alcohol	H2-antagonists
other	 There are rare reports , however , from marketing experiences , of changes in effects of <e1> insulin </e1> or oral <e2> hypoglycemic agents </e2> in the presence of diclofenac that necessitated changes in the doses of such agents .	insulin	hypoglycemic agents
other	 Other Drugs : Based on the results of drug interaction studies , no dosage adjustment is recommended when SUSTIVA ( <e1> efavirenz </e1> ) is given with the following : aluminum/magnesium hydroxide antacids , azithromycin , cetirizine , famotidine , fluconazole , lamivudine , lorazepam , nelfinavir , <e2> paroxetine </e2> , and zidovudine .	efavirenz	paroxetine
other	 Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were <e1> aspirin </e1> , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and <e2> allopurinol </e2> .	aspirin	allopurinol
effect	 Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , MAO inhibitors , and other antidepressants .When <e1> scopolamine </e1> is used concomitantly with injectable <e2> lorazepam </e2> , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	scopolamine	lorazepam
other	 Because there are no data on the compatibility of NovoLog and crystalline <e1> zinc insulin </e1> preparations , <e2> NovoLog </e2> should not be mixed with these preparations .	zinc insulin	NovoLog
effect	 Drugs that reportedly may increase oral <e1> anticoagulant </e1> response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e2> dextrothyroxine </e2> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anticoagulant	dextrothyroxine
mechanism	 Dexamethasone : Steady-state trough concentrations of albendazole sulfoxide were about 56% higher when 8 mg <e1> dexamethasone </e1> was coadministered with each dose of <e2> albendazole </e2> (15 mg/kg/day) in eight neurocysticercosis patients .	dexamethasone	albendazole
other	 Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of <e1> stavudine </e1> and <e2> zidovudine </e2> against HIV .	stavudine	zidovudine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as <e1> ampicillin </e1> and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , <e2> Kadian </e2> , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	ampicillin	Kadian
other	 These data suggest that <e1> ginsenosides </e1> are negatively coupled to three types of calcium channels in bovine chromaffin cell , including an <e2> omega-conotoxin GVIA </e2> -sensitive (N-type) channel , an omega-agatoxin IVA -sensitive (P-type) channel and nimodipine / omega-conotoxin GVIA / omega-agatoxin VIA -resistant (presumptive Q-type) channel .	ginsenosides	omega-conotoxin GVIA
other	 <e1> Rifampin </e1> : Following concomitant administration of a single dose of <e2> ARAVA </e2> to subjects receiving multiple doses of rifampin , M1 peak levels were increased (~40%) over those seen when ARAVA was given alone .	Rifampin	ARAVA
other	 Additionally , anti-malarial drugs , such as <e1> chloroquine </e1> and <e2> mefloquine </e2> , may antagonize the activity of carbamazepine .	chloroquine	mefloquine
other	 <e1> Dolasetron mesylate </e1> did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , <e2> cyclophosphamide </e2> ) in four murine models .	Dolasetron mesylate	cyclophosphamide
other	 Because of the increased risk of adverse reactions in patients who have been taking <e1> benzodiazepines </e1> on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , <e2> alcohol </e2> and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned .	benzodiazepines	alcohol
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , <e1> polymyxins </e1> , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , <e2> lithium </e2> , local anesthetics , procainamide , and quinidine .	polymyxins	lithium
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , <e1> aminoglycosides </e1> , indomethacin ) , myelotoxic (e.g. , cytotoxic chemotherapy) , cardiotoxic (e.g. , <e2> doxorubicin </e2> ) or hepatotoxic (e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	aminoglycosides	doxorubicin
other	 Because there are no data on the compatibility of NovoLog and crystalline <e1> zinc insulin </e1> preparations , <e2> NovoLog </e2> should not be mixed with these preparations .	zinc insulin	NovoLog
mechanism	 Coadministration with compounds that are potent inducers of CYP3A4 (eg , phenobarbital , phenytoin , dexamethasone , <e1> carbamazepine </e1> ) may result in decreased plasma levels of <e2> saquinavir </e2> .	carbamazepine	saquinavir
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1> chymotrypsin </e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e2> ibuprofen </e2> ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chymotrypsin	ibuprofen
other	 Aspirin / <e1> Acetaminophen </e1> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of <e2> Argatroban </e2> 1 g/kg/min . over 4 hours) or acetaminophen (1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5 g/kg/min . over 18 hours) .	Acetaminophen	Argatroban
other	 Tell your doctor if you are taking any of the following drugs : blood thinner s ( Coumadin ) other <e1> antidepressants </e1> metoprolol antihistamines carbamazepine ( Tegretol ) cimetidine ( Tagamet ) estrogens fluoxetine ( Prozac ) intraconazole ( Sporanox ) <e2> ketoconazole </e2> ( Nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	antidepressants	ketoconazole
other	 No interaction was noted with the <e1> MAO-B inhibitor </e1> selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa / <e2> dopa decarboxylase inhibitor </e2> (n=29) .	MAO-B inhibitor	dopa decarboxylase inhibitor
other	 Particular caution should be observed with digitalis preparations since there are conflicting results for the effect of colestipol hydrochloride on the availability of <e1> digoxin </e1> and <e2> digitoxin </e2> .	digoxin	digitoxin
other	 Quinolones , including norfloxacin , may enhance the effects of oral <e1> anticoagulants </e1> , including <e2> warfarin </e2> or its derivatives or similar agents .	anticoagulants	warfarin
other	 No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , <e1> hydrochlorothiazide </e1> , and oral <e2> contraceptives </e2> in healthy volunteers , or given with enalapril to patients with heart failure (NYHA class II and III) .	hydrochlorothiazide	contraceptives
other	 When therapeutic concentrations of furosemide , propranolol , <e1> dipyridamole </e1> , warfarin , quinidine , or naproxen were added to human plasma (in vitro) , the plasma protein binding of <e2> nicardipine HCl </e2> was not altered .	dipyridamole	nicardipine HCl
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> EQUETROTM </e1> due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , <e2> Phenytoin </e2> (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	EQUETROTM	Phenytoin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; <e1> salicylates </e1> ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e2> triclofos sodium </e2> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	salicylates	triclofos sodium
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , anticoagulants ( blood thinner s) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines) , <e1> central nervous system (CNS) depressants </e1> (using these medicines with barbiturates may result in increased CNS depressant effects) , divalproex sodium , valproic acid (using these medicines with <e2> barbiturates </e2> may change the amount of either medicine that you need to take) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control) .	central nervous system (CNS) depressants	barbiturates
mechanism	 Rifampin : When a single 375-mg dose of <e1> Aprepitant </e1> was administered on Day9 of a 14-day regimen of 600 mg/day of <e2> rifampin </e2> , a strong CYP3A4 inducer , the AUC of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold .	Aprepitant	rifampin
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : <e1> adrenocortical steroids </e1> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e2> vitamin C </e2> ; warfarin sodium under-dosage .	adrenocortical steroids	vitamin C
other	 <e1> Phenytoin </e1> : In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on <e2> gabapentin </e2> pharmacokinetics .	Phenytoin	gabapentin
other	 - <e1> Methyldopa </e1> (e.g. , <e2> Aldomet </e2> ) Use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood	Methyldopa	Aldomet
other	 However , since <e1> aspirin </e1> , NSAIDs , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or NSAIDs with <e2> Ibandronate </e2> .	aspirin	Ibandronate
other	 Dopamine Antagonists : Since <e1> apomorphine </e1> is a dopamine agonist , it is possible that <e2> dopamine antagonists </e2> , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of APOKYN .	apomorphine	dopamine antagonists
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( <e1> Relafen </e1> ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , <e2> Aleve </e2> );	Relafen	Aleve
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , <e1> magnesium </e1> salts , <e2> lithium </e2> , local anesthetics , procainamide , and quinidine .	magnesium	lithium
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , <e1> chlorpromazine </e1> [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , <e2> thioridazine </e2> [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	chlorpromazine	thioridazine
other	 Although it has not been established that there is an interaction between Clozapine and benzodiazepines or other <e1> psychotropics </e1> , caution is advised when clozapine is initiated in patients taking a <e2> benzodiazepine </e2> or any other psychotropic drug .	psychotropics	benzodiazepine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1> cinchophen </e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; <e2> mefenamic acid </e2> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	cinchophen	mefenamic acid
effect	 Injection : Lorazepam injection , like other injectable <e1> benzodiazepines </e1> , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , <e2> MAO inhibitors </e2> , and other antidepressants .When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	benzodiazepines	MAO inhibitors
effect	 Drugs that reportedly may increase oral <e1> anticoagulant </e1> response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e2> oxolinic acid </e2> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anticoagulant	oxolinic acid
other	 Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with <e1> ACE inhibitors </e1> , and with some <e2> angiotensin II receptor antagonists </e2> .	ACE inhibitors	angiotensin II receptor antagonists
effect	 In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions , myelosuppression was more profound when <e1> TAXOL </e1> was given after <e2> cisplatin </e2> than with the alternate sequence (ie , TAXOL before cisplatin ) .	TAXOL	cisplatin
other	 Twelve strains of Staphylococcus aureus (a frequent cause of infection in <e1> heroin </e1> , but not in pentazocine and <e2> tripelennamine </e2> , addicts) were completely inhibited by the drug combination .	heroin	tripelennamine
other	 There has been too little experience with the coadministration of <e1> TAMBOCOR </e1> with nifedipine or <e2> diltiazem </e2> to recommend concomitant use .	TAMBOCOR	diltiazem
other	 Tell your doctor if you are taking any of the following drugs : blood thinner s ( Coumadin ) other antidepressants metoprolol antihistamines <e1> carbamazepine </e1> ( Tegretol ) cimetidine ( Tagamet ) estrogens fluoxetine ( Prozac ) intraconazole ( <e2> Sporanox </e2> ) ketoconazole ( Nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	carbamazepine	Sporanox
other	 Patients receiving other <e1> narcotic analgesic </e1> s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , <e2> tricyclic antidepressants </e2> or other CNS depressants (including alcohol ) concomitantly with DILAUDID may exhibit an additive CNS depression .	narcotic analgesic	tricyclic antidepressants
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e1> sulindac </e1> ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	sulindac	trimethoprim
effect	 Other depressasnts such as alcohol , barbiturates , and <e1> MAOIs </e1> may enhance CNS depression when administered with <e2> ethchlorvynol </e2> .	MAOIs	ethchlorvynol
other	 Other Drugs : In small groups of patients (7-10/interaction study) , the concomitant administration of azathioprine , gold , chloroquine , D-penicillamine , prednisolone , doxycycline , or <e1> digitoxin </e1> did not significantly affect the peak levels and AUC values of <e2> diclofenac </e2> .	digitoxin	diclofenac
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1> glucagon </e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e2> sulfamethoxazole </e2> ;unreliable prothrombin time determinations; warfarin sodium overdosage .	glucagon	sulfamethoxazole
int	 A pharmacokinetic interaction between <e1> diltiazem </e1> and <e2> cyclosporine </e2> has been observed during studies involving renal and cardiac transplant patients .	diltiazem	cyclosporine
other	 In patients receiving nonselective monoamine oxidase inhibitors ( <e1> MAOIs </e1> ) (e.g. , <e2> selegiline hydrochloride </e2> ) in combination with serotoninergic agents (e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .	MAOIs	selegiline hydrochloride
other	 Interactions for vitamin D analogues ( <e1> Vitamin D2 </e1> , Vitamin D3 , Calcitriol , and <e2> Calcidiol </e2> ) : Cholestyramine : Cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;	Vitamin D2	Calcidiol
advise	 Therefore , <e1> proton pump inhibitors </e1> should be taken at least 30 minutes prior to <e2> sucralfate </e2> .	proton pump inhibitors	sucralfate
other	 Administration of quinolones with antacids containing aluminum , <e1> magnesium </e1> , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or <e2> zinc </e2> , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	magnesium	zinc
other	 - Anabolic steroids ( nandrolone [e.g. , <e1> Anabolin </e1> ] , oxandrolone [e.g. , Anavar ] , <e2> oxymetholone </e2> [e.g. , Anadrol ] , stanozolol [e.g. , Winstrol ]) or	Anabolin	oxymetholone
other	 <e1> Sirolimus </e1> works differently from the immunosuppressants currently available , and except for increased lipid levels , the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with cyclosporine or <e2> tacrolimus </e2> .	Sirolimus	tacrolimus
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : <e1> adrenocortical steroids </e1> ; alcohol *; antacids ; antihistamines ; barbiturates ; <e2> carbamazepine </e2> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	adrenocortical steroids	carbamazepine
other	 Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic <e1> iron supplement </e1> containing 60 mg of elemental iron (as FeSO4) or <e2> vitamins </e2> supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31% , respectively .	iron supplement	vitamins
other	 <e1> Rifabutin </e1> : Coadministration of rifabutin and <e2> VIRACEPT </e2> resulted in a 32% decrease in nelfinavir plasma AUC and a 207% increase in rifabutin plasma A.C .	Rifabutin	VIRACEPT
other	 The gonadotropin levels may be transiently elevated by <e1> spironolactone </e1> , minimally elevated by levodopa , and suppressed by oral <e2> contraceptives </e2> and digoxin .	spironolactone	contraceptives
other	 Cholestyramine <e1> resin </e1> may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or <e2> propranolol </e2> (basic) , as well as tetracycline penicillin G , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .	resin	propranolol
other	 Effects of Other <e1> Antiepileptic Drugs </e1> on Felbatol Phenytoin : Phenytoin causes an approximate doubling of the clearance of Felbatol ( <e2> felbamate </e2> ) at steady state and , therefore , the addition of phenytoin causes an approximate 45% decrease in the steady-state trough concentrations of Felbatol as compared to the same dose of Felbatol given as monotherapy .	Antiepileptic Drugs	felbamate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; <e1> amiodarone </e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e2> nalidixic acid </e2> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	amiodarone	nalidixic acid
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , <e1> tiagabine </e1> , tramadol , triazolam , valproate , warfarin (5) , <e2> ziprasidone </e2> , and zonisamide .	tiagabine	ziprasidone
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , <e1> amiodarone </e1> , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , <e2> 6-mercaptopurine </e2> , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	amiodarone	6-mercaptopurine
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam ) : Available data from clinical studies of <e1> benzodiazepines </e1> other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , <e2> isoniazid </e2> , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .	benzodiazepines	isoniazid
other	 However , neither <e1> phenobarbital </e1> nor <e2> diazepam </e2> appears to affect Dantrium metabolism .	phenobarbital	diazepam
other	 Bentiromide may interact with acetaminophen (e.g. , Tylenol ) , <e1> chloramphenicol </e1> (e.g. , Chloromycetin ) , local anesthetics (e.g. , benzocaine and <e2> lidocaine </e2> ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some multivitamins ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	chloramphenicol	lidocaine
other	 The serum androgen concentrations of <e1> estradiol </e1> + endotoxin -treated rats did not change significantly , while those of <e2> endotoxin </e2> -treated rats dropped to 30-40%	estradiol	endotoxin
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , <e1> aminoglycosides </e1> , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , <e2> magnesium </e2> salts , lithium , local anesthetics , procainamide , and quinidine .	aminoglycosides	magnesium
other	 Etonogestrel may interact with the following medications : <e1> acetaminophen </e1> ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as <e2> protease inhibitors </e2> ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	acetaminophen	protease inhibitors
other	 Several drug interaction studies have been completed with both <e1> INVIRASE </e1> and <e2> FORTOVASE </e2> .	INVIRASE	FORTOVASE
other	 A 21 (17)% decrease in the steady-state AUC of <e1> ganciclovir </e1> was observed when <e2> VIDEX </e2> was administered 2 hours prior to ganciclovir , but not when the two drugs were administered simultaneously (n = 12) .	ganciclovir	VIDEX
other	 <e1> Resins </e1> : Since bile acid sequestrants may bind other drugs given concurrently , patients should take <e2> TRICOR </e2> at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption .	Resins	TRICOR
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; <e1> allopurinol </e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e2> pyrazolones </e2> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	allopurinol	pyrazolones
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : <e1> adrenocortical steroids </e1> ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; <e2> chlordiazepoxide </e2> ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	adrenocortical steroids	chlordiazepoxide
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; <e1> barbiturates </e1> ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; <e2> griseofulvin </e2> ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	barbiturates	griseofulvin
other	 In three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with <e1> azithromycin </e1> 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with <e2> cimetidine </e2> 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers .	azithromycin	cimetidine
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , <e1> lincomycin </e1> , clindamycin , colistin , and sodium colistemethate ) , <e2> magnesium </e2> salts , lithium , local anesthetics , procainamide , and quinidine .	lincomycin	magnesium
other	 Etonogestrel may interact with the following medications : <e1> acetaminophen </e1> ( Tylenol ) , antibiotics such as ampicillin and tetracycline , <e2> anticonvulsants </e2> ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	acetaminophen	anticonvulsants
advise	 <e1> Lithium </e1> generally should not be given with <e2> diuretics </e2> because they reduce its renal clearance and add a high risk of lithium toxicity .	Lithium	diuretics
other	 In in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by CYP2D6 ( dextromethorphan ) , CYP2C9 ( <e1> warfarin </e1> ) , CYP2C19 ( omeprazole , warfarin ) , and CYP3A4 ( <e2> dextromethorphan </e2> ) substrates .	warfarin	dextromethorphan
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , <e1> b-adrenergic blocking agents </e1> , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , <e2> heparin </e2> , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	b-adrenergic blocking agents	heparin
advise	 If concomitant treatment with <e1> naratriptan </e1> and an <e2> SSRI </e2> is clinically warranted , appropriate observation of the patient is advised .	naratriptan	SSRI
mechanism	 Antidepressants : In vitro data indicate that <e1> nefazodone </e1> inhibits the metabolism of <e2> cisapride </e2> , which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG .	nefazodone	cisapride
other	 In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( <e1> piroxicam </e1> ) , and <e2> digoxin </e2> did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	piroxicam	digoxin
other	 Population pharmacokinetic analyses revealed that MTX , NSAIDs , corticosteroids , and <e1> TNF blocking agents </e1> did not influence <e2> abatacept </e2> clearance .	TNF blocking agents	abatacept
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , <e1> colistin </e1> , and sodium colistemethate ) , magnesium salts , lithium , local <e2> anesthetics </e2> , procainamide , and quinidine .	colistin	anesthetics
other	 The principal drugs given (number of patients in parentheses) were : cardiac glycosides (115) , sedatives and hypnotics (103) , coronary vasodilators (52) , oral hypoglycemics (45) , cough and cold preparations (45) , NSAIDs (38) , <e1> antihyperlipidemics </e1> (29) , antigout drugs (24) , oral contraceptives (18) , bronchodilators (13) , insulin (10) , and <e2> beta blockers </e2> (10) .	antihyperlipidemics	beta blockers
other	 <e1> Valproate </e1> : <e2> Felbatol </e2> causes an increase in steady-state valproate concentrations .	Valproate	Felbatol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1> fenoprofen </e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; <e2> indomethacin </e2> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	fenoprofen	indomethacin
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , <e1> trifluoperazine </e1> [e.g. , Stelazine ] , <e2> triflupromazine </e2> [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	trifluoperazine	triflupromazine
other	 The effect of rifampin on the <e1> warfarin </e1> requirement of our patient appeared to be maximal 5 to 7 days after the initiation of <e2> rifampin </e2> and extended a similar length of time after rifampin withdrawal .	warfarin	rifampin
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> ORENCIA </e1> : MTX , NSAIDs , corticosteroids , <e2> TNF blocking agents </e2> , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .	ORENCIA	TNF blocking agents
int	 In addition to bleeding associated with heparin and vitamin K antagonists , drugs that alter platelet function (such as <e1> acetylsalicylic acid </e1> , dipyridamole and Abciximab ) may increase the risk of bleeding if administered prior to , during , or after <e2> Activase </e2> therapy .	acetylsalicylic acid	Activase
other	 Potential drug interactions between <e1> Keppra </e1> and other AEDs ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of <e2> levetiracetam </e2> and these AEDs during placebo-controlled clinical studies .	Keppra	levetiracetam
other	 Persons taking most antibiotics , <e1> methotrexate </e1> and <e2> pyrimethamine </e2> invalidate folic acid and vitamin B12 diagnostic blood assays .	methotrexate	pyrimethamine
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain <e1> antibiotics </e1> (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , <e2> lithium </e2> , local anesthetics , procainamide , and quinidine .	antibiotics	lithium
other	 Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with <e1> acetaminophen </e1> overdosage or in those taking <e2> methotrexate </e2> .	acetaminophen	methotrexate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1> pyrazolones </e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e2> triclofos sodium </e2> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	pyrazolones	triclofos sodium
other	 The amount of <e1> metformin </e1> absorbed while taking <e2> Acarbose </e2> was bioequivalent to the amount absorbed when taking placebo , as indicated by the plasma AUC values .	metformin	Acarbose
advise	 <e1> Cyclosporine </e1> , tacrolimus and digoxin concentrations should be monitored at the initiation of <e2> Itraconazole </e2> therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .	Cyclosporine	Itraconazole
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1> oxolinic acid </e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e2> thyroid drugs </e2> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	oxolinic acid	thyroid drugs
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( <e1> Gris-PEG </e1> , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , <e2> Norvir </e2> , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Gris-PEG	Norvir
other	 It is , however , possible that concomitant use of other known <e1> photosensitizing agents </e1> such as griseofulvin , <e2> thiazide diuretics </e2> , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution .	photosensitizing agents	thiazide diuretics
other	 BACKGROUND : The effects of combined administration of bombesin and verapamil hydrochloride ( <e1> verapamil </e1> ) , a calcium channel blocker , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by <e2> azoxymethane </e2> ( AOM ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	verapamil	azoxymethane
other	 Interactions may also occur with the following : anti-depressants / anti-anxiety drugs , drugs used to treat an overactive thyroid , <e1> beta-blockers </e1> (e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication (e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing <e2> antihistamines </e2> (e.g. , diphenhydramine ) , any other drugs that may make you drowsy .	beta-blockers	antihistamines
other	 Imidazoles (e . g. , <e1> ketoconazole </e1> , miconazole , clotrimazole , fluconazole , etc.) : in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that <e2> imidazoles </e2> may induce fungal resistance to amphotericin B .	ketoconazole	imidazoles
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , <e1> diazepam </e1> , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , <e2> sulfonamides </e2> , sulfonylureas , thiazide diuretics .	diazepam	sulfonamides
other	 Since the concomitant administration of <e1> warfarin </e1> with amiodarone increases the prothrombin time by 100% after 3 to 4 days , the dose of the <e2> anticoagulant </e2> should be reduced by one-third to one-half , and prothrombin times should be monitored closely .	warfarin	anticoagulant
other	 If signs and symptoms suggestive of digoxin toxicity occur when <e1> enoxacin </e1> and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust <e2> digoxin </e2> doses appropriately .	enoxacin	digoxin
mechanism	 Ritonavir and indinavir : Upon concomitant administration of 5 mg of <e1> Vardenafil </e1> with 600 mg BID <e2> ritonavir </e2> , the Cmax and AUC of ritonavir were reduced by approximately 20% .	Vardenafil	ritonavir
advise	 Therefore , co-administration of <e1> bupropion </e1> with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g. , nortriptyline , <e2> imipramine </e2> , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , haloperidol , risperidone , thioridazine ) , beta-blockers (e.g. , metoprolol ) , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	bupropion	imipramine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( <e1> Lipitor </e1> ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( <e2> rifampin </e2> ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Lipitor	rifampin
other	 There have been reports of interactions of erythromycin with carbamazepine , <e1> cyclosporine </e1> , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and <e2> astemizole </e2> .	cyclosporine	astemizole
other	 The actions of the benzodiazepines may be potentiated by barbiturates , <e1> narcotics </e1> , phenothiazines , monoamine oxidase inhibitors or other <e2> antidepressants </e2> .	narcotics	antidepressants
mechanism	 Ascorbic acid : Doses of <e1> ascorbic acid </e1> ( vitamin C ) 1 g/day have been reported to increase plasma concentration of <e2> synthetic estrogens </e2> by ~47% , possibly by inhibiting conjugation;	ascorbic acid	synthetic estrogens
other	 Administration of quinolones with antacids containing aluminum , magnesium , or <e1> calcium </e1> , with sucralfate , with metal cations such as <e2> iron </e2> , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	calcium	iron
other	 - a <e1> nonsteroidal anti-inflammatory drug </e1> ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( <e2> Orudis </e2> , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	nonsteroidal anti-inflammatory drug	Orudis
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , <e1> fluvoxamine </e1> , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , <e2> verapamil </e2> , zileuton .	fluvoxamine	verapamil
other	 [Stimulation by cerulein --an analog of the octapeptide cholecystokinin--of <e1> 3H-spiroperidol </e1> binding after the long-term administration of neuroleptics ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for <e2> apomorphine </e2> in subcortical structures , whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain .	3H-spiroperidol	apomorphine
other	 - <e1> Phenothiazines </e1> ( acetophenazine [e.g. , <e2> Tindal </e2> ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Phenothiazines	Tindal
mechanism	 The absorption of oral <e1> gemifloxacin </e1> is significantly reduced by the concomitant administration of an antacid containing <e2> aluminum </e2> and magnesium .	gemifloxacin	aluminum
other	 Prednisone / prednisolone : <e1> Rofecoxib </e1> did not have any clinically important effect on the pharmacokinetics of prednisolone or <e2> prednisone </e2> .	Rofecoxib	prednisone
other	 All subjects received <e1> amprenavir </e1> (1,200 mg twice a day) for 4 days , followed by a 7-day washout period , followed by either rifabutin (300 mg once a day [QD]) (cohort 1) or <e2> rifampin </e2> (600 mg QD) (cohort 2) for 14 days .	amprenavir	rifampin
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , <e1> Cataflam </e1> ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , <e2> Naprosyn </e2> , Aleve );	Cataflam	Naprosyn
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	sulfinpyrazone
other	 Oral contraceptives : Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of <e1> ethinyl estradiol </e1> and 1 mg of <e2> norethindrone </e2> , decreased the AUC of ethinyl estradiol by 43% , and decreased the AUC of norethindrone by 8%;	ethinyl estradiol	norethindrone
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , <e1> fluoxetine </e1> , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , <e2> nicotinamide </e2> , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	fluoxetine	nicotinamide
other	 Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving <e1> Alprazolam </e1> (caution is recommended during coadministration with alprazolam ) : Coadministration of <e2> fluoxetine </e2> with alprazolam increased the maximum plasma concentration of alprazolam by 46% , decreased clearance by 21% , increased half-life by 17% , and decreased measured psychomotor performance .	Alprazolam	fluoxetine
other	 In general , most patients treated with <e1> dirithromycin </e1> who are receiving concomitant theophylline therapy may not require empiric adjustment of <e2> theophylline </e2> dosage or monitoring of theophylline plasma concentrations .	dirithromycin	theophylline
other	 Since amiodarone is a substrate for <e1> CYP3A4 </e1> , there is the potential that the use of St . John s Wort in patients receiving amiodarone could result in reduced <e2> amiodarone </e2> levels .	CYP3A4	amiodarone
other	 Although it has not been established that there is an interaction between Clozapine and <e1> benzodiazepines </e1> or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other <e2> psychotropic drug </e2> .	benzodiazepines	psychotropic drug
other	 In vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , <e1> nicardipine </e1> , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and <e2> metformin </e2> showed no influence on the extent of nateglinide protein binding .	nicardipine	metformin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation <e1> anesthetics </e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e2> phenytoin </e2> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anesthetics	phenytoin
effect	 Isoflurane or enflurane administered with <e1> nitrous oxide </e1> / oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of <e2> NIMBEX </e2> .	nitrous oxide	NIMBEX
other	 Interactions may also occur with the following : <e1> anti-depressants </e1> / anti-anxiety drugs , drugs used to treat an overactive thyroid , <e2> beta-blockers </e2> (e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication (e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines (e.g. , diphenhydramine ) , any other drugs that may make you drowsy .	anti-depressants	beta-blockers
other	 The administration of local <e1> anesthetic solutions </e1> containing epinephrine or <e2> norepinephrine </e2> to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .	anesthetic solutions	norepinephrine
other	 <e1> Rofecoxib </e1> did not influence the plasma pharmacokinetics or renal elimination of a single oral dose of <e2> digoxin </e2> .	Rofecoxib	digoxin
other	 Drugs Metabolized by Cytochrome P450IID6 (CYP2D6) : Many drugs , including most antidepressants (SSRIs , many <e1> tricyclics </e1> ) , beta-blockers , antiarrhythmics , and <e2> antipsychotics </e2> are metabolized by the CYP2D6 isoenzyme .	tricyclics	antipsychotics
other	 Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum <e1> antacids </e1> , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of <e2> ciprofloxacin </e2> , resulting in serum and urine levels considerably lower than desired .	antacids	ciprofloxacin
mechanism	 Dicumarol : It has been reported that <e1> allopurinol </e1> prolongs the half-life of the anticoagulant , <e2> dicumarol </e2> .	allopurinol	dicumarol
other	 <e1> Antihistamines </e1> : <e2> Amphetamines </e2> may counteract the sedative effect of antihistamines .	Antihistamines	Amphetamines
effect	 Other drugs which may enhance the neuromuscular blocking action of <e1> nondepolarizing agents </e1> such as NIMBEX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , <e2> polymyxins </e2> , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .	nondepolarizing agents	polymyxins
mechanism	 In a ten-subject study , coadministration of <e1> diltiazem </e1> (120 mg bid) with <e2> lovastatin </e2> resulted in a 3-4 times increase in mean lovastatin AUC and Cmax vs . DRUG0 alone;	diltiazem	lovastatin
effect	 - Phenytoin (e.g. , Dilantin ) Use of <e1> phenytoin </e1> with <e2> sulfapyridine </e2> may increase the chance of side effects affecting the liver and/or the side effects of phenytoin	phenytoin	sulfapyridine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1> dextrothyroxine </e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextrothyroxine	sulfinpyrazone
other	 <e1> Insulin </e1> or Oral Hypoglycemics : <e2> Agents with b-blocking properties </e2> may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .	Insulin	Agents with b-blocking properties
effect	 The blood pressure effect of <e1> SULAR </e1> tended to be greater in patients on <e2> atenolol </e2> than in patients on no other antihypertensive therapy .	SULAR	atenolol
other	 For comprehensive information concerning laboratory test alterations associated with <e1> ritonavir </e1> , physicians should refer to the complete prescribing information for <e2> NORVIR </e2> ( DRUG0 ) .	ritonavir	NORVIR
other	 Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents ) or drugs which inhibit platelet function (eg , <e1> aspirin </e1> and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , <e2> dextran </e2> ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .	aspirin	dextran
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , <e1> amitriptyline </e1> , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , <e2> triazolam </e2> , valproate , warfarin (5) , ziprasidone , and zonisamide .	amitriptyline	triazolam
mechanism	 The following are examples of drugs known to inhibit the metabolism of other related <e1> benzodiazepines </e1> , presumably through inhibition of CYP3A : <e2> nefazodone </e2> , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .	benzodiazepines	nefazodone
other	 While all the selective <e1> serotonin reuptake inhibitors </e1> ( SSRIs ) , e.g. , <e2> fluoxetine </e2> , sertraline , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	serotonin reuptake inhibitors	fluoxetine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , <e1> atorvastatin </e1> ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as <e2> protease inhibitors </e2> ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	atorvastatin	protease inhibitors
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , <e1> carbamazepine </e1> , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , <e2> phenytoin </e2> , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	carbamazepine	phenytoin
mechanism	 <e1> Aminosalicylic acid </e1> may also decrease the absorption of <e2> vitamin B12 </e2> , which can lead to a deficiency .	Aminosalicylic acid	vitamin B12
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1> diazoxide </e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e2> miconazole </e2> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diazoxide	miconazole
other	 Caution should be used when administering or taking TARCEVA with <e1> ketoconazole </e1> and other strong CYP3A4 inhibitors such as , but not limited to , <e2> atazanavir </e2> , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( TAO ) , and voriconazole .	ketoconazole	atazanavir
other	 Other Drugs : In healthy volunteers , amlodipine , <e1> phenytoin </e1> , glyburide , ranitidine , omeprazole , hormone replacement therapy (a combination of conjugated <e2> estrogens </e2> and medroxyprogesterone ) , antacid DRUG0 and magnesium hydroxide s) and theophylline did not affect the pharmacokinetics of TIKOSYN .	phenytoin	estrogens
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> EQUETROTM </e1> are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , <e2> valproate </e2> (1) , verapamil , zileuton .	EQUETROTM	valproate
other	 When <e1> amiodarone </e1> is added to flecainide therapy , plasma <e2> flecainide </e2> levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .	amiodarone	flecainide
other	 Administration of <e1> quinolones </e1> with <e2> antacids </e2> containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	quinolones	antacids
effect	 As with some other <e1> nondepolarizing neuromuscular blocking agents </e1> , the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving <e2> phenytoin </e2> or carbamazepine .	nondepolarizing neuromuscular blocking agents	phenytoin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , <e1> antifungals </e1> ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , <e2> Kaletra </e2> , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	antifungals	Kaletra
effect	 In patients receiving nonselective monoamine oxidase inhibitors ( <e1> MAOIs </e1> ) (e.g. , selegiline hydrochloride ) in combination with serotoninergic agents (e.g. , fluoxetine , fluvoxamine , <e2> paroxetine </e2> , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .	MAOIs	paroxetine
other	 Oral <e1> Hypoglycemic Agents </e1> : In pharmacokinetic studies of MEVACOR in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with glipizide or with <e2> chlorpropamide </e2>	Hypoglycemic Agents	chlorpropamide
other	 Antiarrhythmic agents, class I (such as flecainide , lidocaine , or <e1> quinidine </e1> ) : concurrent use with <e2> arbutamine </e2> may have a proarrhythmic effect .	quinidine	arbutamine
mechanism	 Steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 <e1> Edetate calcium disodium </e1> interferes with the action of <e2> zinc insulin </e2> preparations by chelating the zinc . 7	Edetate calcium disodium	zinc insulin
other	 In patients receiving mercaptopurine ( Purinethol ) or azathioprine ( <e1> Imuran </e1> ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of <e2> mercaptopurine </e2> or azathioprine .	Imuran	mercaptopurine
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of <e1> insulin </e1> : corticosteroids , danazol , <e2> diuretics </e2> , sympathomimetic agents (e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	insulin	diuretics
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1> indomethacin </e1> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e2> oxyphenbutazone </e2> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	indomethacin	oxyphenbutazone
other	 include <e1> terfenadine </e1> , astemizole , cisapride , midazolam , and <e2> triazolam </e2> .	terfenadine	triazolam
mechanism	 <e1> Rifampin </e1> has been reported to increase the <e2> warfarin </e2> requirements in human subjects ingesting these agents simultaneously .	Rifampin	warfarin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1> diazoxide </e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e2> oxolinic acid </e2> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diazoxide	oxolinic acid
other	 <e1> Monoamine Oxidase Inhibitors </e1> and <e2> Tricyclic Antidepressants </e2> : FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	Monoamine Oxidase Inhibitors	Tricyclic Antidepressants
other	 Barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , <e1> corticosteroids </e1> , anticoagulants , and <e2> beta blockers </e2> .	corticosteroids	beta blockers
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all central nervous system depressants (eg , <e1> alcohol </e1> , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , <e2> phenothiazines </e2> , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .	alcohol	phenothiazines
advise	 5HT3 Antagonists : Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of <e1> apomorphine </e1> with drugs of the 5HT3 antagonist class (including , for example , <e2> ondansetron </e2> , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .	apomorphine	ondansetron
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; <e1> aminosalicylic acid </e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; <e2> phenylbutazone </e2> ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	aminosalicylic acid	phenylbutazone
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , <e1> niacinamide </e1> , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , <e2> verapamil </e2> , zileuton .	niacinamide	verapamil
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( <e1> Neoral </e1> , Sandimmune ) , HIV drugs classified as <e2> protease inhibitors </e2> ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Neoral	protease inhibitors
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , <e1> estrogens </e1> and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , <e2> meclofenamic acid </e2> , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .	estrogens	meclofenamic acid
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; <e1> amiodarone </e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e2> phenytoin </e2> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	amiodarone	phenytoin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , <e1> lamotrigine </e1> , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , <e2> oxcarbazepine </e2> , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	lamotrigine	oxcarbazepine
int	 <e1> Etonogestrel </e1> may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( <e2> rifampin </e2> ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Etonogestrel	rifampin
mechanism	 Concomitant administration of <e1> fenofibrate </e1> (equivalent to 145mg TRICOR ) with <e2> pravastatin </e2> (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for pravastatin by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase) , respectively , and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase) , respectively in 23 healthy adults .	fenofibrate	pravastatin
advise	 The use of <e1> FLUDARA </e1> FOR INJECTION in combination with <e2> pentostatin </e2> is not recommended due to the risk of severe pulmonary toxicity .	FLUDARA	pentostatin
advise	 Before taking <e1> glimepiride </e1> , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( Trilisate ) , salsalate ( Disalcid , others) , choline salicylate ( Arthropan ) , magnesium salicylate ( Magan ) , or <e2> bismuth subsalicylate </e2> ( Pepto-Bismol );	glimepiride	bismuth subsalicylate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , <e1> p-aminosalicylic acid </e1> , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , <e2> 6-mercaptopurine </e2> , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	p-aminosalicylic acid	6-mercaptopurine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1> influenza virus vaccine </e1> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e2> quinidine </e2> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	influenza virus vaccine	quinidine
other	 In a parallel group drug interaction study comparing the intravenous prodrug form of <e1> valdecoxib </e1> at 40 mg BID (n=10) vs placebo (n=9) , valdecoxib had no effect on in vitro <e2> aspirin </e2> -mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation .	valdecoxib	aspirin
int	 <e1> Etonogestrel </e1> may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , <e2> Topamax </e2> , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Etonogestrel	Topamax
effect	 The administration of local anesthetic solutions containing <e1> epinephrine </e1> or norepinephrine to patients receiving <e2> monoamine oxidase inhibitors </e2> or tricyclic antidepressants may produce severe , prolonged hypertension .	epinephrine	monoamine oxidase inhibitors
int	 Data from in vitro studies of alprazolam suggest a possible drug interaction with <e1> alprazolam </e1> for the following : <e2> sertraline </e2> and paroxetine .	alprazolam	sertraline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , <e1> nortriptyline </e1> , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , <e2> valproate </e2> , warfarin (5) , ziprasidone , and zonisamide .	nortriptyline	valproate
other	 Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine ( <e1> etodolac </e1> capsules and tablets) results in reduced protein binding of <e2> warfarin </e2> , but there was no change in the clearance of free warfarin .	etodolac	warfarin
other	 - When <e1> Bezalip </e1> or Bezalip retard is used concurrently with anion-exchange resins (e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of Bezalip or <e2> Bezalip retard </e2> is impaired	Bezalip	Bezalip retard
other	 Tell your doctor if you are taking any of the following drugs : blood thinner s ( Coumadin ) other antidepressants metoprolol antihistamines <e1> carbamazepine </e1> ( Tegretol ) cimetidine ( Tagamet ) estrogens fluoxetine ( Prozac ) intraconazole ( Sporanox ) ketoconazole ( <e2> Nizoral </e2> ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	carbamazepine	Nizoral
other	 Magnesium / <e1> Aluminum </e1> -containing Antacid Products : Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium / aluminum -containing <e2> antacid products </e2> .	Aluminum	antacid products
other	 Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and <e1> monoamine oxidase (MAO) inhibitors </e1> (concurrent use with <e2> antihistamines </e2> may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	monoamine oxidase (MAO) inhibitors	antihistamines
effect	 Selective Serotonin Reuptake Inhibitors ( SSRIs ) : <e1> SSRIs </e1> (e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> 5-HT1 agonists </e2> .	SSRIs	5-HT1 agonists
mechanism	 Reciprocal interactions may occur with concomitant use of <e1> Antizol </e1> and drugs that increase or inhibit the cytochrome P450 system (e.g. , phenytoin , carbamazepine , <e2> cimetidine </e2> , ketoconazole ) , though this has not been studied	Antizol	cimetidine
other	 Single doses of either cholestyramine or colestipol <e1> resins </e1> bind the <e2> hydrochlorothiazide </e2> and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .	resins	hydrochlorothiazide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1> diflunisal </e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e2> glucagon </e2> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diflunisal	glucagon
other	 - a nonsteroidal anti-inflammatory drug ( <e1> NSAID </e1> ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , <e2> nabumetone </e2> ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	NSAID	nabumetone
other	 Because <e1> Nalfon </e1> has not been shown to produce any additional effect beyond that obtained with <e2> aspirin </e2> alone and because aspirin increases the rate of excretion of Nalfon , the concomitant use of Nalfon and salicylates is not recommended .	Nalfon	aspirin
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( <e1> Motrin </e1> , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( <e2> Lodine </e2> ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	Motrin	Lodine
other	 Hormonal Contraceptives , Including Oral , Injectable , Transdermal , and Implantable Contraceptives : An interaction study demonstrated that co-administration of <e1> bosentan </e1> and the oral hormonal contraceptive Ortho-Novum produced average decreases of <e2> norethindrone </e2> and ethinyl estradiol levels of 14% and 31% , respectively .	bosentan	norethindrone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , <e1> mirtazapine </e1> , nortriptyline , olanzapine , oral contraceptives (3) , <e2> oxcarbazepine </e2> , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	mirtazapine	oxcarbazepine
advise	 Aspirin : <e1> CELEBREX </e1> can be used with low dose <e2> aspirin </e2> .	CELEBREX	aspirin
other	 however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased <e1> ketoprofen </e1> plasma clearance from 0.07 L/kg/h without <e2> aspirin </e2> to 0.11 L/kg/h with aspirin .	ketoprofen	aspirin
other	 There have been case reports of increased steady-state levels of quinidine , <e1> procainamide </e1> , and <e2> phenytoin </e2> during concomitant therapy with amiodarone .	procainamide	phenytoin
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; <e1> rifampin </e1> ;unreliable prothrombin time determinations; vitamin C ; <e2> warfarin sodium </e2> under-dosage .	rifampin	warfarin sodium
mechanism	 <e1> Quinolones </e1> have been shown to interfere with the metabolism of <e2> caffeine </e2> .	Quinolones	caffeine
other	 Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of <e1> citalopram </e1> and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or <e2> digoxin </e2> .	citalopram	digoxin
other	 In patients taking furosemide , <e1> nifedipine </e1> , diltiazem , ACE inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of <e2> hydrodolasetron </e2> .	nifedipine	hydrodolasetron
other	 Amphotericin , Foscarnet , and Aminoglycosides : Drugs such as <e1> amphotericin </e1> , foscarnet , and <e2> aminoglycosides </e2> may increase the risk of developing peripheral neuropathy or other HIVID -associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure) .	amphotericin	aminoglycosides
mechanism	 Barbiturates , <e1> phenytoin </e1> , or rifampin increased metabolic clearance of <e2> fludrocortisone acetate </e2> because of the induction of hepatic enzymes .	phenytoin	fludrocortisone acetate
other	 Drugs which may enhance the neuromuscular blocking action of TRACRIUM include : enflurane ; isoflurane ; <e1> halothane </e1> ;certain <e2> antibiotics </e2> , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts; procainamide ;and quinidine .	halothane	antibiotics
effect	 Selective Serotonin Reuptake Inhibitors ( SSRIs ) : SSRIs (e.g. , fluoxetine , fluvoxamine , <e1> paroxetine </e1> , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> 5-HT1 agonists </e2> .	paroxetine	5-HT1 agonists
other	 <e1> Antibiotics </e1> : Macrolide antibiotics have been reported to cause a significant decrease in <e2> corticosteroid </e2> clearance .	Antibiotics	corticosteroid
mechanism	 In a study in which the 2 mg <e1> clonazepam </e1> orally disintegrating tablet was administered with and without <e2> propantheline </e2> (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers , the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .	clonazepam	propantheline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : <e1> Acetaminophen </e1> , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , <e2> tiagabine </e2> , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	Acetaminophen	tiagabine
other	 Chlorpropamide : <e1> Chlorpropamide </e1> s plasma half-life may be prolonged by allopurinol , since <e2> allopurinol </e2> and chlorpropamide may compete for excretion in the renal tubule .	Chlorpropamide	allopurinol
other	 Interactions for vitamin D analogues ( Vitamin D2 , Vitamin D3 , Calcitriol , and <e1> Calcidiol </e1> ) : Cholestyramine : <e2> Cholestyramine </e2> has been reported to reduce intestinal absorption of fat soluble vitamins ;	Calcidiol	Cholestyramine
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a <e1> quinolone </e1> , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or <e2> zinc </e2> may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	quinolone	zinc
mechanism	 Naproxen , naproxen sodium and other <e1> NSAIDs </e1> have been reported to reduce the tubular secretion of <e2> methotrexate </e2> in an animal model , possibly increasing the toxicity of methotrexate .	NSAIDs	methotrexate
mechanism	 <e1> Acarbose </e1> has been shown to change the bioavailabillty <e2> digoxin </e2> when they are co-administered , which may require digoxin dose adjustment .	Acarbose	digoxin
other	 The concomitant administration of <e1> rifampin </e1> and warfarin resulted in the need for an unusually high maintenance dose of <e2> warfarin </e2> (20 mg per day) in order to produce a therapeutic effect .	rifampin	warfarin
other	 Reported examples of this interaction include the following : <e1> Immunosuppressive </e1> s : Cyclosporine ( CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of <e2> cyclosporine </e2> resulting in elevated creatinine , despite reduction in dose of cyclosporine .	Immunosuppressive	cyclosporine
effect	 Blunting of the antihypertensive effect of <e1> beta-adrenoceptor blocking agents </e1> by non-steroidal antiinflammatory drugs including <e2> INDOCIN </e2> has been reported .	beta-adrenoceptor blocking agents	INDOCIN
effect	 Compounds in these categories result in a decreased efficacy of <e1> bromocriptine mesylate </e1> : phenothiazines , <e2> haloperidol </e2> , metoclopramide , pimozide .	bromocriptine mesylate	haloperidol
effect	 Patients receiving other narcotic analgesics , <e1> antipsychotics </e1> , antianxiety agents , or other CNS depressants (including alcohol ) concomitantly with <e2> hydrocodone </e2> and acetaminophen tablets may exhibit an additive CNS depression .	antipsychotics	hydrocodone
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> EQUETROTM </e1> due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , <e2> clobazam </e2> , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	EQUETROTM	clobazam
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; <e1> allopurinol </e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e2> quinidine </e2> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	allopurinol	quinidine
other	 Like ibogaine (40 mg/kg) , 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of <e1> ethanol </e1> and <e2> nicotine </e2> in rats;	ethanol	nicotine
effect	 Catecholamine-depleting drugs (e.g. , <e1> reserpine </e1> ) may have an additive effect when given with <e2> beta-blocking </e2> agents .	reserpine	beta-blocking
other	 <e1> Phenobarbital </e1> : Estimates of steady-state pharmacokinetic parameters for DRUG0 or <e2> gabapentin </e2> (300 mg TID;	Phenobarbital	gabapentin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1> ethacrynic acid </e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ethacrynic acid	trimethoprim
other	 Before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another <e1> salicylate </e1> such as magnesium/choline salicylate ( Trilisate ) , salsalate ( Disalcid , others) , choline salicylate ( Arthropan ) , <e2> magnesium salicylate </e2> ( Magan ) , or bismuth subsalicylate ( Pepto-Bismol );	salicylate	magnesium salicylate
other	 Medications can interfere with folate utilization , including : anticonvulsant medications (such as phenytoin , and <e1> primidone </e1> ) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) <e2> sulfasalazine </e2> (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic ) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid .	primidone	sulfasalazine
other	 The urinary excretion of <e1> meclofenamate sodium </e1> is unaffected by <e2> aspirin </e2> , indicating no change in meclofenamate sodium absorption .	meclofenamate sodium	aspirin
other	 Particular caution should be exercised in using preparations containing <e1> sulfur </e1> , resorcinol , or salicylic acid in combination with <e2> DIFFERIN </e2> Gel .	sulfur	DIFFERIN
other	 <e1> filipin </e1> was more potent in lysing human red blood cells , whereas <e2> amphotericin B </e2> was more potent in inhibiting yeast cell growth;	filipin	amphotericin B
other	 Endothelium-intact aortic rings from high- <e1> estradiol </e1> rats were supersensitive to noradrenaline when compared to vehicle- , <e2> progesterone </e2> - and progesterone + high- estradiol -treated rats (pD2 values = 7.77+/-0.12 , 7.21+/-0.13 , 6.93+/-0.04 and 7.22+/-0.18 , respectively) .	estradiol	progesterone
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( <e1> Dilantin </e1> , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	Dilantin	temazepam
advise	 Additionally , <e1> BREVIBLOC </e1> should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine , epinephrine , and <e2> norepinephrine </e2> because of the danger of blocking cardiac contractility when systemic vascular resistance is high .	BREVIBLOC	norepinephrine
other	 - <e1> Anabolic steroids </e1> ( nandrolone [e.g. , Anabolin ] , oxandrolone [e.g. , Anavar ] , <e2> oxymetholone </e2> [e.g. , Anadrol ] , stanozolol [e.g. , Winstrol ]) or	Anabolic steroids	oxymetholone
other	 Caffeine : Two hundred mg of <e1> caffeine </e1> (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal , healthy volunteers who had achieved steady-state blood concentrations of <e2> lomefloxacin </e2> after being dosed at 400 mg qd .	caffeine	lomefloxacin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , <e1> Nizoral </e1> , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , <e2> Viracept </e2> ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Nizoral	Viracept
other	 Administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as <e1> iron </e1> , or with <e2> multivitamins </e2> containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	iron	multivitamins
other	 Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with <e1> acetaminophen </e1> , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac <e2> nitrates </e2> , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	acetaminophen	nitrates
other	 The in vitro anti-cryptosporidial activity of buforin II alone and in combination with <e1> azithromycin </e1> and <e2> minocycline </e2> was investigated .	azithromycin	minocycline
other	 As with other <e1> agents with b-blocking properties </e1> , if COREG is to be administered orally with calcium channel blockers of the verapamil or <e2> diltiazem </e2> type , it is recommended that ECG and blood pressure be monitored .	agents with b-blocking properties	diltiazem
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , <e1> Sporanox </e1> ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( <e2> Astramorph </e2> , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Sporanox	Astramorph
other	 <e1> Beta-adrenergic Blocking Agents </e1> : The effect of flurbiprofen on blood pressure response to <e2> propranolol </e2> and atenolol was evaluated in men with mild uncomplicated hypertension (n = 10) .	Beta-adrenergic Blocking Agents	propranolol
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and <e1> dopamine agonists </e1> , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , <e2> somatostatin analogs </e2> , sulfonamides , sulfonylureas , thiazide diuretics .	dopamine agonists	somatostatin analogs
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , <e1> haloperidol </e1> , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , <e2> oxcarbazepine </e2> , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	haloperidol	oxcarbazepine
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , <e1> chlorpromazine </e1> [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , <e2> Stelazine </e2> ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	chlorpromazine	Stelazine
other	 In a comparison of <e1> digitalis </e1> tolerance in dogs anesthetized with ketamine , Innovar Vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with <e2> pentobarbital </e2> .	digitalis	pentobarbital
other	 Similarly dialyzed were <e1> phenobarbital </e1> , quinidine , and <e2> theophylline </e2> , both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum .	phenobarbital	theophylline
advise	 Therefore , <e1> fenofibrate </e1> should be taken at least 1 hour before or 4-6 hours after a <e2> bile acid binding resin </e2> to avoid impeding its absorption .	fenofibrate	bile acid binding resin
other	 Administration of quinolones with antacids containing aluminum , magnesium , or calcium , with <e1> sucralfate </e1> , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( <e2> didanosine </e2> ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	sucralfate	didanosine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e1> tolbutamide </e1> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e2> warfarin sodium </e2> overdosage .	tolbutamide	warfarin sodium
other	 No depressant effect on blood levels in humans was noted when <e1> colestipol hydrochloride </e1> was administered with any of the following drugs : aspirin , <e2> clindamycin </e2> , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .	colestipol hydrochloride	clindamycin
effect	 In particular , convulsions have been reported when <e1> ethionamide </e1> is administered with <e2> cycloserine </e2> and special care should be taken when the treatment regimen includes both of these drugs .	ethionamide	cycloserine
other	 Bentiromide may interact with acetaminophen (e.g. , <e1> Tylenol </e1> ) , chloramphenicol (e.g. , <e2> Chloromycetin </e2> ) , local anesthetics (e.g. , benzocaine and lidocaine ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some multivitamins ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	Tylenol	Chloromycetin
effect	 <e1> Butalbital </e1> , acetaminophen and caffeine may enhance the effects of : other narcotic analgesic s , alcohol , general anesthetics , tranquilizers such as <e2> chlordiazepoxide </e2> , sedative-hypnotics , or other CNS depressants , causing increased CNS depression .	Butalbital	chlordiazepoxide
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including <e1> ciprofloxacin </e1> , with multivalent cation-containing products such as magnesium or aluminum <e2> antacids </e2> , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	ciprofloxacin	antacids
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , <e1> oxcarbazepine </e1> , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , <e2> triazolam </e2> , valproate , warfarin (5) , ziprasidone , and zonisamide .	oxcarbazepine	triazolam
effect	 Selective serotonin reuptake inhibitors ( SSRIs ) (e.g. , fluoxetine , <e1> fluvoxamine </e1> , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> 5-HT1 agonists </e2> .	fluvoxamine	5-HT1 agonists
other	 Oral <e1> contraceptives </e1> : <e2> Aprepitant </e2> , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the AUC of ethinyl estradiol by 43% , and decreased the AUC of norethindrone by 8%;	contraceptives	Aprepitant
other	 <e1> Quinolones </e1> , including <e2> nalidixic acid </e2> , may enhance the effects of the oral anticoagulant warfarin or its derivatives .	Quinolones	nalidixic acid
other	 <e1> Warfarin </e1> : The effect of valdecoxib on the anticoagulant effect of warfarin (1 - 8 mg/day) was studied in healthy subjects by coadministration of <e2> BEXTRA </e2> 40 mg BID for 7 days .	Warfarin	BEXTRA
other	 <e1> MAO Inhibitors </e1> : Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor <e2> phenelzine </e2> .	MAO Inhibitors	phenelzine
effect	 Immediate and Extended Release Tablets The hypoglycemic action of <e1> sulfonylureas </e1> may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , <e2> sulfonamides </e2> , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	sulfonylureas	sulfonamides
other	 Heparin Sodium Injection should not be mixed with <e1> doxorubicin </e1> , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with <e2> heparin </e2> and a precipitate may form .	doxorubicin	heparin
advise	 Therefore , the combination of <e1> ketoprofen </e1> and <e2> probenecid </e2> is not recommended .	ketoprofen	probenecid
other	 Coadministration of valdecoxib and <e1> Ortho-Novum </e1> 1/35 increased the exposure of norethindrone and <e2> ethinyl estradiol </e2> by 20% and 34% , respectively .	Ortho-Novum	ethinyl estradiol
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , <e1> clonazepam </e1> , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e2> contraceptives </e2> (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	clonazepam	contraceptives
other	 These drugs include the thiazides and other <e1> diuretics </e1> , corticosteroids , phe-nothiazines , thyroid products , <e2> estrogens </e2> , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	diuretics	estrogens
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e1> carbamazepine </e1> ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; <e2> rifampin </e2> ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	carbamazepine	rifampin
other	 Effects of <e1> GABITRIL </e1> on other Antiepilepsy Drugs ( AEDs ) : <e2> Phenytoin </e2> : Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .	GABITRIL	Phenytoin
other	 The blood pressure effect of SULAR tended to be greater in patients on <e1> atenolol </e1> than in patients on no other <e2> antihypertensive </e2> therapy .	atenolol	antihypertensive
other	 Interactions for vitamin D analogues ( Vitamin D2 , Vitamin D3 , Calcitriol , and <e1> Calcidiol </e1> ) : Cholestyramine : <e2> Cholestyramine </e2> has been reported to reduce intestinal absorption of fat soluble vitamins ;	Calcidiol	Cholestyramine
effect	 The hypoglycemic action of <e1> sulfonylurea </e1> may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , <e2> sulfonamides </e2> , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	sulfonylurea	sulfonamides
other	 <e1> Magnesium </e1> - and aluminum -containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability (48%) of <e2> lomefloxacin </e2> .	Magnesium	lomefloxacin
other	 Before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another <e1> salicylate </e1> such as magnesium/choline salicylate ( Trilisate ) , salsalate ( Disalcid , others) , choline salicylate ( <e2> Arthropan </e2> ) , magnesium salicylate ( Magan ) , or bismuth subsalicylate ( Pepto-Bismol );	salicylate	Arthropan
other	 <e1> Theophylline </e1> : Enoxacin is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of <e2> methylxanthines </e2> .	Theophylline	methylxanthines
other	 In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or pentobarbital , the dosage of <e1> ouabain </e1> needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or <e2> Innovar </e2> than with pentobarbital .	ouabain	Innovar
other	 Tell your doctor if you are taking any of the following drugs : blood thinner s ( Coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( Tegretol ) <e1> cimetidine </e1> ( Tagamet ) estrogens fluoxetine ( Prozac ) intraconazole ( Sporanox ) ketoconazole ( Nizoral ) levodopa <e2> lithium </e2> muscle relaxants birth control pills sleeping pills thyroid medications	cimetidine	lithium
effect	 Patients receiving other <e1> narcotic analgesics </e1> , antipsychotics , antianxiety agents , or other CNS depressants (including alcohol ) concomitantly with <e2> hydrocodone </e2> and acetaminophen tablets may exhibit an additive CNS depression .	narcotic analgesics	hydrocodone
other	 Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , <e1> chlordiazepoxide </e1> , diazepam , certain tricyclic antidepressants , <e2> lidocaine </e2> , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	chlordiazepoxide	lidocaine
other	 HCTZ 50 mg QD or HCTZ / triamterene 50/100 mg QD was co-administered with <e1> TIKOSYN </e1> (500 mcg BID) for 5 days (following 2 days of <e2> diuretic </e2> use at half dose) .	TIKOSYN	diuretic
other	 The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered <e1> AVONEX </e1> ) indicates that this alteration in clearance does not necessitate reduction of the <e2> TYSABRI </e2> dose to maintain safety , General) .	AVONEX	TYSABRI
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , <e1> Trileptal </e1> , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , <e2> Kaletra </e2> , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Trileptal	Kaletra
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , <e1> erythromycin </e1> (1) , fluoxetine , fluvoxamine , grapefruit juice , <e2> isoniazid </e2> , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	erythromycin	isoniazid
mechanism	 When <e1> amiodarone </e1> is added to <e2> flecainide </e2> therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .	amiodarone	flecainide
other	 Administration of <e1> non-steroidal anti-inflammatory drugs </e1> concomitantly with cyclosporine has been associated with an increase in <e2> cyclosporine </e2> -induced toxicity , possibly due to decreased synthesis of renal prostacyclin .	non-steroidal anti-inflammatory drugs	cyclosporine
other	 <e1> Glyburide </e1> : The concomitant administration of ciprofloxacin with the <e2> sulfonylurea </e2> glyburide has , on rare occasions , resulted in severe hypoglycemia .	Glyburide	sulfonylurea
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1> quinidine </e1> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e2> warfarin sodium </e2> overdosage .	quinidine	warfarin sodium
other	 Oral contraceptives : Aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the AUC of <e1> ethinyl estradiol </e1> by 43% , and decreased the AUC of <e2> norethindrone </e2> by 8%;	ethinyl estradiol	norethindrone
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of <e1> insulin </e1> : corticosteroids , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , <e2> progestogens </e2> (e.g. , in oral contraceptives ) .	insulin	progestogens
other	 Pharmacokinetic data from these patients demonstrated a decrease in <e1> paclitaxel </e1> clearance of approximately 33% when TAXOL was administered following <e2> cisplatin </e2> .	paclitaxel	cisplatin
other	 Medications can interfere with folate utilization , including : anticonvulsant medications (such as phenytoin , and primidone ) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic ) <e1> Methotrexate </e1> There has been concern about the interaction between vitamin B12 and <e2> folic acid </e2> .	Methotrexate	folic acid
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; <e1> ethchlorvynol </e1> ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral <e2> contraceptives </e2> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	ethchlorvynol	contraceptives
effect	 The concomitant administration of <e1> quinolones </e1> including norfloxacin with <e2> glyburide </e2> (a sulfonylurea agent ) has , on rare occasions , resulted in severe hypoglycemia .	quinolones	glyburide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , <e1> clobazam </e1> , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , <e2> topiramate </e2> , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	clobazam	topiramate
other	 Such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , the <e1> tricyclic antidepressants </e1> , and <e2> clozapine </e2> .	tricyclic antidepressants	clozapine
other	 Other Drugs : In healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy (a combination of conjugated estrogens and <e1> medroxyprogesterone </e1> ) , antacid DRUG0 and magnesium hydroxide s) and <e2> theophylline </e2> did not affect the pharmacokinetics of TIKOSYN .	medroxyprogesterone	theophylline
other	 - a nonsteroidal anti-inflammatory drug ( <e1> NSAID </e1> ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , <e2> indomethacin </e2> ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	NSAID	indomethacin
other	 Patients receiving other narcotic analgesics , <e1> antipsychotics </e1> , antianxiety agents , or other <e2> CNS depressants </e2> (including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression .	antipsychotics	CNS depressants
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , <e1> fluoxetine </e1> , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , <e2> niacinamide </e2> , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	fluoxetine	niacinamide
mechanism	 It is known that CYP1A2 is inhibited by several medicinal products , including <e1> fluvoxamine </e1> , and such medicinal products could theoretically adversely influence the clearance of <e2> anagrelide </e2> .	fluvoxamine	anagrelide
effect	 Administration of <e1> epinephrine </e1> to patients receiving cyclopropane or <e2> halogenated hydrocarbon general anesthetics </e2> such as halothane which sensitize the myocardium , may induce cardiac arrhythmia. .	epinephrine	halogenated hydrocarbon general anesthetics
other	 Addition or deletion of any drug from the therapeutic regimen of patients receiving oral <e1> anticoagulants </e1> may affect patient response to the <e2> anticoagulant </e2> .	anticoagulants	anticoagulant
effect	 Other depressasnts such as alcohol , <e1> barbiturates </e1> , and MAOIs may enhance CNS depression when administered with <e2> ethchlorvynol </e2> .	barbiturates	ethchlorvynol
mechanism	 <e1> DIAMOX </e1> modifies phenytoin metabolism with increased serum levels of <e2> phenytoin </e2> .	DIAMOX	phenytoin
other	 This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction (eg , <e1> anti-arrhythmic </e1> or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or H1-blocking agents , tricyclic antidepressants and <e2> phenothiazines </e2> ) might also contribute to a prolongation of the QTc interval .	anti-arrhythmic	phenothiazines
other	 Dexbrompheniramine can interact with <e1> alcohol </e1> or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and <e2> monoamine oxidase (MAO) inhibitors </e2> (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	alcohol	monoamine oxidase (MAO) inhibitors
other	 The present work involved the administration of both <e1> ethynyl estradiol </e1> and <e2> levonorgestrel </e2> to groups of rats , followed by determination of the homocysteine excretion rate in urine .	ethynyl estradiol	levonorgestrel
mechanism	 In patients given very high doses (3900 mg) of <e1> aspirin </e1> daily , increases in serum salicylate levels were seen when <e2> nizatidine </e2> , 150 mg b.i.d. , was administered concurrently .	aspirin	nizatidine
other	 <e1> Antacids </e1> containing aluminum hydroxide and magnesium hydroxide reduce the oral absorption of <e2> enoxacin </e2> by 75% .	Antacids	enoxacin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , <e1> insulin </e1> , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , <e2> rifampin </e2> , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	insulin	rifampin
other	 Etonogestrel may interact with the following medications : acetaminophen ( <e1> Tylenol </e1> ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as <e2> protease inhibitors </e2> ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Tylenol	protease inhibitors
other	 Co-administration of single 25-mg dose <e1> warfarin </e1> had no effect on the pharmacokinetics of total <e2> lenalidomide </e2> .	warfarin	lenalidomide
mechanism	 Protease inhibitors : Amprenavir , lopinavir , <e1> nelfinavir </e1> , and ritonavir have been shown to decrease plasma levels of <e2> combination hormonal contraceptives </e2> ;	nelfinavir	combination hormonal contraceptives
mechanism	 Warfarin : Co-administration of <e1> bosentan </e1> 500 mg b.i.d . for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and <e2> R-warfarin </e2> (a CYP3A4 substrate) by 29 and 38% , respectively .	bosentan	R-warfarin
other	 Interaction of <e1> GABITRIL </e1> with Other Drugs : Cimetidine : Co-administration of <e2> cimetidine </e2> (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .	GABITRIL	cimetidine
mechanism	 There have been greater than 2-fold increases in previously stable plasma levels of other antidepressants , including <e1> nortriptyline </e1> , when <e2> fluoxetine hydrochloride </e2> has been administered in combination with these agents .	nortriptyline	fluoxetine hydrochloride
other	 These drugs include the thiazides and other diuretics , <e1> corticosteroids </e1> , phenothiazines , thyroid products , estrogens , oral <e2> contraceptives </e2> , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	corticosteroids	contraceptives
other	 In clinical trials , <e1> FLOLAN </e1> was used with digoxin , <e2> diuretics </e2> , anticoagulants , oral vasodilators , and supplemental oxygen .In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated , apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15% , respectively , on the second day of therapy and had returned to baseline values by day 87 .	FLOLAN	diuretics
other	 Interactions may also occur with the following : anti-depressants / <e1> anti-anxiety drugs </e1> , drugs used to treat an overactive thyroid , beta-blockers (e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , <e2> guanadrel </e2> , metrizamide , cabergoline , lithium , narcotic pain medication (e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines (e.g. , diphenhydramine ) , any other drugs that may make you drowsy .	anti-anxiety drugs	guanadrel
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , <e1> protease inhibitors </e1> , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and <e2> zonisamide </e2> .	protease inhibitors	zonisamide
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , <e1> pertechnetate </e1> ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , <e2> mitotane </e2> , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	pertechnetate	mitotane
other	 Interactions may also occur with the following : anti-depressants / anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers (e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , <e1> cabergoline </e1> , lithium , narcotic pain medication (e.g. , <e2> codeine </e2> ) , drugs used to aid sleep , drowsiness-causing antihistamines (e.g. , diphenhydramine ) , any other drugs that may make you drowsy .	cabergoline	codeine
mechanism	 Drugs that cause significant sustained elevation in gastric pH ( histamine H2-receptor antagonists such as ranitidine or <e1> cimetidine </e1> ) may reduce plasma concentrations of <e2> IRESSA </e2> and therefore potentially may reduce efficacy .	cimetidine	IRESSA
other	 Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , <e1> analgesics </e1> , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , <e2> HMG-CoA reductase inhibitors </e2> , prostaglandin synthetase inhibitors (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	analgesics	HMG-CoA reductase inhibitors
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e2> diazoxide </e2> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	diazoxide
other	 Patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other CNS depressants (including alcohol ) concomitantly with <e1> hydrocodone </e1> and <e2> acetaminophen </e2> tablets may exhibit an additive CNS depression .	hydrocodone	acetaminophen
other	 Potential drug interactions between Keppra and other AEDs ( carbamazepine , gabapentin , lamotrigine , <e1> phenobarbital </e1> , phenytoin , primidone and <e2> valproate </e2> ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	phenobarbital	valproate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , <e1> mirtazapine </e1> , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , <e2> tramadol </e2> , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	mirtazapine	tramadol
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , <e1> methadone </e1> , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e2> contraceptives </e2> (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	methadone	contraceptives
other	 Use with <e1> Angiotensln Converting Enzyme Inhibitors </e1> : The use of angiotensin converting enzyme inhibitors to control hypertension in patients on <e2> azathioprine </e2> has been reported to induce severe leukopenia .	Angiotensln Converting Enzyme Inhibitors	azathioprine
other	 <e1> ACE Inhibitors </e1> and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or <e2> angiotensin II receptor antagonists </e2> ( ACEI / ARB ) .	ACE Inhibitors	angiotensin II receptor antagonists
effect	 Anakinra : Concurrent administration of <e1> anakinra </e1> (an interleukin-1 antagonist ) and another <e2> TNF-blocking agent </e2> has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .	anakinra	TNF-blocking agent
other	 Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics : amiodarone , quinidine Antihistamines : astemizole , <e1> terfenadine </e1> Antimigraine : ergot derivatives Antimycobacterial agents : rifampin Benzodiazepines <e2> midazolam </e2> , triazolam GI motility agents : cisapride	terfenadine	midazolam
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e1> pyrazolones </e1> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	pyrazolones	tolbutamide
advise	 Consequently , <e1> estazolam </e1> should be avoided in patients receiving ketoconazole and <e2> itraconazole </e2> , which are very potent inhibitors of CYP3A .	estazolam	itraconazole
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , <e1> Nizoral </e1> , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as <e2> protease inhibitors </e2> ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Nizoral	protease inhibitors
other	 In patients taking <e1> diclofenac </e1> and lithium concomitantly , <e2> lithium </e2> toxicity may develop .	diclofenac	lithium
other	 The effect of <e1> gabapentin </e1> on <e2> cimetidine </e2> was not evaluated .	gabapentin	cimetidine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e1> oxyphenbutazone </e1> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; <e2> sulindac </e2> ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	oxyphenbutazone	sulindac
effect	 Selective Serotonin Reuptake Inhibitors ( SSRIs ) : SSRIs (e.g. , fluoxetine , fluvoxamine , paroxetine , <e1> sertraline </e1> ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> 5-HT1 agonists </e2> .	sertraline	5-HT1 agonists
other	 Pharmacoeconomic analyses indicate that <e1> olanzapine </e1> does not significantly increase , and may even decrease , the overall direct treatment costs of schizophrenia , compared with <e2> haloperidol </e2> .	olanzapine	haloperidol
effect	 Injection : <e1> Lorazepam </e1> injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , <e2> MAO inhibitors </e2> , and other antidepressants .When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	Lorazepam	MAO inhibitors
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , <e1> fluphenazine </e1> [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , <e2> promethazine </e2> [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	fluphenazine	promethazine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , <e1> insulin </e1> , iodinated cholestographic agents , <e2> iodine-containing compounds </e2> , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	insulin	iodine-containing compounds
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , <e1> Topamax </e1> , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( <e2> Prelone </e2> ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Topamax	Prelone
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> finasteride </e1> doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , <e2> analgesics </e2> , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	finasteride	analgesics
mechanism	 Aspirin : In normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of <e1> diflunisal </e1> and <e2> aspirin </e2> were administered concomitantly .	diflunisal	aspirin
other	 Anesthetics / <e1> Sedatives </e1> / Hypnotics / Opioids : Co-administration of PRECEDEX with anesthetics , sedatives , hypnotics , and <e2> opioids </e2> is likely to lead to an enhancement of effects .	Sedatives	opioids
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : <e1> androgens </e1> and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , <e2> phenytoin </e2> , salicylates , tamoxifen .	androgens	phenytoin
other	 Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , <e1> sucralfate </e1> , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , <e2> iron </e2> , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	sucralfate	iron
other	 Therefore , administration of quinolones with <e1> antacids </e1> containing <e2> calcium </e2> , magnesium , or aluminum ;	antacids	calcium
effect	 Drugs that have been reported to diminish oral <e1> anticoagulant </e1> response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; <e2> alcohol </e2> *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	anticoagulant	alcohol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e2> warfarin sodium </e2> overdosage .	bromelains	warfarin sodium
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as <e1> phenylbutazone </e1> , warfarin , thiazide diuretics (acidic) or propranolol (basic) , as well as tetracycline penicillin G , phenobarbital , thyroid and thyroxine preparations , estrogens and <e2> progestins </e2> , and digitalis .	phenylbutazone	progestins
other	 <e1> Imipramine </e1> and <e2> clonazepam </e2> did not change fasting or overload glycemia .	Imipramine	clonazepam
other	 Therapeutic concentrations of <e1> digoxin </e1> , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter <e2> ketorolac tromethamine </e2> protein binding .	digoxin	ketorolac tromethamine
effect	 Curariform muscle relaxants (eg , tubocurarine ) and other drugs , including ether , succinylcholine , <e1> gallamine </e1> , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with <e2> Coly-Mycin M </e2> Parenteral .	gallamine	Coly-Mycin M
other	 - <e1> Methyldopa </e1> (e.g. , Aldomet ) Use of methyldopa with <e2> sulfapyridine </e2> may increase the chance of side effects affecting the liver and/or the blood	Methyldopa	sulfapyridine
other	 Cimetidine , <e1> Ranitidine </e1> : In normal volunteers (n=9) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of <e2> flurbiprofen </e2> resulted with cimetidine .	Ranitidine	flurbiprofen
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , <e1> amiodarone </e1> , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , <e2> levodopa </e2> , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	amiodarone	levodopa
mechanism	 Administration of <e1> eplerenone </e1> with other CYP3A4 inhibitors (e.g. , <e2> erythromycin </e2> 500 mg BID , verapamil 240 mg QD , saquinavir 1200 mg TID , fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold .	eplerenone	erythromycin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , <e1> bupropion </e1> , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , <e2> valproate </e2> , warfarin (5) , ziprasidone , and zonisamide .	bupropion	valproate
other	 Indinavir : Coadministration of indinavir with <e1> VIRACEPT </e1> resulted in an 83% increase in nelfinavir plasma AUC and a 51% increase in <e2> indinavir </e2> plasma A.C .	VIRACEPT	indinavir
other	 <e1> Anticholinergics </e1> antagonize the effects of <e2> antiglaucoma agents </e2> .	Anticholinergics	antiglaucoma agents
mechanism	 Griseofulvin : <e1> Griseofulvin </e1> may induce the metabolism of <e2> combination hormonal contraceptives </e2> causing menstrual changes;	Griseofulvin	combination hormonal contraceptives
effect	 This could lead to decreased salicylate serum levels or increase the risk of <e1> salicylate </e1> toxicity when <e2> corticosteroid </e2> is withdrawn .	salicylate	corticosteroid
other	 <e1> Antipyrine </e1> : Because <e2> atorvastatin </e2> does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .	Antipyrine	atorvastatin
other	 <e1> Selective serotonin reuptake inhibitors </e1> ( SSRIs ) (e.g. , <e2> fluoxetine </e2> , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-HT1 agonists .	Selective serotonin reuptake inhibitors	fluoxetine
mechanism	 Oral doses of <e1> Antizol </e1> (10-20 mg/kg) , via alcohol dehydrogenase inhibition , significantly reduced the rate of elimination of <e2> ethanol </e2> (by approximately 40%) given to healthy volunteers in moderate doses .	Antizol	ethanol
effect	 - The action of sulphonylureas and <e1> insulin </e1> may be enhanced by <e2> Bezalip </e2> or Bezalip retard .	insulin	Bezalip
mechanism	 Coadministration with <e1> valdecoxib </e1> increased exposure of <e2> omeprazole </e2> (AUC) by 46% .	valdecoxib	omeprazole
other	 <e1> Ritonavir </e1> : Coadministration of ritonavir with <e2> VIRACEPT </e2> resulted in a 152% increase in nelfinavir plasma AUC and very little change in ritonavir plasma A.C .	Ritonavir	VIRACEPT
other	 Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g. , <e1> Marplan </e1> ) , phenelzine (e.g. , Nardil ) , procarbazine (e.g. , Matulane ) , selegiline (e.g. , <e2> Eldepryl </e2> ) , and tranylcypromine (e.g. , Parnate ) : Using these medicines with L-tryptophan may increase the chance of side effects .	Marplan	Eldepryl
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , <e1> bacitracin </e1> , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local <e2> anesthetics </e2> , procainamide , and quinidine .	bacitracin	anesthetics
effect	 Anesthetics / Sedatives / Hypnotics / Opioids : Co-administration of <e1> PRECEDEX </e1> with anesthetics , sedatives , hypnotics , and <e2> opioids </e2> is likely to lead to an enhancement of effects .	PRECEDEX	opioids
other	 No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when <e1> entacapone </e1> was coadministered with a levodopa / <e2> dopa decarboxylase inhibitor </e2> (n=29) .	entacapone	dopa decarboxylase inhibitor
effect	 A rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of <e1> selective serotonin reuptake inhibitors </e1> ( SSRIs ) and agents for migraine therapy , such as Imitrex ( sumatriptan succinate ) and <e2> dihydroergotamine </e2> .	selective serotonin reuptake inhibitors	dihydroergotamine
other	 When CANCIDAS is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , <e1> dexamethasone </e1> , or carbamazepine , use of a daily dose of 70 mg of <e2> CANCIDAS </e2> should be considered	dexamethasone	CANCIDAS
other	 Based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination (e.g. , <e1> cimetidine </e1> and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination (e.g. , <e2> phenobarbital </e2> and phenytoin ) .	cimetidine	phenobarbital
other	 May interact with the following : beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the <e1> adrenergic bronchodilators </e1> from working properly) and disopyramide , <e2> quinidine </e2> , phenothiazines , and procainamide (these medicines may increase the risk of heart problems) .	adrenergic bronchodilators	quinidine
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , <e1> glucocorticoids </e1> , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , <e2> praziquantel </e2> , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	glucocorticoids	praziquantel
mechanism	 Ampicillin : In a study of healthy volunteers , <e1> chloroquine </e1> significantly reduced the bioavailability of <e2> ampicillin </e2> .	chloroquine	ampicillin
other	 Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of <e1> fosinoprilat </e1> as compared with <e2> fosinopril </e2> administered alone , suggesting that antacids may impair absorption of fosinopril .	fosinoprilat	fosinopril
effect	 Beta-adrenergic receptor antagonists ( <e1> beta-blockers </e1> ) and <e2> BROVANA </e2> may interfere with the effect of each other when administered concurrently .	beta-blockers	BROVANA
other	 Therefore , co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , <e1> haloperidol </e1> , risperidone , thioridazine ) , beta-blockers (e.g. , <e2> metoprolol </e2> ) , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	haloperidol	metoprolol
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> ORENCIA </e1> : MTX , <e2> NSAIDs </e2> , corticosteroids , TNF blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .	ORENCIA	NSAIDs
other	 Oral <e1> Contraceptives </e1> : Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive <e2> norethindrone </e2> / ethinyl estradiol (1 mg /35 mcg combination , Ortho-Novum 1/35 ) .	Contraceptives	norethindrone
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , aminoglycosides , indomethacin ) , myelotoxic (e.g. , <e1> cytotoxic </e1> chemotherapy) , cardiotoxic (e.g. , <e2> doxorubicin </e2> ) or hepatotoxic (e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	cytotoxic	doxorubicin
other	 Patients who begin taking <e1> diclofenac </e1> or who increase their diclofenac dose or any other <e2> NSAID </e2> while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .	diclofenac	NSAID
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , <e1> Nuprin </e1> , others) , ketoprofen ( Orudis , Orudis KT , <e2> Oruvail </e2> ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	Nuprin	Oruvail
other	 [A pharmacological analysis of the effect of angiotensin on stimulated gastric secretion] Chronic experiments on dogs with gastric fistulas were carried out to study the influence of angiotensin 1 and angiotensin 2 on <e1> pentagastrin </e1> - and <e2> histamine </e2> -induced gastric acid secretion .	pentagastrin	histamine
other	 - <e1> Anticoagulants </e1> : Interaction studies in humans have shown <e2> bumetanide </e2> to have no effect on warfarin metabolism or on plasma prothrombin activity .	Anticoagulants	bumetanide
other	 In several well-controlled studies , <e1> guanfacine </e1> was administered together with <e2> diuretics </e2> with no drug interactions reported .	guanfacine	diuretics
other	 Antiarrhythmics : Other antiarrhythmic drugs , such as quinidine , procainamide , <e1> disopyramide </e1> , and phenytoin , have been used concurrently with <e2> amiodarone </e2> .	disopyramide	amiodarone
other	 Interactions for vitamin D analogues ( Vitamin D2 , <e1> Vitamin D3 </e1> , Calcitriol , and Calcidiol ) : Cholestyramine : <e2> Cholestyramine </e2> has been reported to reduce intestinal absorption of fat soluble vitamins ;	Vitamin D3	Cholestyramine
other	 However , administration of <e1> 4-methylpyrazole </e1> (90 mg kg(-1) body weight) to rats 2 hours prior to 1,3-difluoroacetone (100 mg kg(-1) body weight) was ineffective in preventing <e2> (-)-erythro-fluorocitrate </e2> synthesis and did not diminish fluoride or citrate accumulation in vivo .	4-methylpyrazole	(-)-erythro-fluorocitrate
other	 Concomitant administration of FACTIVE and <e1> calcium carbonate </e1> , cimetidine , omeprazole , or an <e2> estrogen </e2> / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .	calcium carbonate	estrogen
mechanism	 In healthy subjects receiving <e1> cimetidine </e1> (1 gm daily) for one week , plasma <e2> flecainide </e2> levels increased by about 30% and half-life increased by about 10% .	cimetidine	flecainide
other	 Benzthiazide may interact with alcohol , blood thinner s , <e1> decongestant drugs </e1> (allergy , cold , and sinus medicines) , diabetic drugs , lithium , norepinephrine , NSAIDs like <e2> Aleve </e2> or Ibuprofen , and high blood pressure medications .	decongestant drugs	Aleve
mechanism	 Probenecid : <e1> Probenecid </e1> is known to interact with the metabolism or renal tubular excretion of many drugs (e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , <e2> clofibrate </e2> , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .	Probenecid	clofibrate
other	 Amphotericin , Foscarnet , and <e1> Aminoglycosides </e1> : Drugs such as <e2> amphotericin </e2> , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID -associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure) .	Aminoglycosides	amphotericin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , <e1> bupropion </e1> , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , <e2> ziprasidone </e2> , and zonisamide .	bupropion	ziprasidone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1> anabolic steroids </e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e2> clofibrate </e2> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anabolic steroids	clofibrate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , <e1> cyclosporin </e1> , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , <e2> warfarin </e2> (5) , ziprasidone , and zonisamide .	cyclosporin	warfarin
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , <e1> Thorazine </e1> ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , <e2> thioridazine </e2> [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Thorazine	thioridazine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , <e1> delavirdine </e1> , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , <e2> verapamil </e2> , zileuton .	delavirdine	verapamil
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , <e1> doxycycline </e1> , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , <e2> protease inhibitors </e2> , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	doxycycline	protease inhibitors
other	 <e1> Dopamine Antagonists </e1> : Since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the <e2> neuroleptics </e2> ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of APOKYN .	Dopamine Antagonists	neuroleptics
other	 Drug Interactions : <e1> Flupenthixol </e1> may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ) : MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of <e2> Tricyclic antidepressants </e2>	Flupenthixol	Tricyclic antidepressants
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , <e1> carbamazepine </e1> , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , <e2> iodine-containing compounds </e2> , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	carbamazepine	iodine-containing compounds
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a <e1> quinolone </e1> , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , <e2> VIDEX </e2> chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	quinolone	VIDEX
other	 <e1> Central nervous system depressant </e1> (CNS) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , <e2> methyldopa </e2> , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers	Central nervous system depressant	methyldopa
other	 In vitro data suggest that <e1> itraconazole </e1> , when compared to <e2> ketoconazole </e2> , has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole .	itraconazole	ketoconazole
mechanism	 Acid-catalyzed ethanolysis of <e1> temazepam </e1> in anhydrous and aqueous <e2> ethanol </e2> solutions .	temazepam	ethanol
other	 In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , <e1> propanolol </e1> , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and <e2> warfarin </e2> , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .	propanolol	warfarin
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , <e1> vincristine </e1> , and <e2> prednisone </e2> (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	vincristine	prednisone
effect	 The hypoglycemic effect of <e1> tolbutamide </e1> has been reported to increase when <e2> Atromid-S </e2> is given concurrently .	tolbutamide	Atromid-S
other	 Drug Interactions : Flupenthixol may interact with some drugs , like <e1> Monoamine oxidase inhibitors </e1> ( MAOI ) : <e2> MAOI </e2> could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	Monoamine oxidase inhibitors	MAOI
other	 These drugs include the thiazides and other diuretics , corticosteroids , <e1> phenothiazines </e1> , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , <e2> calcium channel blocking drugs </e2> , and isoniazid .	phenothiazines	calcium channel blocking drugs
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and <e1> sodium colistimethate </e1> ) , magnesium salts , lithium , local anesthetics , <e2> procainamide </e2> , and quinidine .	sodium colistimethate	procainamide
other	 - Cholestyramine and <e1> colestipol </e1> resins : <e2> Cholestytamine </e2> and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract	colestipol	Cholestytamine
other	 Cholestyramine and <e1> Charcoal </e1> Administration of cholestyramine or <e2> activated charcoal </e2> in patients (n=13) and volunteers (n=96) resulted in a rapid and significant decrease in plasma M1 (the active metabolite of leflunomide ) concentration .	Charcoal	activated charcoal
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; <e1> dextran </e1> ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e2> phenyramidol </e2> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextran	phenyramidol
other	 In addition , <e1> oxcarbazepine </e1> and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of <e2> dihydropyridine calcium antagonists </e2> and oral contraceptives , resulting in a lower plasma concentration of these drugs .	oxcarbazepine	dihydropyridine calcium antagonists
other	 Drug/Laboratory Test Interferences : Dicumarol and <e1> indanedione anticoagulants </e1> , including <e2> anisindione </e2> , or their metabolites may color alkaline urine red-orange , which may interfere with spectrophotometrically determined urinary laboratory tests .	indanedione anticoagulants	anisindione
other	 - a nonsteroidal anti-inflammatory drug ( <e1> NSAID </e1> ) such as ibuprofen ( <e2> Motrin </e2> , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	NSAID	Motrin
effect	 Cytotoxic Agents : Enhanced bone marrow suppression by <e1> cyclophosphamide </e1> and other cytotoxic agents has been reported among patients with neoplastic disease , except leukemia , in the presence of <e2> allopurinol </e2> .	cyclophosphamide	allopurinol
other	 HIV Protease Inhibitors : <e1> Indinavir </e1> (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC , a 7-fold increase in vardenafil Cmax and a 2-fold increase in <e2> vardenafil </e2> half-life .	Indinavir	vardenafil
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1> ethacrynic acid </e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e2> influenza virus vaccine </e2> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ethacrynic acid	influenza virus vaccine
other	 These drugs include the thiazides and other <e1> diuretics </e1> , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and <e2> isoniazid </e2> .	diuretics	isoniazid
mechanism	 The concomitant use of other CYP3A4 inhibitors such as diltiazem and <e1> erythromycin </e1> with transdermal <e2> fentanyl </e2> may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .	erythromycin	fentanyl
other	 No depressant effect on blood levels in humans was noted when <e1> colestipol hydrochloride </e1> was administered with any of the following drugs : aspirin , <e2> clindamycin </e2> , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .	colestipol hydrochloride	clindamycin
effect	 <e1> INDOCIN </e1> can reduce the antihypertensive effects of <e2> captopril </e2> and losartan .	INDOCIN	captopril
other	 These drugs include the thiazides and other diuretics , corticosteroids , <e1> phenothiazines </e1> , thyroid products , <e2> estrogens </e2> , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	phenothiazines	estrogens
other	 Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g. , intravenous <e1> aminoglycosides </e1> (e.g. , tobramycin , gentamicin , and amikacin ) , <e2> amphotericin B </e2> , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .	aminoglycosides	amphotericin B
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or propranolol (basic) , as well as tetracycline penicillin G , <e1> phenobarbital </e1> , thyroid and <e2> thyroxine </e2> preparations , estrogens and progestins , and digitalis .	phenobarbital	thyroxine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , <e1> azole antifungals </e1> , cimetidine , clarithromycin (1) , dalfopristin , <e2> danazol </e2> , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	azole antifungals	danazol
other	 Some <e1> drugs </e1> /substances are known to accelerate the metabolism of <e2> amiodarone </e2> by stimulating the synthesis of CYP3A4 (enzyme induction) .	drugs	amiodarone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1> indomethacin </e1> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e2> prolonged narcotics </e2> ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	indomethacin	prolonged narcotics
mechanism	 <e1> Phenobarbital </e1> : Decreases <e2> aspirin </e2> effectiveness by enzyme induction .	Phenobarbital	aspirin
effect	 Dopamine D2 receptor antagonists (e.g. , phenothiazines , butyrophenones , <e1> risperidone </e1> ) and isoniazid may reduce the therapeutic effects of <e2> levodopa </e2> .	risperidone	levodopa
other	 <e1> Diethyl pyrocarbonate </e1> , at pH 7.0 , was used to chemically modify exposed histidine residues on <e2> toxin A </e2> .	Diethyl pyrocarbonate	toxin A
other	 Although there are no study data to evaluate the possibility , <e1> nitric oxide donor compounds </e1> , including sodium nitroprusside and <e2> nitroglycerin </e2> , may have an additive effect with INOmax on the risk of developing methemoglobinemia .	nitric oxide donor compounds	nitroglycerin
other	 Antithyroid agents may decrease thyroidal uptake of <e1> sodium iodide I131 </e1> , a rebound in uptake may occur up to 5 days after sudden withdrawal of <e2> Carbimazole </e2> .	sodium iodide I131	Carbimazole
other	 In vitro studies evaluating the minimum inhibitory concentration (MIC) of <e1> vancomycin </e1> , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these <e2> antibiotics </e2> with EXTRANEAL .	vancomycin	antibiotics
other	 Effect of <e1> diazepam </e1> and <e2> midazolam </e2> on the antinociceptive effect of morphine , metamizol and indomethacin in mice .	diazepam	midazolam
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( <e1> Orudis </e1> , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , <e2> Aleve </e2> );	Orudis	Aleve
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( <e1> Gris-PEG </e1> , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , <e2> Viracept </e2> ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Gris-PEG	Viracept
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1> oxolinic acid </e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e2> triclofos sodium </e2> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	oxolinic acid	triclofos sodium
effect	 ETHANOL / NUTRITION / HERB INTERACTIONS : Food : CNS effects of caffeine may be enhanced if <e1> combination hormonal contraceptives </e1> are used concurrently with <e2> caffeine </e2> .	combination hormonal contraceptives	caffeine
other	 <e1> Calcium Channel Blockers </e1> , Dihydropyridine : e.g. , felodipine , <e2> nifedipine </e2> , nicardipine	Calcium Channel Blockers	nifedipine
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , <e1> lamotrigine </e1> , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , <e2> Phenytoin </e2> (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	lamotrigine	Phenytoin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1> metronidazole </e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e2> pentoxifylline </e2> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	metronidazole	pentoxifylline
other	 <e1> Acetaminophen </e1> and <e2> methotrexate </e2> - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .	Acetaminophen	methotrexate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , <e1> levothyroxine </e1> , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and <e2> zonisamide </e2> .	levothyroxine	zonisamide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , <e1> buspirone </e1> , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , <e2> theophylline </e2> , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	buspirone	theophylline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , <e1> amitriptyline </e1> , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , <e2> warfarin </e2> (5) , ziprasidone , and zonisamide .	amitriptyline	warfarin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1> ranitidine </e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ranitidine	tolbutamide
other	 During clinical trials , <e1> iloprost </e1> was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , <e2> antipyretics </e2> , nonsteroidal antiinflammatories , corticosteroids , and other medications .	iloprost	antipyretics
effect	 <e1> Imipramine hydrochloride </e1> may potentiate the effects of <e2> CNS depressant drugs </e2> .	Imipramine hydrochloride	CNS depressant drugs
effect	 Some reports have shown that the concomitant administration of <e1> thiazides </e1> with <e2> vitamin D </e2> causes hypercalcemia .	thiazides	vitamin D
other	 ACE Inhibitors and <e1> Angiotensin II Receptor Antagonists </e1> (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving <e2> INSPRA </e2> 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( ACEI / ARB ) .	Angiotensin II Receptor Antagonists	INSPRA
other	 Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , <e1> benzodiazepines </e1> , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , <e2> prostaglandin synthetase inhibitors </e2> (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	benzodiazepines	prostaglandin synthetase inhibitors
other	 The fraction of <e1> STADOL NS </e1> absorbed is unaffected by the concomitant administration of a <e2> nasal vasoconstrictor </e2> ( oxymetazoline ) , but the rate of absorption is decreased .	STADOL NS	nasal vasoconstrictor
other	 Concurrent use of butorphanol with central nervous system depressants (e.g. , alcohol , barbiturates , <e1> tranquilizers </e1> , and <e2> antihistamines </e2> ) may result in increased central nervous system depressant effects .	tranquilizers	antihistamines
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : <e1> corticosteroids </e1> , niacin , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , <e2> isoniazid </e2> , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	corticosteroids	isoniazid
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e1> sulfinpyrazone </e1> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e2> warfarin sodium </e2> overdosage .	sulfinpyrazone	warfarin sodium
other	 Hormonal Contraceptives , Including Oral , Injectable , Transdermal , and Implantable Contraceptives : An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of <e1> norethindrone </e1> and <e2> ethinyl estradiol </e2> levels of 14% and 31% , respectively .	norethindrone	ethinyl estradiol
other	 Oral neomycin inhibits the gastrointestinal absorption of <e1> penicillin V </e1> , oral vitamin B-12 , methotrexate and <e2> 5-fluorouracil </e2> .	penicillin V	5-fluorouracil
other	 The absorption of <e1> tetracycline </e1> , furosemide , penicillin G , hydrochlorothiazide , and <e2> gemfibrozil </e2> was significantly decreased when given simultaneously with colestipol hydrochloride ;	tetracycline	gemfibrozil
other	 Coingestion of acetaminophen with <e1> theophylline </e1> , phenobarbital with acetaminophen , and <e2> valproic acid </e2> with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	theophylline	valproic acid
other	 When coadministered with <e1> SUSTIVA </e1> in treatment-naive patients , the recommended dose of <e2> atazanavir </e2> is 300 mg with ritonavir 100 mg and SUSTIVA 600 mg (all once daily) .	SUSTIVA	atazanavir
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , <e1> diuretics </e1> , sympathomimetic agents (e.g. , epinephrine , albuterol , <e2> terbutaline </e2> ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	diuretics	terbutaline
other	 The objective of this study was to determine if there is a pharmacokinetic interaction when <e1> amprenavir </e1> is given with <e2> rifabutin </e2> or rifampin and to determine the effects of these drugs on the erythromycin breath test (ERMBT) .	amprenavir	rifabutin
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , <e1> fluphenazine </e1> [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , <e2> Compazine </e2> ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	fluphenazine	Compazine
other	 Oral Contraceptives Rofecoxib did not have any clinically important effect on the pharmacokinetics of <e1> ethinyl estradiol </e1> and <e2> norethindrone </e2> .	ethinyl estradiol	norethindrone
other	 Concomitant administration of FACTIVE and <e1> calcium carbonate </e1> , cimetidine , omeprazole , or an <e2> estrogen </e2> / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .	calcium carbonate	estrogen
other	 Products containing <e1> calcium </e1> and other multivalent cations (such as <e2> aluminum </e2> , magnesium , iron ) are likely to interfere with absorption of Ibandronate .	calcium	aluminum
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( <e1> thiocyanate </e1> , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , <e2> insulin </e2> , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	thiocyanate	insulin
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> EQUETROTM </e1> are the following : Acetazolamide , azole antifungals , cimetidine , <e2> clarithromycin </e2> (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	EQUETROTM	clarithromycin
advise	 The concomitant use of <e1> H2 blockers </e1> or proton pump inhibitors with <e2> SPRYCEL </e2> is not recommended .	H2 blockers	SPRYCEL
other	 Diminished urinary excretion of <e1> norfloxacin </e1> has been reported during the concomitant administration of <e2> probenecid </e2> and norfloxacin .	norfloxacin	probenecid
other	 Central Nervous System Depressants : The concomitant use of DURAGESIC ( fentanyl transdermal system) with other central nervous system depressants , including but not limited to other opioids , sedatives , <e1> hypnotics </e1> , tranquilizers (e.g. , benzodiazepines ) , general anesthetics , <e2> phenothiazines </e2> , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	hypnotics	phenothiazines
effect	 Dexamethasone at 10(-10) M or <e1> retinyl acetate </e1> at about 3 X 10(-9) M inhibits proliferation stimulated by <e2> EGF </e2> .	retinyl acetate	EGF
other	 Chlorotrianisene may interact with <e1> antidepressants </e1> , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , <e2> somatropin </e2> , tamoxifen , and warfarin .	antidepressants	somatropin
other	 Avoid the use of preparations such as decongestants and local <e1> anesthetics </e1> which contain any sympathomimetic amine (e.g. , epinephrine , <e2> norepinephrine </e2> ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .	anesthetics	norepinephrine
other	 When used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , <e1> midazolam </e1> , rifabutin , sildenafil , theophylline (intravenous and oral) , triazolam , trimethoprim / sulfamethoxazole or <e2> zidovudine </e2> .	midazolam	zidovudine
other	 The pharmacokinetics of <e1> naltrexone </e1> and its major metabolite 6-beta-naltrexol were unaffected following co-administration with <e2> Acamprosate </e2> .	naltrexone	Acamprosate
effect	 Other <e1> nonsteroidal anti-inflammatory drugs </e1> that inhibit prostaglandin synthesis have been shown to interfere with <e2> thiazide diuretics </e2> in some studies and with potassium-sparing diuretics .	nonsteroidal anti-inflammatory drugs	thiazide diuretics
other	 Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including <e1> protease inhibitors </e1> , macrolide antibiotics , and <e2> azole antifungals </e2> , the effect of Panretin gel on the steady-state concentrations of these drugs is not known .	protease inhibitors	azole antifungals
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : <e1> aminoglutethimide </e1> , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , <e2> nitroprusside </e2> , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	aminoglutethimide	nitroprusside
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with <e1> alprazolam </e1> or other benzodiazepines (caution is recommended during coadministration with alprazolam ) : Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , <e2> macrolide antibiotics </e2> such as erythromycin and clarithromycin , and grapefruit juice .	alprazolam	macrolide antibiotics
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute <e1> alcohol </e1> intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , <e2> tolbutamide </e2> , trazodone	alcohol	tolbutamide
effect	 The action of the <e1> benzodiazepines </e1> may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , <e2> monoamine oxidase inhibitors </e2> , narcotics , phenothiazines , psychotropic medications , or other drugs that produce CNS depression .	benzodiazepines	monoamine oxidase inhibitors
other	 <e1> Ethosuximide </e1> : <e2> Amphetamines </e2> may delay intestinal absorption of ethosuximide .	Ethosuximide	Amphetamines
effect	 <e1> Barbiturates </e1> may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , <e2> theophylline </e2> , corticosteroids , anticoagulants , and beta blockers .	Barbiturates	theophylline
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , <e1> indomethacin </e1> ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , <e2> Aleve </e2> );	indomethacin	Aleve
other	 Macrolide Antibiotics (e . g . erythromycin and troleandomycin ) : Agents of the ergot alkaloid class , of which D.H.E. 45 ( <e1> dihydroergotamine mesylate </e1> ) Injection , USP is a member , have been shown to interact with <e2> antibiotics </e2> of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .	dihydroergotamine mesylate	antibiotics
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , <e1> citalopram </e1> , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , <e2> tiagabine </e2> , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	citalopram	tiagabine
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( <e1> Orudis </e1> , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and <e2> naproxen </e2> ( Anaprox , Naprosyn , Aleve );	Orudis	naproxen
other	 No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including <e1> cyclosporine </e1> , corticosteroids , and either azathioprine or <e2> mycophenolate mofetil </e2> .	cyclosporine	mycophenolate mofetil
effect	 Digitalis : <e1> Thyroid preparations </e1> may potentiate the toxic effects of <e2> digitalis </e2> .	Thyroid preparations	digitalis
other	 Coadministration of single , oral doses of zaleplon with <e1> erythromycin </e1> (10 mg and 800 mg , respectively) , a strong , selective CYP3A4 inhibitor produced a 34% increase in <e2> zaleplon </e2> s maximal plasma concentrations and a 20% increase in the area under the plasma concentration-time curve .	erythromycin	zaleplon
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , <e1> p-aminosalicylic acid </e1> , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , <e2> iodine-containing compounds </e2> , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	p-aminosalicylic acid	iodine-containing compounds
mechanism	 The AUC of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given <e1> ciprofloxacin </e1> and <e2> didanosine </e2> -placebo tablets concurrently .	ciprofloxacin	didanosine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , <e1> Nizoral </e1> , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , <e2> morphine </e2> ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Nizoral	morphine
other	 Therapeutic concentrations of digoxin , warfarin , <e1> ibuprofen </e1> , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter <e2> ketorolac tromethamine </e2> protein binding .	ibuprofen	ketorolac tromethamine
other	 Potential drug interactions between <e1> Keppra </e1> and other AEDs ( carbamazepine , gabapentin , lamotrigine , <e2> phenobarbital </e2> , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	Keppra	phenobarbital
other	 The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose ( <e1> NaCMC </e1> ) and carboxymethylcellulose-cysteine ( CMC-Cys ) conjugates on the intestinal permeation of sodium fluorescein ( NaFlu ) and model peptide drugs , <e2> bacitracin </e2> and insulin .	NaCMC	bacitracin
other	 Oral <e1> Contraceptives </e1> : <e2> Valdecoxib </e2> (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone / ethinyl estradiol (1 mg /35 mcg combination , Ortho-Novum 1/35 ) .	Contraceptives	Valdecoxib
other	 <e1> Antiretroviral </e1> plasma and urine sampling were conducted on Days 1 , 7 , and 21 for <e2> zidovudine </e2> and on Days 7 and 21 for dideoxyinosine .	Antiretroviral	zidovudine
effect	 <e1> Clidinium </e1> may decrease the effect of phenothiazines , <e2> levodopa </e2> , and ketoconazole .	Clidinium	levodopa
effect	 There is thus an enhancement effect of <e1> PGF2alpha </e1> upon the reaction of placental vessels to <e2> oxytocin </e2> in vitro .	PGF2alpha	oxytocin
other	 - a monoamine oxidase inhibitor ( <e1> MAOI </e1> ) such as <e2> isocarboxazid </e2> ( Marplan ) , tranylcypromine ( Parnate ) , or phenelzine ( Nardil );	MAOI	isocarboxazid
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , <e1> androgens </e1> and related anabolic hormones , complex anions ( thiocyanate , perchlorate , <e2> pertechnetate </e2> ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	androgens	pertechnetate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; <e1> prolonged narcotics </e1> ; <e2> pyrazolones </e2> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	prolonged narcotics	pyrazolones
other	 <e1> Alpha-blockers </e1> : When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of <e2> terazosin </e2> , significant hypotension developed in a substantial number of subjects .	Alpha-blockers	terazosin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , <e1> chloral hydrate </e1> , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , <e2> 6-mercaptopurine </e2> , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	chloral hydrate	6-mercaptopurine
other	 However , neither <e1> phenobarbital </e1> nor diazepam appears to affect <e2> Dantrium </e2> metabolism .	phenobarbital	Dantrium
other	 Some <e1> drugs </e1> /substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of <e2> CYP3A4 </e2> (enzyme induction) .	drugs	CYP3A4
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1> indomethacin </e1> ; <e2> influenza virus vaccine </e2> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	indomethacin	influenza virus vaccine
other	 Drugs which may enhance the neuromuscular blocking action of TRACRIUM include : enflurane ; isoflurane ; halothane ;certain antibiotics , especially the <e1> aminoglycosides </e1> and polymyxins ; lithium ; magnesium salts; procainamide ;and <e2> quinidine </e2> .	aminoglycosides	quinidine
other	 Benzodiazepines : Combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , <e1> chlordiazepoxide </e1> , diazepam ) and increase the clearance of others ( lorazepam , <e2> oxazepam </e2> , temazepam ) .	chlordiazepoxide	oxazepam
other	 This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and <e1> monoamine oxidase (MAO) inhibitors </e1> (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of <e2> antihistamines </e2> ) .	monoamine oxidase (MAO) inhibitors	antihistamines
other	 Renal function should be monitored carefully if high doses of <e1> aminoglycosides </e1> are to be administered with MAXIPIME because of the increased potential of nephrotoxicity and ototoxicity of <e2> aminoglycoside antibiotics </e2> .	aminoglycosides	aminoglycoside antibiotics
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> finasteride </e1> doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , <e2> benzodiazepines </e2> , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	finasteride	benzodiazepines
other	 It may also interact with <e1> amantadine </e1> or other anticholinergic drugs or <e2> MAOIs </e2> , which may intensify the anticholinergic action .	amantadine	MAOIs
other	 Drug-Drug Interactions Between <e1> Keppra </e1> And Other Antiepileptic Drugs ( <e2> AEDs </e2> ) Phenytoin Keppra (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .	Keppra	AEDs
mechanism	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma <e1> phenytoin </e1> concentrations include : acute <e2> alcohol </e2> intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone	phenytoin	alcohol
other	 [Stimulation by cerulein --an analog of the octapeptide cholecystokinin--of <e1> 3H-spiroperidol </e1> binding after the long-term administration of neuroleptics ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for <e2> apomorphine </e2> in subcortical structures , whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain .	3H-spiroperidol	apomorphine
other	 No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , <e1> hydrochlorothiazide </e1> , and oral contraceptives in healthy volunteers , or given with <e2> enalapril </e2> to patients with heart failure (NYHA class II and III) .	hydrochlorothiazide	enalapril
effect	 Clinically significant effects have been reported with the <e1> tricyclic antidepressants </e1> when used concomitantly with <e2> cimetidine </e2> .	tricyclic antidepressants	cimetidine
advise	 After stopping <e1> Fluvoxamine </e1> Tablets , at least 2 weeks should be allowed before starting a <e2> MAOI </e2> .	Fluvoxamine	MAOI
other	 <e1> Corticosteroids </e1> : A relationship of functional antagonism exists between <e2> vitamin D analogues </e2> , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .	Corticosteroids	vitamin D analogues
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e1> glucagon </e1> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; <e2> oxyphenbutazone </e2> ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	glucagon	oxyphenbutazone
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all <e1> central nervous system depressants </e1> (eg , alcohol , <e2> sedatives </e2> , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .	central nervous system depressants	sedatives
other	 If chlorprothixene is given concomitantly with <e1> opioids </e1> , the <e2> opioid </e2> dose should be reduced (by approx . 50%) , because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively .	opioids	opioid
mechanism	 Administration of <e1> quinolones </e1> with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( <e2> didanosine </e2> ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	quinolones	didanosine
other	 - Cholestyramine and <e1> colestipol </e1> resins : Cholestytamine and colestipol <e2> resins </e2> have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract	colestipol	resins
effect	 Patients taking <e1> Acamprosate </e1> concomitantly with <e2> antidepressants </e2> more commonly reported both weight gain and weight loss , compared with patients taking either medication alone .	Acamprosate	antidepressants
effect	 Dopamine D2 receptor antagonists (e.g. , phenothiazines , butyrophenones , <e1> risperidone </e1> ) and isoniazid may reduce the therapeutic effects of <e2> levodopa </e2> .	risperidone	levodopa
other	 Oral <e1> Contraceptives </e1> Multiple doses of <e2> cefditoren pivoxil </e2> had no effect on the pharmacokinetics of ethinyl estradiol , the estrogenic component in most oral contraceptives .	Contraceptives	cefditoren pivoxil
other	 Magnesium - and/or aluminum -containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing <e1> zinc </e1> or other metal cations , or <e2> Videx </e2> ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE .	zinc	Videx
mechanism	 <e1> Anticholinergic drugs </e1> may antagonize the effects of the drugs that alter gastrointestinal motility , such as <e2> metoclopramide </e2> .	Anticholinergic drugs	metoclopramide
other	 - Phenothiazines ( acetophenazine [e.g. , <e1> Tindal </e1> ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , <e2> Vesprin </e2> ] , trimeprazine [e.g. , Temaril ]) or	Tindal	Vesprin
other	 Drug-Drug Interactions Given the primary CNS effects of aripiprazole , caution should be used when ABILIFY is taken in combination with other <e1> centrally acting drugs </e1> and <e2> alcohol </e2> .	centrally acting drugs	alcohol
other	 <e1> Magnesium </e1> : Magnesium -containing preparations (eg , <e2> antacids </e2> ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin D by patients on chronic renal dialysis .	Magnesium	antacids
other	 Interactions with Mixed Agonist/Antagonist Opioid Analgesics : Agonist/antagonist analgesics (eg , pentazocine , nalbuphine , <e1> butorphanol </e1> , dezocine and buprenorphine ) should NOT be administered to a patient who has received or is receiving a course of therapy with a <e2> pure agonist opioid analgesic </e2> such as Levo-Dromoran .	butorphanol	pure agonist opioid analgesic
effect	 <e1> Butalbital </e1> , acetaminophen and caffeine may enhance the effects of : other narcotic analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , <e2> sedative-hypnotics </e2> , or other CNS depressants , causing increased CNS depression .	Butalbital	sedative-hypnotics
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as <e1> ampicillin </e1> and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , <e2> cyclosporine </e2> ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	ampicillin	cyclosporine
other	 <e1> Magnesium </e1> - and/or aluminum -containing antacids , products containing ferrous sulfate ( <e2> iron </e2> ) , multivitamin preparations containing zinc or other metal cations , or Videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE .	Magnesium	iron
other	 <e1> Erythromycin </e1> and clarithromycin (and possibly other <e2> macrolide antibiotics </e2> ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .	Erythromycin	macrolide antibiotics
other	 In vitro binding studies with human serum proteins indicate that <e1> glipizide </e1> binds differently than tolbutamide and does not interact with salicylate or <e2> dicumarol </e2> .	glipizide	dicumarol
other	 Although glucocorticoids have been shown to reduce PROLEUKIN -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 <e1> Beta-blockers </e1> and other <e2> antihypertensives </e2> may potentiate the hypotension seen with PROLEUKIN .	Beta-blockers	antihypertensives
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , <e1> alprazolam </e1> , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , <e2> tiagabine </e2> , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	alprazolam	tiagabine
other	 Antiacid , clarithromycin , <e1> Didanosine </e1> , Fluconazole , Fluoxetine , Indanavir , Ketoconazole , Phenytoin , Phenobarbitol , carbamazepine , Rifabutin , <e2> Rifampin </e2> , Ritanovir , Saquinavir .	Didanosine	Rifampin
other	 <e1> Benzodiazepines </e1> : Combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , <e2> oxazepam </e2> , temazepam ) .	Benzodiazepines	oxazepam
effect	 Recovery of hoof twitch from 50% to 75% took 7.7 +/- 0.7 min for atracurium alone and 11.5 +/- 2.7 min for <e1> atracurium </e1> plus <e2> gentamycin </e2> (P = 0.03) .	atracurium	gentamycin
other	 Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , <e1> ketoconazole </e1> , erythromycin and <e2> azithromycin </e2> .	ketoconazole	azithromycin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1> dextrothyroxine </e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e2> glucagon </e2> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextrothyroxine	glucagon
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; <e1> aminosalicylic acid </e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e2> chymotrypsin </e2> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	aminosalicylic acid	chymotrypsin
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral <e1> contraceptives </e1> ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; <e2> warfarin sodium </e2> under-dosage .	contraceptives	warfarin sodium
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA : MTX , NSAIDs , corticosteroids , TNF blocking agents , azathioprine , <e1> chloroquine </e1> , gold , hydroxychloroquine , leflunomide , sulfasalazine , and <e2> anakinra </e2> .	chloroquine	anakinra
other	 Magnesium - and/or aluminum -containing <e1> antacids </e1> , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or Videx ( <e2> didanosine </e2> ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE .	antacids	didanosine
advise	 Patients on oral <e1> antidiabetic agents </e1> receiving <e2> VELCADE </e2> treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication .	antidiabetic agents	VELCADE
mechanism	 Pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33% when <e1> TAXOL </e1> was administered following <e2> cisplatin </e2> .	TAXOL	cisplatin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , <e1> dalfopristin </e1> , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , <e2> fluvoxamine </e2> , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	dalfopristin	fluvoxamine
other	 Therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other <e1> antidepressants </e1> , phenothiazines , carbamazepine , and Type 1C antiarrhythmics (eg , <e2> propafenone </e2> , flecainide , and encainide ) , or that inhibit this enzyme (eg , quinidine ) , should be approached with caution .	antidepressants	propafenone
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; <e1> carbamazepine </e1> ; <e2> chloral hydrate </e2> *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	carbamazepine	chloral hydrate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e1> ethacrynic acid </e1> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e2> miconazole </e2> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ethacrynic acid	miconazole
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> ORENCIA </e1> : MTX , NSAIDs , corticosteroids , TNF blocking agents , azathioprine , <e2> chloroquine </e2> , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .	ORENCIA	chloroquine
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and <e1> tetracycline </e1> , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( <e2> Prelone </e2> ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	tetracycline	Prelone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1> influenza virus vaccine </e1> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e2> quinidine </e2> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	influenza virus vaccine	quinidine
other	 Clinical studies with celecoxib have identified potentially significant interactions with <e1> fluconazole </e1> and <e2> lithium </e2> .	fluconazole	lithium
other	 It is structurally distinct from the other currently available HMGCoA reductase inhibitors ( lovastatin , <e1> simvastatin </e1> , and <e2> pravastatin </e2> ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	simvastatin	pravastatin
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all central nervous system depressants (eg , <e1> alcohol </e1> , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and <e2> antihistamines </e2> ) may result in additive central nervous system depressant effects .	alcohol	antihistamines
mechanism	 The interaction is a consequence of blocking hepatic metabolism of <e1> vardenafil </e1> by <e2> ritonavir </e2> , a highly potent CYP3A4 inhibitor , which also inhibits CYP2C9 .	vardenafil	ritonavir
advise	 <e1> Sildenafil </e1> dose should not exceed a maximum of 25 mg in a 48- hour period in patients receiving concomitant <e2> indinavir </e2> therapy .	Sildenafil	indinavir
mechanism	 Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 (eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , <e1> carbamazepine </e1> , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with <e2> saquinavir </e2> ;	carbamazepine	saquinavir
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , <e1> estrogens </e1> and estrogen-containing compounds , 5-fluorouracil , <e2> furosemide </e2> , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .	estrogens	furosemide
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , <e1> androgens </e1> and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , <e2> chloral hydrate </e2> , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	androgens	chloral hydrate
other	 <e1> Olanzapine </e1> , a thienobenzodiazepine derivative , is a <e2> second generation (atypical) antipsychotic agent </e2> which has proven efficacy against the positive and negative symptoms of schizophrenia .	Olanzapine	second generation (atypical) antipsychotic agent
effect	 - Drugs whose efficacy is impaired by <e1> phenytoin </e1> include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , <e2> estrogens </e2> , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin D .	phenytoin	estrogens
other	 The risk of a potential interaction between <e1> NovoSeven </e1> and <e2> coagulation factor </e2> concentrates has not been adequately evaluated in preclinical or clinical studies .	NovoSeven	coagulation factor
other	 Central Nervous System Depressants : The concomitant use of DURAGESIC ( fentanyl transdermal system) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers (e.g. , <e1> benzodiazepines </e1> ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and <e2> alcohol </e2> , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	benzodiazepines	alcohol
other	 In another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome P450 3A4 , increased the exposure (AUC) of <e1> des-ciclesonide </e1> by approximately 3.6-fold at steady state , while levels of <e2> ciclesonide </e2> remained unchanged .	des-ciclesonide	ciclesonide
other	 Also , concomitant administration of <e1> quinolones </e1> with products containing iron , <e2> multivitamins </e2> containing zinc , or Videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .	quinolones	multivitamins
effect	 - The action of sulphonylureas and <e1> insulin </e1> may be enhanced by <e2> Bezalip </e2> or Bezalip retard .	insulin	Bezalip
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1> anabolic steroids </e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anabolic steroids	quinine
effect	 However , the systemic administration of some <e1> quinolones </e1> has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic <e2> cyclosporine </e2> concomitantly .	quinolones	cyclosporine
other	 With the morning dose of <e1> ceftibuten </e1> on day 6 , each volunteer received a single intravenous infusion of <e2> theophylline </e2> (4 mg/kg) .	ceftibuten	theophylline
other	 Heparin , other anticoagulants , <e1> thrombolytics </e1> , and <e2> anti platelet agents </e2> are associated with an increase in bleeding .	thrombolytics	anti platelet agents
mechanism	 However , in the second study , administration of 12 g <e1> cholestyramine </e1> 1 hour before the evening meal and 0.3 mg <e2> cerivastatin sodium </e2> approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8% , and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone .	cholestyramine	cerivastatin sodium
other	 Rifampin : Co-administration of VIOXX with <e1> rifampin </e1> 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50% decrease in <e2> rofecoxib </e2> plasma concentrations .	rifampin	rofecoxib
other	 Bentiromide may interact with acetaminophen (e.g. , Tylenol ) , chloramphenicol (e.g. , <e1> Chloromycetin </e1> ) , local anesthetics (e.g. , benzocaine and lidocaine ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some <e2> multivitamins </e2> ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	Chloromycetin	multivitamins
other	 Therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , <e1> phenothiazines </e1> , carbamazepine , and Type 1C antiarrhythmics (e.g. , propafenone , <e2> flecainide </e2> and encainide ) , or that inhibit this enzyme (e.g. , quinidine ) , should be approached with caution .	phenothiazines	flecainide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : <e1> alcohol </e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	alcohol	sulfonamides
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( <e1> Lipitor </e1> ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , <e2> phenylbutazone </e2> , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Lipitor	phenylbutazone
other	 When combined with ofloxacin , KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of <e1> rifampicin </e1> (or <e2> rifabutin </e2> ) and ofloxacin .	rifampicin	rifabutin
other	 Beta-adrenergic blocking agents : Coadministration of <e1> beta-adrenergic blocking agents </e1> did not have any effect on either the safety or efficacy of <e2> ibutilide </e2> in the clinical trials .	calcium channel blockers	ibutilide
effect	 - <e1> Lofexidine </e1> may enhance the CNS depressive effects of alcohol , <e2> barbiturates </e2> and other sedatives	Lofexidine	barbiturates
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , <e1> Advil </e1> , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( <e2> Daypro </e2> ) , and naproxen ( Anaprox , Naprosyn , Aleve );	Advil	Daypro
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; <e1> chymotrypsin </e1> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chymotrypsin	tolbutamide
other	 Chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , <e1> corticotropin </e1> , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and <e2> warfarin </e2> .	corticotropin	warfarin
other	 The <e1> threohydrobupropion </e1> metabolite of <e2> bupropion </e2> does not appear to be produced by the cytochrome P450 isoenzymes .	threohydrobupropion	bupropion
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> ORENCIA </e1> : <e2> MTX </e2> , NSAIDs , corticosteroids , TNF blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .	ORENCIA	MTX
effect	 Pharmacodynamic Interactions : The CNS-depressant action of the <e1> benzodiazepine class </e1> of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the DRUG0 , DRUG0 and butyrophenone classes of antipsychotic agents , <e2> monoamine oxidase inhibitors </e2> and the tricyclic antidepressants , and by other anticonvulsant drugs .	benzodiazepine class	monoamine oxidase inhibitors
other	 Digoxin , Nimodipine and Losartan : Bosentan has no significant pharmacokinetic interactions with <e1> digoxin </e1> and <e2> nimodipine </e2> , and losartan has no significant effect on plasma levels of bosentan .	digoxin	nimodipine
other	 The concomitant intake of alcohol and <e1> Acamprosate </e1> does not affect the pharmacokinetics of either <e2> alcohol </e2> or acamprosate .	Acamprosate	alcohol
other	 <e1> Corticosteroids </e1> : Dexamethasone : <e2> Aprepitant </e2> , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on Day 1 , and Aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on Days 2 through 5 , increased the AUC of dexamethasone , a CYP3A4 substrate by 2.2-fold , on Days 1 and 5 .	Corticosteroids	Aprepitant
other	 <e1> Calcium Antagonist </e1> s : After repeated co-administration of <e2> Trileptal </e2> , the AUC of felodipine was lowered by 28% [90% CI : 20-33] .	Calcium Antagonist	Trileptal
mechanism	 Antacids containing aluminum hydroxide and <e1> magnesium hydroxide </e1> reduce the oral absorption of <e2> enoxacin </e2> by 75% .	magnesium hydroxide	enoxacin
other	 <e1> Antacids </e1> : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with <e2> fosinopril </e2> administered alone , suggesting that antacids may impair absorption of fosinopril .	Antacids	fosinopril
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( <e1> thiocyanate </e1> , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , <e2> sulfonamides </e2> , sulfonylureas , thiazide diuretics .	thiocyanate	sulfonamides
other	 Coadministration of <e1> esomeprazole </e1> 30 mg and diazepam , a CYP2C19 substrate , resulted in a 45% decrease in clearance of <e2> diazepam </e2> .	esomeprazole	diazepam
other	 No interactions have been observed between nizatidine and <e1> theophylline </e1> , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and <e2> warfarin </e2> .	theophylline	warfarin
mechanism	 Binding to Serum Proteins : The following agents may either inhibit <e1> levothyroxine sodium </e1> binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , <e2> estrogens </e2> and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .	levothyroxine sodium	estrogens
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1> indomethacin </e1> ; influenza virus vaccine ;inhalation <e2> anesthetics </e2> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	indomethacin	anesthetics
other	 There is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium channel-blockers , <e1> ACE inhibitors </e1> , and <e2> diuretics </e2> (both thiazide -like and loop) .	ACE inhibitors	diuretics
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , <e1> fluphenazine </e1> [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , <e2> thioridazine </e2> [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	fluphenazine	thioridazine
mechanism	 Probenecid : Concomitant administration of <e1> TORADOL </e1> ORAL and <e2> probenecid </e2> resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .	TORADOL	probenecid
effect	 Tricyclic Antidepressants : Use of <e1> thyroid products </e1> with imipramine and other <e2> tricyclic antidepressants </e2> may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .	thyroid products	tricyclic antidepressants
other	 While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A , compounds that are potent CYP3A inducers (such as carbamazepine , <e1> phenytoin </e1> , rifampin , and barbiturates ) would be expected to decrease <e2> estazolam </e2> concentrations .	phenytoin	estazolam
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , <e1> Advil </e1> , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , <e2> Oruvail </e2> ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , Aleve );	Advil	Oruvail
advise	 Therefore , co-administration of <e1> bupropion </e1> with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g. , nortriptyline , <e2> imipramine </e2> , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , haloperidol , risperidone , thioridazine ) , beta-blockers (e.g. , metoprolol ) , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	bupropion	imipramine
mechanism	 Single doses of either <e1> cholestyramine </e1> or colestipol resins bind the <e2> hydrochlorothiazide </e2> and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .	cholestyramine	hydrochlorothiazide
other	 The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including <e1> nonsteroidal anti-inflammatory agents </e1> and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , <e2> coumarins </e2> , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	nonsteroidal anti-inflammatory agents	coumarins
other	 These agents , including <e1> norfloxacin </e1> , ciprofloxacin , ofloxacin , enoxacin , and <e2> lomefloxacin </e2> , have been extensively studied and have demonstrated efficacy and safety profiles comparable to those of other traditional agents for the treatment of complicated or uncomplicated urinary tract infections and prostatitis .	norfloxacin	lomefloxacin
other	 Decreasing the concentration of CMC-Cys , exhibiting 7.3% (m/m) of immobilised <e1> cysteine </e1> (CMC-Cys7.3) from 1% (m/v) to 0.5% (m/v) decreased the R-value of <e2> NaFlu </e2> from 1.8 to 1.2 .	cysteine	NaFlu
other	 however , it is considered to be unlikely that this decrease of phosphorylated <e1> lamivudine </e1> concentration is of clinical significance , as lamivudine is a more efficient substrate for deoxycytidine kinase than <e2> zalcitabine </e2> .	lamivudine	zalcitabine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e1> oxolinic acid </e1> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	oxolinic acid	trimethoprim
other	 <e1> Intestinal adsorbents </e1> (e . g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e . g. , <e2> amylase </e2> , pancreatin ) may reduce the effect of Acarbose and should not be taken concomitantly .	Intestinal adsorbents	amylase
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e1> nalidixic acid </e1> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e2> quinidine </e2> ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	nalidixic acid	quinidine
effect	 Because <e1> lithium </e1> may enhance the serotonergic effects of <e2> escitalopram </e2> , caution should be exercised when LEXAPRO and lithium are coadministered .	lithium	escitalopram
other	 Concomitant treatment with thrombolytics (eg , rt-PA or <e1> streptokinase </e1> ) may : - increase the risk of bleeding complications - considerably enhance the effect of <e2> REFLUDAN </e2> on aPTT prolongation	streptokinase	REFLUDAN
other	 It is recommended that serum <e1> lithium </e1> levels be monitored frequently if <e2> enalapril </e2> is administered concomitantly with lithium .	lithium	enalapril
other	 <e1> Digoxin </e1> : Some calcium blockers may increase the concentration of <e2> digitalis preparations </e2> in the blood .	Digoxin	digitalis preparations
other	 <e1> Antipyrine </e1> : Antipyrine pharmacokinetics were not significantly different before and after <e2> tiagabine </e2> multiple-dose regimens .	Antipyrine	tiagabine
other	 poor metabolizers of debrisoquin : Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine , fluoxetine , <e1> paroxetine </e1> , and <e2> propafenone </e2> ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	paroxetine	propafenone
effect	 Patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other <e1> CNS depressants </e1> (including alcohol ) concomitantly with <e2> hydrocodone </e2> and acetaminophen tablets may exhibit an additive CNS depression .	CNS depressants	hydrocodone
effect	 Anesthetics / Sedatives / Hypnotics / Opioids : Co-administration of <e1> PRECEDEX </e1> with anesthetics , sedatives , hypnotics , and <e2> opioids </e2> is likely to lead to an enhancement of effects .	PRECEDEX	opioids
other	 Administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of <e1> amiodarone </e1> and <e2> desethylamiodarone </e2> .	amiodarone	desethylamiodarone
other	 Amiodarone may suppress certain CYP450 enzymes , including <e1> CYP1A2 </e1> , CYP2C9 , CYP2D6 , and <e2> CYP3A4 </e2> .	CYP1A2	CYP3A4
other	 BACKGROUND : The effects of combined administration of <e1> bombesin </e1> and verapamil hydrochloride ( <e2> verapamil </e2> ) , a calcium channel blocker , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane ( AOM ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	bombesin	verapamil
other	 Other Drugs : In healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy (a combination of conjugated estrogens and <e1> medroxyprogesterone </e1> ) , antacid DRUG0 and <e2> magnesium hydroxide </e2> s) and theophylline did not affect the pharmacokinetics of TIKOSYN .	medroxyprogesterone	magnesium hydroxide
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as ibuprofen ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , <e1> Orudis KT </e1> , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and naproxen ( Anaprox , Naprosyn , <e2> Aleve </e2> );	Orudis KT	Aleve
other	 Effects of Other Antiepileptic Drugs on Felbatol <e1> Phenytoin </e1> : Phenytoin causes an approximate doubling of the clearance of <e2> Felbatol </e2> ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45% decrease in the steady-state trough concentrations of Felbatol as compared to the same dose of Felbatol given as monotherapy .	Phenytoin	Felbatol
other	 Netilmicin should not be administered concomitantly with potent loop diuretics such as <e1> furosemide </e1> and <e2> ethacrynic acid </e2> as the potential for ototoxicity is enhanced by the combination .	furosemide	ethacrynic acid
other	 Corticosteroids , Methylxanthines and <e1> Diuretics </e1> : Concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of <e2> beta2-agonists. </e2>	Diuretics	beta2-agonists.
other	 certain <e1> antipsychotic medications </e1> (such as <e2> sertindole </e2> );	tetracyclic antidepressants	maprotiline
other	 Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing <e1> transferrin </e1> (1 microgram/ml) , EGF (10 ng/ml) , and <e2> insulin </e2> (3.7 micrograms/ml or 0.1 IU/ml) .	transferrin	insulin
mechanism	 Probenecid : Concomitant administration of <e1> TORADOL </e1> ORAL and <e2> probenecid </e2> resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .	TORADOL	probenecid
other	 <e1> Vitamin D </e1> : The coadministration of any of the <e2> vitamin D analogues </e2> should be avoided as this could create possible additive effects and hypercalcemia .	Vitamin D	vitamin D analogues
other	 Therefore , co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g. , nortriptyline , imipramine , <e1> desipramine </e1> , paroxetine , fluoxetine , sertraline ) , antipsychotics (e.g. , haloperidol , risperidone , thioridazine ) , beta-blockers (e.g. , metoprolol ) , and <e2> Type 1C antiarrhythmics </e2> (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	desipramine	Type 1C antiarrhythmics
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; <e1> metronidazole </e1> ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; <e2> thyroid drugs </e2> ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	metronidazole	thyroid drugs
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , <e1> colistin </e1> , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and <e2> quinidine </e2> .	colistin	quinidine
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; <e1> chloral hydrate </e1> *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e2> vitamin C </e2> ; warfarin sodium under-dosage .	chloral hydrate	vitamin C
other	 In in vivo studies , 10- to 30-mg/day doses of <e1> aripiprazole </e1> had no significant effect on metabolism by CYP2D6 ( <e2> dextromethorphan </e2> ) , CYP2C9 ( warfarin ) , CYP2C19 ( omeprazole , warfarin ) , and CYP3A4 ( dextromethorphan ) substrates .	aripiprazole	dextromethorphan
int	 There have been reports of interactions of <e1> erythromycin </e1> with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , <e2> bromocriptine </e2> , valproate , terfenadine , and astemizole .	erythromycin	bromocriptine
other	 <e1> Antidepressants </e1> : In vitro data indicate that nefazodone inhibits the metabolism of <e2> cisapride </e2> , which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG .	Antidepressants	cisapride
effect	 A potential interaction between oral <e1> miconazole </e1> and oral <e2> hypoglycemic agents </e2> leading to severe hypoglycemia has been reported .	miconazole	hypoglycemic agents
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1> chloral hydrate </e1> *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chloral hydrate	quinine
advise	 Use lowest possible dose of atorvastatin with careful monitoring , or consider <e1> HMG-CoA reductase inhibitors </e1> that are not primarily metabolized by CYP3A4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with <e2> CRIXIVAN </e2> .	HMG-CoA reductase inhibitors	CRIXIVAN
mechanism	 <e1> Rifampin </e1> significantly decreased the AUC(ss) of <e2> amprenavir </e2> by 82% , but amprenavir had no effect on rifampin pharmacokinetics .	Rifampin	amprenavir
other	 It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing <e1> antacids </e1> for at least 4 hours following <e2> ethambutol </e2> administration .	antacids	ethambutol
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> EQUETROTM </e1> due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , <e2> cyclosporin </e2> , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	EQUETROTM	cyclosporin
effect	 With simultaneous dosing of <e1> Vardenafil </e1> 20 mg and <e2> terazosin </e2> 10 mg , 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg .	Vardenafil	terazosin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1> diflunisal </e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diflunisal	sulfinpyrazone
mechanism	 Single doses of either <e1> cholestyramine </e1> or colestipol resins bind the <e2> hydrochlorothiazide </e2> and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .	cholestyramine	hydrochlorothiazide
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> EQUETROTM </e1> due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , <e2> amitriptyline </e2> , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	EQUETROTM	amitriptyline
other	 Effects of Other Antiepileptic Drugs on Felbatol Phenytoin : Phenytoin causes an approximate doubling of the clearance of <e1> Felbatol </e1> ( felbamate ) at steady state and , therefore , the addition of <e2> phenytoin </e2> causes an approximate 45% decrease in the steady-state trough concentrations of Felbatol as compared to the same dose of Felbatol given as monotherapy .	Felbatol	phenytoin
effect	 Patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other <e1> CNS depressants </e1> (including alcohol ) concomitantly with <e2> hydrocodone </e2> and acetaminophen tablets may exhibit an additive CNS depression .	CNS depressants	hydrocodone
advise	 If antacids are required during OMNICEF therapy , <e1> OMNICEF </e1> should be taken at least 2 hours before or after the <e2> antacid </e2> .	OMNICEF	antacid
other	 <e1> Antiretroviral </e1> plasma and urine sampling were conducted on Days 1 , 7 , and 21 for <e2> zidovudine </e2> and on Days 7 and 21 for dideoxyinosine .	Antiretroviral	zidovudine
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or <e1> propranolol </e1> (basic) , as well as <e2> tetracycline </e2> penicillin G , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .	propranolol	tetracycline
other	 Injection : <e1> Lorazepam </e1> injection , like other injectable <e2> benzodiazepines </e2> , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , MAO inhibitors , and other antidepressants .When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	Lorazepam	benzodiazepines
mechanism	 Administration of <e1> eplerenone </e1> with other CYP3A4 inhibitors (e.g. , <e2> erythromycin </e2> 500 mg BID , verapamil 240 mg QD , saquinavir 1200 mg TID , fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold .	eplerenone	erythromycin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , <e1> atorvastatin </e1> ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , <e2> Kadian </e2> , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	atorvastatin	Kadian
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , <e1> fluoxetine </e1> , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , <e2> verapamil </e2> , zileuton .	fluoxetine	verapamil
other	 Cephalosporins - <e1> Cephalosporins </e1> containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , <e2> latamoxef </e2> ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	Cephalosporins	latamoxef
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , <e1> Topamax </e1> , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( <e2> Theo-Dur </e2> ) , and vitamin C .	Topamax	Theo-Dur
other	 When <e1> ouabain </e1> was applied to the muscle in the presence of phentolamine , both first and second contractile responses to <e2> PTX </e2> were abolished .	ouabain	PTX
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , <e1> Compazine </e1> ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , <e2> Mellaril </e2> ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	Compazine	Mellaril
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation <e1> anesthetics </e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; <e2> warfarin sodium </e2> overdosage .	anesthetics	warfarin sodium
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; <e1> antibiotics </e1> ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e2> ibuprofen </e2> ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	antibiotics	ibuprofen
other	 These agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , <e1> NSAIDs </e1> (including <e2> ketorolac tromethamine </e2> ) , dipyridamole , or sulfinpyrazone .	NSAIDs	ketorolac tromethamine
other	 Concurrent administration of <e1> indinavir </e1> and didanosine significantly reduces the level of exposure to indinavir , but it is unclear how soon after <e2> didanosine </e2> administration indinavir may be given safely .	indinavir	didanosine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1> chlorpropamide </e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e2> nalidixic acid </e2> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chlorpropamide	nalidixic acid
other	 Ketoconazole : When a single 125-mg dose of Aprepitant was administered on Day5 of a 10-day regimen of 400 mg/day of <e1> ketoconazole </e1> , a strong CYP3A4 inhibitor , the AUC of <e2> aprepitant </e2> increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .	ketoconazole	aprepitant
other	 <e1> Antihypertensives </e1> : Amiodarone should be used with caution in patients receiving - receptor blocking agents (e.g. , propranolol , a CYP3A4 inhibitor) or calcium channel antagonists (e.g. , verapamil , a CYP3A4 substrate , and diltiazem , a <e2> CYP3A4 </e2> inhibitor) because of the possible potentiation of bradycardia , sinus arrest , and AV block;	Antihypertensives	CYP3A4
advise	 Drugs that Lower Seizure Threshold : Concurrent administration of <e1> WELLBUTRIN </e1> and agents (e.g. , <e2> antipsychotics </e2> , other antidepressants , theophylline , systemic steroids , etc.) that lower seizure threshold should be undertaken only with extreme caution .	WELLBUTRIN	antipsychotics
other	 It may increase excretion of barbiturates , <e1> lithium </e1> , and <e2> ASA </e2> and may also increase the toxicity of salicylates .	lithium	ASA
other	 <e1> Probenecid </e1> or Cimetidine : Concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of <e2> zalcitabine </e2> .	Probenecid	zalcitabine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation <e1> anesthetics </e1> ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; <e2> pyrazolones </e2> ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anesthetics	pyrazolones
other	 Digoxin : In a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , <e1> ketoprofen </e1> did not alter the serum levels of <e2> digoxin </e2> .	ketoprofen	digoxin
other	 [Stimulation by cerulein --an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of <e1> haloperidol </e1> (0.25 mg/kg) and <e2> pyreneperone </e2> (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures , whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain .	haloperidol	pyreneperone
other	 The <e1> zidovudine </e1> study dosed subjects with 1200 mg/day of <e2> azithromycin </e2> (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg , five times/day of zidovudine .	zidovudine	azithromycin
other	 Because <e1> lithium </e1> may enhance the serotonergic effects of escitalopram , caution should be exercised when <e2> LEXAPRO </e2> and lithium are coadministered .	lithium	LEXAPRO
other	 Aminoglutethimide diminishes the effect of <e1> coumarin </e1> and <e2> warfarin </e2> .	coumarin	warfarin
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or <e1> propranolol </e1> (basic) , as well as tetracycline penicillin G , phenobarbital , thyroid and thyroxine preparations , <e2> estrogens </e2> and progestins , and digitalis .	propranolol	estrogens
other	 Anesthetics / Sedatives / Hypnotics / Opioids : Co-administration of PRECEDEX with anesthetics , <e1> sedatives </e1> , hypnotics , and <e2> opioids </e2> is likely to lead to an enhancement of effects .	sedatives	opioids
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e1> ibuprofen </e1> ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ibuprofen	sulfinpyrazone
other	 Although not studied systematically in clinical trials , no drug interactions were observed when vecuronium , <e1> pancuronium </e1> , or atracurium were administered following varying degrees of recovery from single doses or infusions of <e2> NIMBEX </e2> .	pancuronium	NIMBEX
other	 Butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesic s , <e1> alcohol </e1> , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other <e2> CNS depressants </e2> , causing increased CNS depression .	alcohol	CNS depressants
other	 Effect of Other Drugs on the Pharmacokinetics of Clonazepam : Literature reports suggest that <e1> ranitidine </e1> , an agent that decreases stomach acidity , does not greatly alter <e2> clonazepam </e2> pharmacokinetics .	ranitidine	clonazepam
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; <e1> chloral hydrate </e1> *; chlorpropamide ; <e2> chymotrypsin </e2> ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chloral hydrate	chymotrypsin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; <e1> methylphenidate </e1> ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	methylphenidate	tolbutamide
mechanism	 In a multiple-dose study , <e1> enoxacin </e1> caused a dose-related increase in the mean elimination half-life of <e2> caffeine </e2> , thereby decreasing the clearance of caffeine by up to 80% and leading to a five-fold increase in the AUC and the half-life of caffeine .	enoxacin	caffeine
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; <e1> aminosalicylic acid </e1> ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	aminosalicylic acid	sulfonamides
other	 <e1> Tetracycline </e1> , a <e2> bacteriostatic antibiotic </e2> , may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided .	Tetracycline	bacteriostatic antibiotic
other	 Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , <e1> VIDEX </e1> chewable/buffered tablets or pediatric powder , or products containing <e2> calcium </e2> , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	VIDEX	calcium
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , <e1> clofibrate </e1> ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and <e2> vitamin C </e2> .	clofibrate	vitamin C
other	 Drug/Laboratory Test Interactions <e1> Cephalosporins </e1> , including <e2> cefotaxime sodium </e2> , are known to occasionally induce a positive direct Coombs test .	Cephalosporins	cefotaxime sodium
other	 In a similar study with <e1> tamsulosin </e1> in healthy volunteers , 1 of 24 subjects dosed with <e2> Vardenafil </e2> 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg .	tamsulosin	Vardenafil
effect	 Hypotension : Patients on Diuretic Therapy : Patients on <e1> diuretics </e1> and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with <e2> enalapril </e2> or enalaprilat .	diuretics	enalapril
advise	 Nicardipine HCl usually does not alter the plasma levels of digoxin , however , serum <e1> digoxin </e1> levels should be evaluated after concomitant therapy with <e2> nicardipine HCl </e2> is initiated .	digoxin	nicardipine HCl
other	 Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , <e1> nefazodone </e1> , nicardipine , propofol , protease inhibitors , quinidine , and <e2> verapamil </e2> .	nefazodone	verapamil
other	 Additional reductions in blood pressure may occur when FLOLAN is administered with diuretics , <e1> antihypertensive agents </e1> , or other <e2> vasodilators </e2> .	antihypertensive agents	vasodilators
other	 cimetidine ) and many that are substrates for P450 2D6 (many other antidepressants , <e1> phenothiazines </e1> , and the Type 1C antiarrhythmics <e2> propafenone </e2> and flecainide ) .	phenothiazines	propafenone
other	 An interaction study with <e1> warfarin </e1> showed no clinically significant effect of <e2> anastrozole </e2> on warfarin pharmacokinetics or anticoagulant activity .	warfarin	anastrozole
other	 Effects of Felbatol on Low-Dose Combination Oral Contraceptives A group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg <e1> ethinyl estradiol </e1> and 75 mg <e2> gestodene </e2> for at least 3 months received 2400 mg/day of felbamate from midcycle (day 15) to midcycle (day 14) of two consecutive oral contraceptive cycles .	ethinyl estradiol	gestodene
other	 The co-administration of Natrecor with IV <e1> vasodilators </e1> such as nitroglycerin , <e2> nitroprusside </e2> , milrinone , or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials) .	vasodilators	nitroprusside
mechanism	 Dicumarol : It has been reported that <e1> allopurinol </e1> prolongs the half-life of the anticoagulant , <e2> dicumarol </e2> .	allopurinol	dicumarol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; <e1> naproxen </e1> ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	naproxen	sulfonamides
other	 Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g. , <e1> Marplan </e1> ) , phenelzine (e.g. , <e2> Nardil </e2> ) , procarbazine (e.g. , Matulane ) , selegiline (e.g. , Eldepryl ) , and tranylcypromine (e.g. , Parnate ) : Using these medicines with L-tryptophan may increase the chance of side effects .	Marplan	Nardil
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , <e1> clofibrate </e1> , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , <e2> meclofenamic acid </e2> , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .	clofibrate	meclofenamic acid
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of <e1> insulin </e1> : corticosteroids , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , <e2> somatropin </e2> , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	insulin	somatropin
other	 Protein Binding In vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding) , tolbutamide , <e1> prednisolone </e1> (10% decrease in binding) , or <e2> warfarin </e2> .	prednisolone	warfarin
other	 Theophylline : The effect of steady-state <e1> fluvoxamine </e1> l50 mg bid on the pharmacokinetics of a single dose of <e2> Theophylline </e2> (375 mg) as 442 mg aminophylline was evaluated in 12 healthy non-smoking , male volunteers .	fluvoxamine	Theophylline
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , <e1> Trileptal </e1> , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , <e2> phenylbutazone </e2> , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Trileptal	phenylbutazone
other	 There was no evidence of drug interactions in clinical studies in which <e1> dobutamine </e1> was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and <e2> acetaminophen </e2> .	dobutamine	acetaminophen
effect	 In both species , <e1> (-)-NANM </e1> , but not (+)-NANM , antagonized the rate-decreasing effects of <e2> morphine </e2> on FI and FR responding .	(-)-NANM	morphine
other	 Tell your doctor if you are taking any of the following drugs : blood thinner s ( <e1> Coumadin </e1> ) other antidepressants metoprolol antihistamines carbamazepine ( <e2> Tegretol </e2> ) cimetidine ( Tagamet ) estrogens fluoxetine ( Prozac ) intraconazole ( Sporanox ) ketoconazole ( Nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	Coumadin	Tegretol
effect	 There have been reports of theophylline -related side-effects in patients on concomitant <e1> theophylline </e1> - <e2> quinolone </e2> therapy .	theophylline	quinolone
other	 Since higher doses of <e1> ketoconazole </e1> (400 mg daily) may result in higher increases in Cmax and AUC , a single 2.5 mg dose of <e2> Vardenafil </e2> should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily .	ketoconazole	Vardenafil
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , <e1> amiodarone </e1> , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , <e2> methylphenidate </e2> , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone	amiodarone	methylphenidate
other	 In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( <e1> acetylsalicylic acid </e1> ) , NSAIDs ( piroxicam ) , and <e2> digoxin </e2> did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	acetylsalicylic acid	digoxin
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of EQUETROTM are the following : Cisplatin , doxorubicin HCL , felbamate , rifampin , phenobarbital , Phenytoin (2) , <e1> primidone </e1> , methsuximide , and theophylline Thus , if a patient has been titrated to a stable dosage on EQUETROTM , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for <e2> EQUETROTM </e2> may be necessary .	primidone	EQUETROTM
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : <e1> aminoglycosides </e1> (e.g. , gentamicin , <e2> amikacin </e2> ) , amphotericin B , cyclosporine , non-steroidal anti-inflammatory drugs (e.g. , ibuprofen ) , tacrolimus , vancomycin .	aminoglycosides	amikacin
effect	 Both the sedative and anticholinergic effects of the <e1> major tranquilizers </e1> are also additive to those of <e2> desipramine </e2> .	major tranquilizers	desipramine
effect	 The action of the <e1> benzodiazepines </e1> may be potentiated by anticonvulsants , <e2> antihistamines </e2> , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce CNS depression .	benzodiazepines	antihistamines
other	 <e1> Cimetidine </e1> , caffeine , and <e2> erythromycin </e2> may increase plasma levels of Clozapine , potentially resulting in adverse effects .	Cimetidine	erythromycin
mechanism	 plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g. , cimetidine , <e1> fluoxetine </e1> ) and decreased by the concomitant administration of hepatic enzyme inducers (e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with <e2> CMI </e2> as well .	fluoxetine	CMI
other	 When ouabain was applied to the muscle in the presence of <e1> phentolamine </e1> , both first and second contractile responses to <e2> PTX </e2> were abolished .	phentolamine	PTX
other	 <e1> Cholestyramine </e1> and colestipol resins : Absorption of hydrochlorothiazide is impaired in the presence of <e2> anionic exchange resins </e2> .	Cholestyramine	anionic exchange resins
other	 <e1> alcohol </e1> , barbiturates and other <e2> CNS depressants </e2> ;	alcohol	CNS depressants
mechanism	 <e1> Aminosalicylic acid </e1> may also decrease the absorption of <e2> vitamin B12 </e2> , which can lead to a deficiency .	Aminosalicylic acid	vitamin B12
other	 Antacids : In a single dose study (n=6) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the Cmax and AUC of mefenamic acid by 125% and 36% , respectively . A number of compounds are inhibitors of CYP2C9 including fluconazole , <e1> lovastatin </e1> and <e2> trimethoprim </e2> .	lovastatin	trimethoprim
other	 Warfarin , Digoxin , Salicylate , and <e1> Heparin </e1> The in vitro binding of <e2> warfarin </e2> to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL .	Heparin	warfarin
other	 - Drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , <e1> estrogens </e1> , furosemide , oral contraceptives , <e2> rifampin </e2> , quinidine , theophylline , vitamin D .	estrogens	rifampin
other	 Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics , <e1> hypnotics </e1> and <e2> sedatives </e2> (including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	hypnotics	sedatives
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , <e1> risperidone </e1> , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and <e2> zonisamide </e2> .	risperidone	zonisamide
other	 Imidazoles (e . g. , ketoconazole , miconazole , <e1> clotrimazole </e1> , fluconazole , etc.) : in vitro and animal studies with the combination of <e2> amphotericin B </e2> and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B .	clotrimazole	amphotericin B
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , <e1> danazol </e1> , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , <e2> ketoconazole </e2> , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	danazol	ketoconazole
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1> indomethacin </e1> ; influenza virus vaccine ;inhalation anesthetics ; <e2> mefenamic acid </e2> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	indomethacin	mefenamic acid
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : <e1> aminoglutethimide </e1> , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , <e2> dopamine </e2> and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	aminoglutethimide	dopamine
other	 Additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , <e1> hypnotics </e1> , alcohol , and other <e2> opiate analgesics </e2> .	hypnotics	opiate analgesics
other	 These medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , <e1> angiotensin converting enzyme inhibitors </e1> , intravenous and oral nitrates , ticlopidine , and <e2> aspirin </e2> .	angiotensin converting enzyme inhibitors	aspirin
other	 Warfarin , <e1> Digoxin </e1> , Salicylate , and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by <e2> ketorolac tromethamine </e2> (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL .	Digoxin	ketorolac tromethamine
other	 In clinical studies , <e1> Tilade </e1> has been co-administered with other anti-asthma medications , including inhaled and oral <e2> bronchodilators </e2> , and inhaled corticosteroids , with no evidence of increased frequency of adverse events or laboratory abnormalities .	Tilade	bronchodilators
effect	 Other depressasnts such as alcohol , barbiturates , and <e1> MAOIs </e1> may enhance CNS depression when administered with <e2> ethchlorvynol </e2> .	MAOIs	ethchlorvynol
other	 It is recommended that plasma <e1> lithium </e1> levels be monitored when <e2> ketoprofen </e2> is coadministered with lithium .	lithium	ketoprofen
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; <e1> quinidine </e1> ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	quinidine	quinine
int	 A pharmacokinetic interaction between <e1> diltiazem </e1> and <e2> cyclosporine </e2> has been observed during studies involving renal and cardiac transplant patients .	diltiazem	cyclosporine
other	 Co-administration of <e1> aliskiren </e1> did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , <e2> metformin </e2> , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .	aliskiren	metformin
other	 There was no evidence of drug interactions in clinical studies in which <e1> dobutamine </e1> was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , <e2> isosorbide dinitrate </e2> , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .	dobutamine	isosorbide dinitrate
other	 Etonogestrel may interact with the following medications : acetaminophen ( <e1> Tylenol </e1> ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( <e2> Neoral </e2> , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Tylenol	Neoral
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , <e1> ethionamide </e1> , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , <e2> thiazide diuretics </e2> .	ethionamide	thiazide diuretics
other	 Coadministration of <e1> valdecoxib </e1> (10 mg BID for 7 days) with glyburide (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of <e2> glyburide </e2> .	valdecoxib	glyburide
other	 Bentiromide may interact with acetaminophen (e.g. , Tylenol ) , chloramphenicol (e.g. , <e1> Chloromycetin </e1> ) , local <e2> anesthetics </e2> (e.g. , benzocaine and lidocaine ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some multivitamins ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	Chloromycetin	anesthetics
other	 Medications can interfere with folate utilization , including : anticonvulsant medications (such as phenytoin , and <e1> primidone </e1> ) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) <e2> sulfasalazine </e2> (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic ) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid .	primidone	sulfasalazine
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , <e1> chlorpromazine </e1> [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , <e2> Sparine </e2> ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	chlorpromazine	Sparine
advise	 Before taking <e1> glimepiride </e1> , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( Trilisate ) , salsalate ( Disalcid , others) , <e2> choline salicylate </e2> ( Arthropan ) , magnesium salicylate ( Magan ) , or bismuth subsalicylate ( Pepto-Bismol );	glimepiride	choline salicylate
advise	 however , as with other NSAIDs , concomitant administration of <e1> Lodine </e1> and <e2> aspirin </e2> is not generally recommended because of the potential of increased adverse effects .	Lodine	aspirin
other	 Drugs which may enhance the neuromuscular blocking action of TRACRIUM include : <e1> enflurane </e1> ; isoflurane ; halothane ;certain antibiotics , especially the <e2> aminoglycosides </e2> and polymyxins ; lithium ; magnesium salts; procainamide ;and quinidine .	enflurane	aminoglycosides
other	 Benzthiazide may interact with alcohol , <e1> blood thinner </e1> s , <e2> decongestant drugs </e2> (allergy , cold , and sinus medicines) , diabetic drugs , lithium , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	blood thinner	decongestant drugs
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> EQUETROTM </e1> are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , <e2> delavirdine </e2> , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	EQUETROTM	delavirdine
other	 <e1> Phenobarbital </e1> : Coadministration of <e2> felbamate </e2> with phenobarbital causes an increase in phenobarbital plasma concentrations , In 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough (Cmin) phenobarbital concentration was 14.2 micrograms/mL .	Phenobarbital	felbamate
advise	 Concomitant administration of <e1> naproxen </e1> and <e2> aspirin </e2> is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .	naproxen	aspirin
mechanism	 Ascorbic acid : Doses of <e1> ascorbic acid </e1> ( vitamin C ) 1 g/day have been reported to increase plasma concentration of <e2> synthetic estrogens </e2> by ~47% , possibly by inhibiting conjugation;	ascorbic acid	synthetic estrogens
effect	 The administration of local anesthetic solutions containing epinephrine or <e1> norepinephrine </e1> to patients receiving <e2> monoamine oxidase inhibitors </e2> or tricyclic antidepressants may produce severe , prolonged hypertension .	norepinephrine	monoamine oxidase inhibitors
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , <e1> vincristine </e1> , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving <e2> antiretroviral </e2> therapy .	vincristine	antiretroviral
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , <e1> estrogens </e1> , progestogens (e.g. , in oral <e2> contraceptives </e2> ) .	estrogens	contraceptives
other	 ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction , such as certain <e1> calcium antagonists </e1> (particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes) , or antiarrhythmic agents , such as <e2> disopyramide </e2> , are used concurrently .	calcium antagonists	disopyramide
advise	 Special consideration should be given to the administration of <e1> ETHYOL </e1> in patients receiving <e2> antihypertensive medications </e2> or other drugs that could cause or potentiate hypotension .	ETHYOL	antihypertensive medications
other	 In patients taking <e1> diclofenac </e1> and lithium concomitantly , <e2> lithium </e2> toxicity may develop .	diclofenac	lithium
mechanism	 Although no clinical studies have been conducted , it is likely that the metabolism of <e1> levobupivacaine </e1> may be affected by the known CYP3A4 inducers (such as phenytoin , phenobarbital , rifampin ) , CYP3A4 inhibitors (azole antimycotics e.g. , <e2> ketoconazole </e2> ;	levobupivacaine	ketoconazole
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e1> miconazole </e1> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; <e2> oxolinic acid </e2> ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	miconazole	oxolinic acid
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1> dextrothyroxine </e1> ; <e2> diazoxide </e2> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextrothyroxine	diazoxide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; <e1> amiodarone </e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e2> ranitidine </e2> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	amiodarone	ranitidine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , <e1> androgens </e1> and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , <e2> phenytoin </e2> , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	androgens	phenytoin
other	 ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction , such as certain <e1> calcium antagonists </e1> (particularly of the phenylalkylamine [ <e2> verapamil </e2> ] and benzothiazepine [ diltiazem ] classes) , or antiarrhythmic agents , such as disopyramide , are used concurrently .	calcium antagonists	verapamil
other	 <e1> Potassium-sparing diuretics </e1> (e.g. , spironolactone , triamterene , or amiloride ) , <e2> potassium </e2> supplements , or potassium -containing salt substitutes may lead to significant increases in serum DRUG0 .	Potassium-sparing diuretics	potassium
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1> chlorpropamide </e1> ; chymotrypsin ; cimetidine ; cinchophen ; <e2> clofibrate </e2> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chlorpropamide	clofibrate
other	 Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g. , <e1> Marplan </e1> ) , phenelzine (e.g. , Nardil ) , <e2> procarbazine </e2> (e.g. , Matulane ) , selegiline (e.g. , Eldepryl ) , and tranylcypromine (e.g. , Parnate ) : Using these medicines with L-tryptophan may increase the chance of side effects .	Marplan	procarbazine
other	 <e1> Anticoagulants </e1> : Potentiation of warfarin -type ( CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving <e2> amiodarone </e2> and can result in serious or fatal bleeding .	Anticoagulants	amiodarone
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , <e1> danazol </e1> , diuretics , sympathomimetic agents (e.g. , epinephrine , salbutamol , terbutaline ) , <e2> isoniazid </e2> , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	danazol	isoniazid
other	 Administration of quinolones with antacids containing aluminum , magnesium , or <e1> calcium </e1> , with sucralfate , with metal cations such as iron , or with multivitamins containing <e2> iron </e2> or zinc , or with formulations containing divalent and trivalent cations such as VIDEX ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .	calcium	iron
other	 <e1> Dolasetron mesylate </e1> did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , <e2> doxorubicin </e2> , cyclophosphamide ) in four murine models .	Dolasetron mesylate	doxorubicin
effect	 The effects of <e1> adenosine </e1> are antagonized by <e2> methylxanthines </e2> such as caffeine and theophylline .	adenosine	methylxanthines
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , <e1> mesoridazine </e1> [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , promazine [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , trifluoperazine [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , <e2> Temaril </e2> ]) or	mesoridazine	Temaril
other	 In patients taking <e1> diclofenac </e1> and lithium concomitantly , <e2> lithium </e2> toxicity may develop .	diclofenac	lithium
other	 If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / <e1> hypnotics </e1> , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of desipramine and benzodiazepines (e.g. , chlordiazepoxide or <e2> diazepam </e2> ) are additive .	hypnotics	diazepam
other	 <e1> Slow-channel calcium blockers </e1> , such as <e2> verapamil </e2> , diltiazem and nifedipine , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	Slow-channel calcium blockers	verapamil
other	 The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose ( <e1> NaCMC </e1> ) and carboxymethylcellulose-cysteine ( CMC-Cys ) conjugates on the intestinal permeation of <e2> sodium fluorescein </e2> ( NaFlu ) and model peptide drugs , bacitracin and insulin .	NaCMC	sodium fluorescein
mechanism	 <e1> Tagamet </e1> , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , <e2> phenytoin </e2> , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	Tagamet	phenytoin
other	 <e1> Warfarin </e1> : No significant differences were observed in the steady-state pharmacokinetics of <e2> R-warfarin </e2> or S-warfarin with the addition of tiagabine given as a single dose .	Warfarin	R-warfarin
effect	 <e1> Amphetamines </e1> may enhance the effects of <e2> tricyclic antidepressants </e2> .	Amphetamines	tricyclic antidepressants
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( <e1> Lipitor </e1> ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( <e2> Theo-Dur </e2> ) , and vitamin C .	Lipitor	Theo-Dur
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , <e1> sympathomimetic agents </e1> (e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , <e2> thyroid hormones </e2> , estrogens , progestogens (e.g. , in oral contraceptives ) .	sympathomimetic agents	thyroid hormones
other	 Effects of <e1> GABITRIL </e1> on other Antiepilepsy Drugs ( AEDs ) : <e2> Phenytoin </e2> : Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .	GABITRIL	Phenytoin
other	 Therefore , co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g. , nortriptyline , imipramine , desipramine , paroxetine , <e1> fluoxetine </e1> , sertraline ) , antipsychotics (e.g. , haloperidol , risperidone , <e2> thioridazine </e2> ) , beta-blockers (e.g. , metoprolol ) , and Type 1C antiarrhythmics (e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .	fluoxetine	thioridazine
other	 Drug Interactions : The central anticholinergic syndrome can occur when DRUG0 agents such as AKINETON are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain <e1> narcotic analgesics </e1> such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain <e2> antiarrhythmics </e2> such as the quinidine salts , and antihistamines .	narcotic analgesics	antiarrhythmics
other	 Concomitant administration of FACTIVE and <e1> calcium carbonate </e1> , cimetidine , omeprazole , or an <e2> estrogen </e2> / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .	calcium carbonate	estrogen
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , <e1> amiodarone </e1> , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , <e2> rifampin </e2> , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	amiodarone	rifampin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( <e1> Atromid-S </e1> ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , <e2> temazepam </e2> , theophylline ( Theo-Dur ) , and vitamin C .	Atromid-S	temazepam
other	 <e1> Magnesium </e1> - and aluminum -containing <e2> antacids </e2> , administered concomitantly with lomefloxacin , significantly decreased the bioavailability (48%) of lomefloxacin .	Magnesium	antacids
other	 <e1> Diuretics </e1> : <e2> Diclofenac </e2> and other NSAIDs can inhibit the activity of diuretics .	Diuretics	Diclofenac
other	 Phenobarbital : Coadministration of <e1> felbamate </e1> with phenobarbital causes an increase in <e2> phenobarbital </e2> plasma concentrations , In 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough (Cmin) phenobarbital concentration was 14.2 micrograms/mL .	felbamate	phenobarbital
other	 Saquinavir : Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with <e1> VIRACEPT </e1> resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in <e2> saquinavir </e2> plasma A.C .	VIRACEPT	saquinavir
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> EQUETROTM </e1> are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , <e2> niacinamide </e2> , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	EQUETROTM	niacinamide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; <e1> anabolic steroids </e1> ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e2> ibuprofen </e2> ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	anabolic steroids	ibuprofen
other	 The results indicate that a spinal <e1> naloxone </e1> -sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine -induced tail-flick inhibition , and suggest that intraventricular <e2> beta-endorphin </e2> and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;	naloxone	beta-endorphin
other	 <e1> Methotrexate </e1> : <e2> Ibuprofen </e2> , as well as other nonsteroidal anti-inflammatory drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .	Methotrexate	Ibuprofen
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , <e1> asparaginase </e1> , clofibrate , estrogens and <e2> estrogen-containing compounds </e2> , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .	asparaginase	estrogen-containing compounds
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , <e1> diazepam </e1> , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , <e2> mitotane </e2> , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	diazepam	mitotane
other	 The combination of therapeutic doses of intravenous <e1> dantrolene sodium </e1> and verapamil in <e2> halothane </e2> a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .	dantrolene sodium	halothane
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , <e1> antifungals </e1> ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , <e2> Fortovase </e2> , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	antifungals	Fortovase
other	 <e1> Adrenergic blockers </e1> Adrenergic blockers are inhibited by <e2> amphetamines </e2> .	Adrenergic blockers	amphetamines
other	 Endothelium-intact aortic rings from high- <e1> estradiol </e1> rats were supersensitive to noradrenaline when compared to vehicle- , <e2> progesterone </e2> - and progesterone + high- estradiol -treated rats (pD2 values = 7.77+/-0.12 , 7.21+/-0.13 , 6.93+/-0.04 and 7.22+/-0.18 , respectively) .	estradiol	progesterone
other	 <e1> Hormonal Contraceptives </e1> , Including Oral , Injectable , Transdermal , and Implantable Contraceptives : An interaction study demonstrated that co-administration of bosentan and the oral <e2> hormonal contraceptive </e2> Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31% , respectively .	Hormonal Contraceptives	hormonal contraceptive
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , <e1> thiazide diuretics </e1> (acidic) or propranolol (basic) , as well as tetracycline <e2> penicillin G </e2> , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .	thiazide diuretics	penicillin G
other	 In rats , simultaneous ingestion of <e1> disulfiram </e1> and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with <e2> nitrites </e2> in the rat stomach to form a nitrosamine , which is tumorigenic .	disulfiram	nitrites
other	 Binding to Serum Proteins : The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , <e1> asparaginase </e1> , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , <e2> salicylates </e2> , tamoxifen .	asparaginase	salicylates
other	 <e1> Vitamin A </e1> and oral retinoids : Concomitant administration of vitamin A and/or other oral retinoids with <e2> acitretin </e2> must be avoided because of the risk of hypervitaminosis A .	Vitamin A	acitretin
other	 However , there are limited in vivo data suggesting a modest CYP2D6 inhibitory effect for <e1> escitalopram </e1> , i.e. , coadministration of escitalopram (20 mg/day for 21 days) with the <e2> tricyclic antidepressant </e2> desipramine (single dose of 50 mg) , a substrate for CYP2D6 , resulted in a 40% increase in Cmax and a 100% increase in AUC of desipramine .	escitalopram	tricyclic antidepressant
effect	 In addition to bleeding associated with heparin and vitamin K antagonists , drugs that alter platelet function (such as acetylsalicylic acid , <e1> dipyridamole </e1> and Abciximab ) may increase the risk of bleeding if administered prior to , during , or after <e2> Activase </e2> therapy .	dipyridamole	Activase
other	 Thus , concomitant therapy with <e1> warfarin </e1> and <e2> Lodine </e2> should not require dosage adjustment of either drug .	warfarin	Lodine
other	 <e1> Quinolone Antibiotic </e1> s : <e2> VIDEX </e2> should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .	Quinolone Antibiotic	VIDEX
other	 Medications can interfere with folate utilization , including : anticonvulsant medications (such as phenytoin , and primidone ) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) <e1> triamterene </e1> (a diuretic ) Methotrexate There has been concern about the interaction between vitamin B12 and <e2> folic acid </e2> .	triamterene	folic acid
other	 Drugs That Should Not Be Coadministered With VIRACEPT <e1> Antiarrhythmics </e1> : <e2> amiodarone </e2> , quinidine Antihistamines : astemizole , terfenadine Antimigraine : ergot derivatives Antimycobacterial agents : rifampin Benzodiazepines midazolam , triazolam GI motility agents : cisapride	Antiarrhythmics	amiodarone
effect	 Beta-blockers , clonidine , lithium salts , and <e1> alcohol </e1> may either potentiate or weaken the blood-glucose-lowering effect of <e2> insulin </e2> .	alcohol	insulin
other	 <e1> Nonsteroidal Anti-Inflammatory Drugs </e1> : The administration of <e2> diflunisal </e2> to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin .	Nonsteroidal Anti-Inflammatory Drugs	diflunisal
other	 Haemodynamic effects of <e1> glucose </e1> and <e2> insulin </e2> were additive when somatostatin was co-administered but not under basal conditions .	glucose	insulin
effect	 - Drugs whose efficacy is impaired by <e1> phenytoin </e1> include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral <e2> contraceptives </e2> , rifampin , quinidine , theophylline , vitamin D .	phenytoin	contraceptives
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; <e1> cholestyramine </e1> ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ;oral contraceptives ; <e2> paraldehyde </e2> ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; vitamin C ; warfarin sodium under-dosage .	cholestyramine	paraldehyde
other	 Cytochrome P-450 inducers , such as <e1> phenytoin </e1> , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30% decrease in plasma <e2> clonazepam </e2> levels .	phenytoin	clonazepam
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; <e2> clofibrate </e2> ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	clofibrate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e1> diazoxide </e1> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; <e2> miconazole </e2> ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diazoxide	miconazole
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; <e1> fenoprofen </e1> ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; <e2> mefenamic acid </e2> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	fenoprofen	mefenamic acid
other	 - a <e1> diuretic </e1> (water pill) such as hydrochlorothiazide ( HCTZ , <e2> Hydrodiuril </e2> ) , chlorothiazide ( Diuril ) , and others;	diuretic	Hydrodiuril
other	 - Drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , <e1> coumarin </e1> , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , <e2> rifampin </e2> , quinidine , theophylline , vitamin D .	coumarin	rifampin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; <e1> pentoxifylline </e1> ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	pentoxifylline	quinine
other	 Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g. , intravenous aminoglycosides (e.g. , tobramycin , gentamicin , and amikacin ) , <e1> amphotericin B </e1> , foscarnet , intravenous pentamidine , <e2> vancomycin </e2> , and non-steroidal anti-inflammatory agents ] is contraindicated .	amphotericin B	vancomycin
other	 Warfarin , <e1> Digoxin </e1> , Salicylate , and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when <e2> ketorolac </e2> plasma concentrations reach 5 to10 m g/mL .	Digoxin	ketorolac
other	 However , since aspirin , NSAIDs , and <e1> bisphosphonates </e1> are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or NSAIDs with <e2> Ibandronate </e2> .	bisphosphonates	Ibandronate
other	 Drugs That Should Not Be Coadministered With VIRACEPT <e1> Antiarrhythmics </e1> : amiodarone , quinidine Antihistamines : astemizole , terfenadine Antimigraine : <e2> ergot derivatives </e2> Antimycobacterial agents : rifampin Benzodiazepines midazolam , triazolam GI motility agents : cisapride	Antiarrhythmics	ergot derivatives
other	 Magnesium - and/or aluminum -containing antacids , products containing ferrous sulfate ( <e1> iron </e1> ) , multivitamin preparations containing zinc or other metal cations , or Videx ( <e2> didanosine </e2> ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE .	iron	didanosine
other	 Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics : amiodarone , quinidine Antihistamines : <e1> astemizole </e1> , terfenadine Antimigraine : ergot derivatives Antimycobacterial agents : rifampin Benzodiazepines midazolam , triazolam GI motility agents : <e2> cisapride </e2>	astemizole	cisapride
effect	 The action of the <e1> benzodiazepines </e1> may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , <e2> psychotropic medications </e2> , or other drugs that produce CNS depression .	benzodiazepines	psychotropic medications
other	 In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and <e1> warfarin </e1> , the bioavailability of <e2> fosinoprilat </e2> was not altered by coadministration of fosinopril with any one of these drugs .	warfarin	fosinoprilat
advise	 Nevertheless , caution is indicated in the coadministration of <e1> TCAs </e1> with any of the <e2> SSRIs </e2> and also in switching from one class to the other .	TCAs	SSRIs
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; <e1> methyldopa </e1> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e2> phenyramidol </e2> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	methyldopa	phenyramidol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1> cinchophen </e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; <e2> trimethoprim </e2> / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	cinchophen	trimethoprim
other	 Tell your doctor if you are taking any of the following drugs : <e1> blood thinner </e1> s ( Coumadin ) other <e2> antidepressants </e2> metoprolol antihistamines carbamazepine ( Tegretol ) cimetidine ( Tagamet ) estrogens fluoxetine ( Prozac ) intraconazole ( Sporanox ) ketoconazole ( Nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications	blood thinner	antidepressants
other	 <e1> Cimetidine </e1> : Cimetidine does not affect the pharmacokinetics of fosfomycin when coadministered with <e2> MONUROL </e2> .	Cimetidine	MONUROL
other	 [The GABA-ergic system and brain edema] It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of diazepam , phenazepam , <e1> phenibut </e1> and <e2> amizyl </e2> and reduces the action of phentolamine .	phenibut	amizyl
other	 Coadministration of <e1> VIRACEPT </e1> and drugs that induce CYP3A may decrease <e2> nelfinavir </e2> plasma concentrations and reduce its therapeutic effect .	VIRACEPT	nelfinavir
other	 poor metabolizers of <e1> debrisoquin </e1> : Interactions of carvedilol with strong inhibitors of CYP2D6 (such as <e2> quinidine </e2> , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	debrisoquin	quinidine
mechanism	 Previous studies have demonstrated a significant reduction in the oral bioavailability of <e1> trovafloxacin </e1> and ciprofloxacin when administered concomitantly with an intravenous <e2> opiate </e2> such as morphine .	trovafloxacin	opiate
other	 Oral contraceptives : <e1> Aprepitant </e1> , when given once daily for 14 days as a 100-mg capsule with an oral <e2> contraceptive </e2> containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the AUC of ethinyl estradiol by 43% , and decreased the AUC of norethindrone by 8%;	Aprepitant	contraceptive
other	 The oral dexamethasone doses should be reduced by approximately 50% when coadministered with <e1> Aprepitant </e1> , to achieve exposures of <e2> dexamethasone </e2> similar to those obtained when it is given without Aprepitant .	Aprepitant	dexamethasone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , <e1> clonazepam </e1> , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e2> contraceptives </e2> (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	clonazepam	contraceptives
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : <e1> alcohol </e1> *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; <e2> nalidixic acid </e2> ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	alcohol	nalidixic acid
other	 When used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , <e1> sildenafil </e1> , theophylline (intravenous and oral) , triazolam , trimethoprim / <e2> sulfamethoxazole </e2> or zidovudine .	sildenafil	sulfamethoxazole
other	 To investigate the effects of antimicrobial combinations of <e1> GL </e1> with four kinds of antibiotics ( ampicillin , <e2> cefazolin </e2> , oxytetracycline and chloramphenicol ) , the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain .	GL	cefazolin
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e . g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , <e1> colistin </e1> , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , <e2> procainamide </e2> , and quinidine .	colistin	procainamide
other	 Heparin , other <e1> anticoagulants </e1> , thrombolytics , and <e2> anti platelet agents </e2> are associated with an increase in bleeding .	anticoagulants	anti platelet agents
advise	 Particular caution is recommended when administering <e1> Gleevec </e1> with CYP3A4 substrates that have a narrow therapeutic window (e.g. , cyclosporine or <e2> pimozide </e2> ) .	Gleevec	pimozide
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; <e1> phenytoin </e1> ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; <e2> sulfonamides </e2> , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	phenytoin	sulfonamides
advise	 Multivitamins , or other products containing iron or zinc , antacids or <e1> sucralfate </e1> should not be administered concomitantly with , or within 2 hours of , the administration of <e2> norfloxacin </e2> , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	sucralfate	norfloxacin
other	 Benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , <e1> cephalothin </e1> , erythromycin , and <e2> sulfamethoxazole </e2> have no influence in vitro on the protein binding of diclofenac in human serum .	cephalothin	sulfamethoxazole
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , <e1> buspirone </e1> , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , <e2> tramadol </e2> , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	buspirone	tramadol
other	 In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including <e1> anti-arrhythmic agents </e1> such as quinidine and procainamide , <e2> cardiac glycosides </e2> and tricyclic anti-depressants .	anti-arrhythmic agents	cardiac glycosides
mechanism	 Concomitant use of <e1> SPRYCEL </e1> and drugs that inhibit CYP3A4 (eg , ketoconazole , itraconazole , <e2> erythromycin </e2> , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .	SPRYCEL	erythromycin
other	 However , other published reports describe modest elevations (less than two-fold) of <e1> clozapine </e1> and metabolite concentrations when clozapine was taken with paroxetine , <e2> fluoxetine </e2> , and sertraline .	clozapine	fluoxetine
other	 Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with <e1> acetaminophen </e1> , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme (ACE) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , <e2> H2 antagonists </e2> , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors (also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	acetaminophen	H2 antagonists
other	 As <e1> MHD </e1> , the predominant plasma substrate , is only a weak inducer of UDP-glucuronyl transferase , it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through UDP-glucuronyl transferase (e.g. , valproic acid , <e2> lamotrigine </e2> ) .	MHD	lamotrigine
mechanism	 Mineral Oil -Concomitant intake of <e1> mineral oil </e1> and <e2> vitamin K </e2> may reduce the absorption of vitamin K .	colestipol	vitamin K
effect	 The concurrent use of two or more drugs with anticholinergic activity--such as an antipsychotic drug (eg , chlorpromazine ) , an <e1> antiparkinsonian drug </e1> (eg , trihexyphenidyl ) , and/or a tricyclic antidepressant (eg , <e2> amitriptyline </e2> )--commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .	antiparkinsonian drug	amitriptyline
other	 The principal drugs given (number of patients in parentheses) were : cardiac glycosides (115) , sedatives and hypnotics (103) , coronary vasodilators (52) , oral hypoglycemics (45) , cough and cold preparations (45) , <e1> NSAIDs </e1> (38) , antihyperlipidemics (29) , antigout drugs (24) , oral contraceptives (18) , bronchodilators (13) , <e2> insulin </e2> (10) , and beta blockers (10) .	NSAIDs	insulin
mechanism	 Although there was no effect of Aprepitant on the plasma AUC of DRUG0 or S(-) warfarin determined on Day 3 , there was a 34% decrease in <e1> S(-)warfarin </e1> (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with <e2> Aprepitant </e2> .	S(-)warfarin	Aprepitant
other	 <e1> Amphotericin B </e1> or potassium-depleting diuretics ( benzothiadiazines and related drugs , <e2> ethacrynic acid </e2> and furosemide ) enhanced hypokalemia .	Amphotericin B	ethacrynic acid
other	 ZEBETA should be used with care when <e1> myocardial depressants </e1> or inhibitors of AV conduction , such as certain calcium antagonists (particularly of the phenylalkylamine [ <e2> verapamil </e2> ] and benzothiazepine [ diltiazem ] classes) , or antiarrhythmic agents , such as disopyramide , are used concurrently .	myocardial depressants	verapamil
advise	 However , since aspirin , NSAIDs , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of <e1> aspirin </e1> or NSAIDs with <e2> Ibandronate </e2> .	aspirin	Ibandronate
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , <e1> Sandimmune </e1> ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( <e2> Theo-Dur </e2> ) , and vitamin C .	Sandimmune	Theo-Dur
other	 Carbamazepine : <e1> Tiagabine </e1> had no effect on the steady-state plasma concentrations of <e2> carbamazepine </e2> or its epoxide metabolite in patients with epilepsy .	Tiagabine	carbamazepine
other	 - Phenothiazines ( acetophenazine [e.g. , Tindal ] , chlorpromazine [e.g. , Thorazine ] , fluphenazine [e.g. , Prolixin ] , mesoridazine [e.g. , Serentil ] , perphenazine [e.g. , Trilafon ] , prochlorperazine [e.g. , Compazine ] , <e1> promazine </e1> [e.g. , Sparine ] , promethazine [e.g. , Phenergan ] , thioridazine [e.g. , Mellaril ] , <e2> trifluoperazine </e2> [e.g. , Stelazine ] , triflupromazine [e.g. , Vesprin ] , trimeprazine [e.g. , Temaril ]) or	promazine	trifluoperazine
other	 The effect of <e1> cyclosporine </e1> on <e2> diltiazem </e2> plasma concentrations has not been evaluated .	cyclosporine	diltiazem
other	 Drug Interactions : a . Drugs Enhancing <e1> Heparin </e1> Effect : Oral <e2> anticoagulants </e2> : Heparin sodium may prolong the one-stage prothrombin time .	Heparin	anticoagulants
other	 Metformin : In healthy subjects given single 500 mg doses of <e1> cephalexin </e1> and metformin , plasma <e2> metformin </e2> mean cmax and AUC increased by an average of 34% and 24% , respectively , and metformin mean renal clearance decreased by 14% .	cephalexin	metformin
other	 Co-administration of <e1> MYOBLOC </e1> and aminoglycosides or other agents interfering with neuromuscular transmission (e.g. , curare-like compounds ) should only be performed with caution as the effect of the <e2> toxin </e2> may be potentiated .	BOTOX	toxin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; <e1> ranitidine </e1> *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / <e2> sulfamethoxazole </e2> ;unreliable prothrombin time determinations; warfarin sodium overdosage .	ranitidine	sulfamethoxazole
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides (e.g. , gentamicin , amikacin ) , <e1> amphotericin B </e1> , cyclosporine , non-steroidal anti-inflammatory drugs (e.g. , <e2> ibuprofen </e2> ) , tacrolimus , vancomycin .	amphotericin B	ibuprofen
other	 Exposed histidines on <e1> toxin A </e1> are available for <e2> zinc </e2> chelation , and these have been exploited in the development of a novel purification protocol for toxin A using zinc -chelating chromatography .	toxin A	zinc
other	 Given the anticonvulsant properties of carbamazepine , <e1> EQUETROTM </e1> may reduce the thyroid function as has been reported with other <e2> anticonvulsants </e2> .	EQUETROTM	anticonvulsants
effect	 Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or <e1> retinyl acetate </e1> (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of <e2> EGF </e2> .	retinyl acetate	EGF
other	 Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , <e1> alcohol </e1> and sedative use as part of the history prior to any procedure in which the use of <e2> ROMAZICON </e2> is planned .	alcohol	ROMAZICON
other	 The intensity , uniformity and time course of anticoagulant interference by <e1> phenobarbital </e1> , secobarbital , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving <e2> coumarin </e2> therapy .	phenobarbital	coumarin
other	 Anesthetics / Sedatives / <e1> Hypnotics </e1> / Opioids : Co-administration of <e2> PRECEDEX </e2> with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .	Hypnotics	PRECEDEX
other	 The clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with <e1> magnesium </e1> / <e2> aluminum </e2> -containing antacids .	magnesium	aluminum
other	 Effect of Other Drugs on the Pharmacokinetics of <e1> Clonazepam </e1> : Literature reports suggest that <e2> ranitidine </e2> , an agent that decreases stomach acidity , does not greatly alter clonazepam pharmacokinetics .	Clonazepam	ranitidine
other	 The effectiveness of progestin -only pills is reduced by hepatic enzyme-inducing drugs such as the <e1> anticonvulsants </e1> phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug <e2> rifampin </e2> .	anticonvulsants	rifampin
other	 <e1> Benzodiazepines </e1> : Combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , <e2> oxazepam </e2> , temazepam ) .	Benzodiazepines	oxazepam
other	 The incidence of upper gastrointestinal events in patients concomitantly taking <e1> aspirin </e1> or NSAIDs was similar in patients taking <e2> ibandronate </e2> 2.5 mg daily (21.7%) and 150 mg once monthly (22.0%) .	aspirin	ibandronate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , <e1> b-adrenergic blocking agents </e1> , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , <e2> phenytoin </e2> , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	b-adrenergic blocking agents	phenytoin
mechanism	 Similarly , <e1> ethanol </e1> decreased the rate of elimination of <e2> Antizol </e2> (by approximately 50%) by the same mechanism .	ethanol	Antizol
other	 If desipramine hydrochloride is to be combined with other <e1> psychotropic agents </e1> such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of <e2> desipramine </e2> and benzodiazepines (e.g. , chlordiazepoxide or diazepam ) are additive .	psychotropic agents	desipramine
mechanism	 Probenecid : <e1> Probenecid </e1> increases both free and bound <e2> ketoprofen </e2> by reducing the plasma clearance of ketoprofen to about one-third , as well as decreasing its protein binding .	Probenecid	ketoprofen
other	 Ritonavir - Combined administration of a single dose of <e1> ritonavir </e1> (600 mg) , both a CYP3A4 substrate and a potent inhibitor of CYP3A4 , and <e2> escitalopram </e2> (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram .	ritonavir	escitalopram
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; <e1> indomethacin </e1> ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; <e2> quinine </e2> ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	indomethacin	quinine
other	 Because of foscarnet s tendency to cause renal impairment , the use of FOSCAVIR should be avoided in combination with potentially nephrotoxic drugs such as <e1> aminoglycosides </e1> , amphotericin B and intravenous <e2> pentamidine </e2> unless the potential benefits outweigh the risks to the patient .	aminoglycosides	pentamidine
other	 Anticonvulsants : In a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term <e1> anticonvulsant </e1> therapy (eg , phenytoin , <e2> carbamazepine </e2> , or phenobarbital ) than in healthy volunteers .	anticonvulsant	carbamazepine
advise	 <e1> ZEBETA </e1> should be used with care when myocardial depressants or inhibitors of AV conduction , such as certain calcium antagonists (particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ <e2> diltiazem </e2> ] classes) , or antiarrhythmic agents , such as disopyramide , are used concurrently .	ZEBETA	diltiazem
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , <e1> perchlorate </e1> , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , <e2> ethionamide </e2> , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	perchlorate	ethionamide
other	 ACE Inhibitors and <e1> Angiotensin II Receptor Antagonists </e1> (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving <e2> INSPRA </e2> 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( ACEI / ARB ) .	Angiotensin II Receptor Antagonists	INSPRA
other	 Concomitant administration of an <e1> aluminum </e1> -containing antacid had no significant effect in the bioavailability of <e2> 6MNA </e2> .	aluminum	6MNA
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , <e1> cyclosporine </e1> ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and <e2> vitamin C </e2> .	cyclosporine	vitamin C
effect	 Risk of Anaphylactic Reaction : Although it is known that patients on <e1> beta-blockers </e1> may be refractory to <e2> epinephrine </e2> in the treatment of anaphylactic shock , beta-blockers can , in addition , interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks .	beta-blockers	epinephrine
other	 Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol , <e1> diltiazem </e1> , and <e2> verapamil </e2> .	diltiazem	verapamil
other	 These include probenecid , <e1> cholestyramine </e1> , and some antibiotics (e.g . <e2> erythromycin </e2> , rifamipicin , ampicillin and chloramphenicol ) .	cholestyramine	erythromycin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; <e1> amiodarone </e1> ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; <e2> ethacrynic acid </e2> ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	amiodarone	ethacrynic acid
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; <e1> monoamine oxidase inhibitors </e1> ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; <e2> sulfinpyrazone </e2> ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	monoamine oxidase inhibitors	sulfinpyrazone
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; <e2> methyldopa </e2> ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	methyldopa
other	 In addition , studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol (40 mg twice daily) , phenytoin , <e1> theophylline </e1> , or oral <e2> contraceptives </e2> .	theophylline	contraceptives
other	 Do not mix <e1> TORADOL </e1> and <e2> morphine </e2> in the same syringe .	TORADOL	morphine
effect	 Drug Interactions : The central anticholinergic syndrome can occur when DRUG0 agents such as <e1> AKINETON </e1> are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain <e2> narcotic analgesics </e2> such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .	AKINETON	narcotic analgesics
other	 cimetidine ) and many that are substrates for P450 2D6 (many other <e1> antidepressants </e1> , phenothiazines , and the <e2> Type 1C antiarrhythmics </e2> propafenone and flecainide ) .	antidepressants	Type 1C antiarrhythmics
other	 It is recommended that serum <e1> lithium </e1> levels be monitored frequently if <e2> enalapril </e2> is administered concomitantly with lithium .	lithium	enalapril
other	 Drugs which may enhance the neuromuscular blocking action of TRACRIUM include : enflurane ; isoflurane ; halothane ;certain antibiotics , especially the <e1> aminoglycosides </e1> and polymyxins ; lithium ; <e2> magnesium </e2> salts; procainamide ;and quinidine .	aminoglycosides	magnesium
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , <e1> antithyroid drugs </e1> , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , <e2> resorcinol </e2> , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	antithyroid drugs	resorcinol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1> chlorpropamide </e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; <e2> tolbutamide </e2> ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chlorpropamide	tolbutamide
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> EQUETROTM </e1> are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , <e2> nefazodone </e2> , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	EQUETROTM	nefazodone
other	 <e1> Amphotericin B </e1> or potassium-depleting diuretics ( benzothiadiazines and related drugs , <e2> ethacrynic acid </e2> and furosemide ) enhanced hypokalemia .	Amphotericin B	ethacrynic acid
other	 If <e1> desipramine hydrochloride </e1> is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of desipramine and benzodiazepines (e.g. , <e2> chlordiazepoxide </e2> or diazepam ) are additive .	desipramine hydrochloride	chlordiazepoxide
other	 - a <e1> monoamine oxidase inhibitor </e1> ( MAOI ) such as isocarboxazid ( Marplan ) , tranylcypromine ( Parnate ) , or phenelzine ( <e2> Nardil </e2> );	monoamine oxidase inhibitor	Nardil
other	 Etonogestrel may interact with the following medications : <e1> acetaminophen </e1> ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , <e2> Norvir </e2> , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	acetaminophen	Norvir
other	 Antimycobacterial Agents : rifampin CONTRAINDICATED since the coadministration of this product with <e1> saquinavir </e1> in an <e2> antiretroviral </e2> regimen reduces the plasma concentrations of saquinavir .	saquinavir	antiretroviral
other	 <e1> Antibiotics </e1> : In vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma <e2> cisapride </e2> levels and prolongation of the QT interval on the ECG .	Antibiotics	cisapride
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , <e1> Crixivan </e1> , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( <e2> Theo-Dur </e2> ) , and vitamin C .	Crixivan	Theo-Dur
advise	 The daily dose of <e1> ENABLEX </e1> should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g. , ketoconazole , itraconazole , <e2> ritonavir </e2> , nelfinavir , clarithromycin and nefazadone) .	ENABLEX	ritonavir
other	 Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some <e1> azoles </e1> and other drugs that are highly protein bound , <e2> salicylates </e2> , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	azoles	salicylates
other	 Effects of Felbatol on Low-Dose <e1> Combination Oral Contraceptives </e1> A group of 24 nonsmoking , healthy white female volunteers established on an oral <e2> contraceptive </e2> regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle (day 15) to midcycle (day 14) of two consecutive oral contraceptive cycles .	Combination Oral Contraceptives	contraceptive
effect	 These results suggest that the analgesic effect of <e1> STADOL NS </e1> may be diminished when it is administered shortly after <e2> sumatriptan </e2> nasal spray , but by 30 minutes any such reduction in effect should be minimal .	STADOL NS	sumatriptan
mechanism	 Quinolone Antibiotic s : VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of <e1> ciprofloxacin </e1> are decreased when administered with antacids containing magnesium , calcium , or <e2> aluminum </e2> .	ciprofloxacin	aluminum
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; <e1> bromelains </e1> ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; <e2> diazoxide </e2> ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	bromelains	diazoxide
other	 Valproate : Available data suggest that there is no significant effect of <e1> valproate </e1> on the clearance of Felbatol at steady state , Therefore , the addition of valproate is not expected to cause a clinically important effect on <e2> Felbatol </e2> ( felbamate ) plasma concentrations .	valproate	Felbatol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; <e1> influenza virus vaccine </e1> ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e2> triclofos sodium </e2> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	influenza virus vaccine	triclofos sodium
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , <e1> cyclosporin </e1> , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , <e2> risperidone </e2> , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	cyclosporin	risperidone
advise	 If you are also using a steroid inhaler , take <e1> bitolterol </e1> first and then wait about 15 minutes before using the <e2> steroid </e2> inhaler .	bitolterol	steroid
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , <e1> sympathomimetic agents </e1> (e.g. , epinephrine , albuterol , <e2> terbutaline </e2> ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	sympathomimetic agents	terbutaline
other	 Blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by <e1> non-steroidal antiinflammatory drugs </e1> including <e2> INDOCIN </e2> has been reported .	non-steroidal antiinflammatory drugs	INDOCIN
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus <e1> bleomycin </e1> ) without receiving <e2> antiretroviral </e2> therapy .	bleomycin	antiretroviral
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , <e1> amiodarone </e1> , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , H2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , <e2> sulfonamides </e2> , tolbutamide , trazodone	amiodarone	sulfonamides
other	 Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics (acidic) or propranolol (basic) , as well as tetracycline penicillin G , <e1> phenobarbital </e1> , thyroid and <e2> thyroxine </e2> preparations , estrogens and progestins , and digitalis .	phenobarbital	thyroxine
other	 Quinolones , including <e1> nalidixic acid </e1> , may enhance the effects of the oral <e2> anticoagulant </e2> warfarin or its derivatives .	nalidixic acid	anticoagulant
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of EQUETROTM are the following : Acetazolamide , azole antifungals , cimetidine , clarithromycin (1) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin (1) , <e1> fluoxetine </e1> , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , <e2> protease inhibitors </e2> , propoxyphene , quinine , quinupristin , troleandomycin , valproate (1) , verapamil , zileuton .	fluoxetine	protease inhibitors
effect	 <e1> Midazolam </e1> used at doses of 1.25 mg/kg and 2.5 mg/kg decreased the antinociceptive effect of morphine , <e2> metamizol </e2> (only in the tail-flick test) and indomethacin .	Midazolam	metamizol
other	 These drugs include the thiazides and other diuretics , corticosteroids , <e1> phenothiazines </e1> , thyroid products , estrogens , oral contraceptives , phenytoin , <e2> nicotinic acid </e2> , sympathomimetics , calcium channel blocking drugs , and isoniazid .	phenothiazines	nicotinic acid
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , <e1> Nizoral </e1> , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as <e2> protease inhibitors </e2> ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Nizoral	protease inhibitors
advise	 Due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine -containing or <e1> ergot-type medications </e1> (like dihydroergotamine or methysergide ) and <e2> FROVA </e2> within 24 hours of each other should be avoided (see a href= frova_od.htm#CI CONTRAINDICATIONS) .	ergot-type medications	FROVA
other	 Exposed histidines on toxin A are available for <e1> zinc </e1> chelation , and these have been exploited in the development of a novel purification protocol for <e2> toxin A </e2> using zinc -chelating chromatography .	zinc	toxin A
effect	 Although neither dexamethasone nor <e1> retinyl acetate </e1> affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone , they modify the mitogenic effect of <e2> EGF </e2> and insulin .	retinyl acetate	EGF
other	 Therefore , interactions could occur following concomitant administration of <e1> psychotropic drugs </e1> (e.g. , narcotics , analgesics , <e2> antiemetics </e2> , sedatives , tranquilizers ) .	psychotropic drugs	antiemetics
other	 Other Drugs : In healthy volunteers , <e1> amlodipine </e1> , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy (a combination of conjugated <e2> estrogens </e2> and medroxyprogesterone ) , antacid DRUG0 and magnesium hydroxide s) and theophylline did not affect the pharmacokinetics of TIKOSYN .	amlodipine	estrogens
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , <e1> insulin </e1> , iodinated cholestographic agents , iodine-containing compounds , <e2> levodopa </e2> , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	insulin	levodopa
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; <e1> allopurinol </e1> ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e2> phenyramidol </e2> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	allopurinol	phenyramidol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; <e1> cinchophen </e1> ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; <e2> mefenamic acid </e2> ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	cinchophen	mefenamic acid
other	 Drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol *; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate *; chlordiazepoxide ; cholestyramine ;diet high in vitamin K ; diuretics *; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; <e1> meprobamate </e1> ;oral contraceptives ; paraldehyde ; primidone ; ranitidine *; rifampin ;unreliable prothrombin time determinations; <e2> vitamin C </e2> ; warfarin sodium under-dosage .	meprobamate	vitamin C
other	 Bentiromide may interact with acetaminophen (e.g. , Tylenol ) , <e1> chloramphenicol </e1> (e.g. , Chloromycetin ) , local anesthetics (e.g. , benzocaine and lidocaine ) , para-aminobenzoic acid ( PABA )-containing preparations (e.g. , sunscreens and some <e2> multivitamins </e2> ) , procainamide (e.g. , Pronestyl ) , sulfonamides (sulfa medicines) , thiazide diuretics (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) .	chloramphenicol	multivitamins
mechanism	 therefore , it is theoretically possible that <e1> lansoprazole </e1> may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g . ketoconazole , ampicillin esters , <e2> iron </e2> salts , digoxin ) .	lansoprazole	iron
other	 Increased plasma concentrations of <e1> terfenadine </e1> , astemizole , and <e2> cisapride </e2> cause QT prolongation and have been associated with torsades de pointes-type ventricular tachycardia , sometimes fatal .	terfenadine	cisapride
mechanism	 Co-administration of <e1> ketoconazole </e1> , a strong inhibitor of CYP3A4 , increased <e2> cinacalcet </e2> exposure following a single 90 mg dose of Sensipar by 2.3 fold .	ketoconazole	cinacalcet
other	 <e1> Dopamine D2 receptor antagonists </e1> (e.g. , phenothiazines , <e2> butyrophenones </e2> , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .	Dopamine D2 receptor antagonists	butyrophenones
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , <e1> Phenobarbital </e1> , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( <e2> Astramorph </e2> , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	Phenobarbital	Astramorph
other	 <e1> 5HT3 Antagonists </e1> : Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the <e2> 5HT3 antagonist class </e2> (including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .	5HT3 Antagonists	5HT3 antagonist class
advise	 Close supervision and careful adjustment of dosage are required when <e1> Anafranil </e1> is administered with anticholinergic or <e2> sympathomimetic drugs </e2> .	Anafranil	sympathomimetic drugs
other	 In vitro studies indicate CYP3A4 isoform and CYP1A2 isoform mediate the metabolism of levobupivacaine to <e1> desbutyl levobupivacaine </e1> and <e2> 3-hydroxy levobupivacaine </e2> , respectively .	desbutyl levobupivacaine	3-hydroxy levobupivacaine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , <e1> amiodarone </e1> , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , <e2> metoclopramide </e2> , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	amiodarone	metoclopramide
other	 The serum concentration of <e1> phenytoin </e1> increased dramatically from 16.6 to 49.1 microg/mL when <e2> fluvoxamine </e2> was coadministered , although the daily dosage of phenytoin and other drugs had not changed .	phenytoin	fluvoxamine
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , <e1> sympathomimetic agents </e1> (e.g. , epinephrine , <e2> salbutamol </e2> , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens (e.g. , in oral contraceptives ) .	sympathomimetic agents	salbutamol
other	 acetaminophen / <e1> theophylline </e1> , lidocaine / quinidine , phenobarbital / acetaminophen , phenobarbital / valproic acid , quinidine / <e2> lidocaine </e2> , theophylline / acetaminophen , and valproic acid / phenobarbital .	theophylline	lidocaine
other	 <e1> Cimetidine </e1> : In a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of <e2> isradipine </e2> on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%) .	Cimetidine	isradipine
other	 - <e1> Cholestyramine </e1> and colestipol resins : Cholestytamine and <e2> colestipol </e2> resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract	Cholestyramine	colestipol
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , <e1> ethionamide </e1> , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , <e2> iodine-containing compounds </e2> , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	ethionamide	iodine-containing compounds
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , <e1> heparin </e1> , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , <e2> lovastatin </e2> , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .	heparin	lovastatin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( <e1> Agenerase </e1> , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and <e2> vitamin C </e2> .	Agenerase	vitamin C
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; <e1> diflunisal </e1> ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; <e2> glucagon </e2> ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	diflunisal	glucagon
other	 In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , <e1> nifedipine </e1> , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of <e2> fosinopril </e2> with any one of these drugs .	nifedipine	fosinopril
other	 <e1> Antidiabetic drugs </e1> : (oral agents and insulin ) - dosage adjustment of the <e2> antidiabetic drug </e2> may be required .	Antidiabetic drugs	antidiabetic drug
other	 Concurrent administration of <e1> indinavir </e1> and didanosine significantly reduces the level of exposure to indinavir , but it is unclear how soon after <e2> didanosine </e2> administration indinavir may be given safely .	indinavir	didanosine
other	 If desipramine hydrochloride is to be combined with other psychotropic agents such as <e1> tranquilizers </e1> or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of desipramine and benzodiazepines (e.g. , <e2> chlordiazepoxide </e2> or diazepam ) are additive .	tranquilizers	chlordiazepoxide
other	 The availability of potent <e1> non-nucleoside reverse transcriptase inhibitor </e1> ( NNRTI )-based regimens for antiretroviral therapy and concerns regarding protease inhibitor ( <e2> PI </e2> )-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	non-nucleoside reverse transcriptase inhibitor	PI
advise	 Therefore , <e1> ketoconazole </e1> should be administered with caution with intranasal <e2> ciclesonide </e2> .	ketoconazole	ciclesonide
other	 Erythromycin and clarithromycin (and possibly other <e1> macrolide antibiotics </e1> ) and <e2> tetracycline </e2> may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .	macrolide antibiotics	tetracycline
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , antibiotics such as ampicillin and tetracycline , <e1> anticonvulsants </e1> ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , clofibrate ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , <e2> rifadin </e2> ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	anticonvulsants	rifadin
effect	 Hypotension : Patients on Diuretic Therapy : Patients on <e1> diuretics </e1> and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or <e2> enalaprilat </e2> .	diuretics	enalaprilat
other	 Concomitant administration of FACTIVE and <e1> calcium carbonate </e1> , cimetidine , omeprazole , or an <e2> estrogen </e2> / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .	calcium carbonate	estrogen
other	 Concomitant cyclophosphamide , <e1> doxorubicin </e1> , vincristine , and prednisone chemotherapy plus <e2> highly active antiretroviral </e2> therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	doxorubicin	highly active antiretroviral
other	 Interactions with Other CNS Agents : Concurrent use of Levo-Dromoran with all central nervous system depressants (eg , alcohol , sedatives , <e1> hypnotics </e1> , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , <e2> phenothiazines </e2> , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .	hypnotics	phenothiazines
other	 Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of <e1> fosinoprilat </e1> as compared with fosinopril administered alone , suggesting that <e2> antacids </e2> may impair absorption of fosinopril .	fosinoprilat	antacids
mechanism	 Drugs that induce hepatic enzymes such as <e1> phenobarbital </e1> , phenytoin and rifampin may increase the clearance of <e2> corticosteroids </e2> and may require increases in corticosteroid dose to achieve the desired response .	phenobarbital	corticosteroids
int	 Therefore , <e1> linezolid </e1> has the potential for interaction with adrenergic and <e2> serotonergic agents </e2> .	linezolid	serotonergic agents
other	 <e1> Anticonvulsants </e1> : carbamazepine , phenobarbital , <e2> phenytoin </e2>	Anticonvulsants	phenytoin
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1> dextrothyroxine </e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; <e2> ibuprofen </e2> ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextrothyroxine	ibuprofen
advise	 Hypersensitivity Reactions : Patients with a history of severe hypersensitivity reactions to products containing Cremophor EL (eg , cyclosporin for injection concentrate and <e1> teniposide </e1> for injection concentrate) should not be treated with <e2> TAXOL </e2> .	teniposide	TAXOL
other	 MAO inhibitors , <e1> narcotic analgesics </e1> (e.g. , meperidine ) , nitrates and <e2> nitrites </e2> , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .	narcotic analgesics	nitrites
other	 Other Drugs : In healthy volunteers , <e1> amlodipine </e1> , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone ) , antacid DRUG0 and magnesium hydroxide s) and theophylline did not affect the pharmacokinetics of <e2> TIKOSYN </e2> .	amlodipine	TIKOSYN
other	 <e1> Butyrophenones </e1> (such as <e2> haloperidol </e2> ) and phenothiazines can suppress the dopamine rgic renal and mesenteric vasodilation induced with low dose DRUG0 infusion .	Butyrophenones	haloperidol
other	 In a study involving healthy subjects receiving <e1> TAMBOCOR </e1> and propranolol concurrently , plasma flecainide levels were increased about 20% and <e2> propranolol </e2> levels were increased about 30% compared to control values .	TAMBOCOR	propranolol
other	 Animals dosed with <e1> 1,3-difluoroacetone </e1> did not display the 2-3 hour lag phase in either <e2> (-)-erythro-fluorocitrate </e2> synthesis or in citrate and fluoride accumulation characteristic of animals dosed with 1,3-difluoro-2-propanol .	1,3-difluoroacetone	(-)-erythro-fluorocitrate
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , anticoagulants ( blood thinner s) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines) , central nervous system (CNS) depressants (using these medicines with <e1> barbiturates </e1> may result in increased CNS depressant effects) , divalproex sodium , valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take) , and oral <e2> contraceptives </e2> containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control) .	barbiturates	contraceptives
other	 - a nonsteroidal anti-inflammatory drug ( NSAID ) such as <e1> ibuprofen </e1> ( Motrin , Advil , Nuprin , others) , ketoprofen ( Orudis , Orudis KT , Oruvail ) , diclofenac ( Voltaren , Cataflam ) , etodolac ( Lodine ) , indomethacin ( Indocin ) , nabumetone ( Relafen ) , oxaprozin ( Daypro ) , and <e2> naproxen </e2> ( Anaprox , Naprosyn , Aleve );	ibuprofen	naproxen
other	 Hormonal Contraceptives , Including Oral , Injectable , Transdermal , and Implantable Contraceptives : An interaction study demonstrated that co-administration of <e1> bosentan </e1> and the oral hormonal contraceptive Ortho-Novum produced average decreases of <e2> norethindrone </e2> and ethinyl estradiol levels of 14% and 31% , respectively .	bosentan	norethindrone
other	 <e1> Quinolone Antibiotic </e1> s : VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing <e2> magnesium </e2> , calcium , or aluminum .	Quinolone Antibiotic	magnesium
other	 <e1> Cimetidine </e1> - In subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in <e2> citalopram </e2> AUC and Cmax of 43% and 39% , respectively .	Cimetidine	citalopram
other	 Clozapine may potentiate the hypotensive effects of <e1> antihypertensive drugs </e1> and the anticholinergic effects of <e2> atropine </e2> -type drugs .	antihypertensive drugs	atropine
other	 Probenecid : As with other b-lactam antibiotics , co-administration of probenecid with <e1> cefditoren pivoxil </e1> resulted in an increase in the plasma exposure of <e2> cefditoren </e2> , with a 49% increase in mean Cmax , a 122% increase in mean AUC , and a 53% increase in half-life .	cefditoren pivoxil	cefditoren
mechanism	 Cytochrome P-450 inducers , such as phenytoin , carbamazepine and <e1> phenobarbital </e1> , induce <e2> clonazepam </e2> metabolism , causing an approximately 30% decrease in plasma clonazepam levels .	phenobarbital	clonazepam
other	 Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs : Alcohol : When <e1> Duloxetine </e1> and ethanol were administered several hours apart so that peak concentrations of each would coincide , Duloxetine did not increase the impairment of mental and motor skills caused by <e2> alcohol </e2> .	Duloxetine	alcohol
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; <e1> chlorpropamide </e1> ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; <e2> triclofos sodium </e2> ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	chlorpropamide	triclofos sodium
other	 HMG-CoA Reductase Inhibitors : Simvastatin ( <e1> CYP3A4 </e1> substrate) in combination with <e2> amiodarone </e2> has been associated with reports of myopathy/rhabdomyolysis .	CYP3A4	amiodarone
other	 Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of <e1> citalopram </e1> and <e2> digoxin </e2> (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin .	citalopram	digoxin
other	 Etonogestrel may interact with the following medications : acetaminophen ( Tylenol ) , <e1> antibiotics </e1> such as ampicillin and tetracycline , anticonvulsants ( Dilantin , Phenobarbital , Tegretol , Trileptal , Topamax , Felbatol ) , antifungals ( Gris-PEG , Nizoral , Sporanox ) , atorvastatin ( Lipitor ) , <e2> clofibrate </e2> ( Atromid-S ) , cyclosporine ( Neoral , Sandimmune ) , HIV drugs classified as protease inhibitors ( Agenerase , Crixivan , Fortovase , Invirase , Kaletra , Norvir , Viracept ) , morphine ( Astramorph , Kadian , MS Contin ) , phenylbutazone , prednisolone ( Prelone ) , rifadin ( rifampin ) , St . Johns wort , temazepam , theophylline ( Theo-Dur ) , and vitamin C .	antibiotics	clofibrate
other	 Drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol *; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate *; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; <e1> dextrothyroxine </e1> ; diazoxide ;dietary deficiencies; diflunisal ; disulfiram ;drugs affecting blood elements; ethacrynic acid ; fenoprofen ; glucagon ;hepatotoxic drugs; ibuprofen ; indomethacin ; influenza virus vaccine ;inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; <e2> phenyramidol </e2> ; phenytoin ;prolonged hot weather; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine *; salicylates ; sulfinpyrazone ; sulfonamides , long acting; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ;unreliable prothrombin time determinations; warfarin sodium overdosage .	dextrothyroxine	phenyramidol
other	 <e1> Probenecid </e1> : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , <e2> benzodiazepines </e2> , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .	Probenecid	benzodiazepines
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following : Acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , <e1> desipramine </e1> , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral <e2> contraceptives </e2> (3) , oxcarbazepine , Phenytoin (4) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin (5) , ziprasidone , and zonisamide .	desipramine	contraceptives
effect	 It is concluded that <e1> ketamine </e1> is not a short-acting drug and that concomitant use with <e2> halothane </e2> would be expected to prolong further the duration of its action on the central nervous system .	ketamine	halothane
